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ABSTRACT 
Helminths are paraphyletic group of parasitic metazoans that collectively consist of the 
nematodes, trematodes, cestodes and platyhleminthes. Helminth infections are 
characterized, amongst other things, by IL -4 and IL -13 production from CD4' Th2 cells. IL -4 
and IL -13 induce alternatively activated macrophages (AAMO) via their action on the IL -4Ra 
receptor subunit. AAMO are also implicated in numerous other diseases such as fibrosis, 
allergy, cancer and diabetes. 
STAT6 drives IL -4Ra- dependent transcription in AAMC , leading to the induction of many 
genes including Arg -1, YM1 and RELMa. IL -4 also induces macrophage proliferation, a 
phenotype observed in vivo, but not in vitro. In vitro studies have shown that IL -4 up- 
regulates macrophage mitochondria) metabolism in a process dependent upon the Iigand- 
dependent transcription factor PPARy (peroxisome proliferator activator receptor gamma). 
In spite of the far -reaching effects of IL -4 on macrophage biology and physiology, we are 
unaware of the true role(s) of AAMCD during helminth infection. 
In this thesis I present two transcriptomic analyses of macrophage responses to filarial 
nematode infection. In the first case we define IL -4Ra- dependent components of the 
macrophage response to nematode infection. Using RNA -Seq, WT and IL- 4Ra -/- mice 
implanted with the parasitic nematode Brugia malayi are compared against inflammatory - 
like thioglycollate- elicited macrophages. This has allowed us to infer an anti -inflammatory 
phenotype for nematode -elicited macrophages (NeMO) in vivo. We also identify an 
unanticipated role for NeMD in the production of complement components in response to 
B. malayi challenge. During this project I develop a method to map transcription start site 
(TSS) usage with RNA -Seq data, this algorithm has been developed into the software 'TSS- 
Predictor' and is presented in chapter 3. Using TSS- Predictor we define TSS usage in our 
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RNA -Seq dataset, and a subsequent analysis of transcription factor binding sites in AAMCD- 
associated promoters confirms a role for PPARs in AAMCD in vivo. Furthermore, we find that 
PPAR6, but not PPARy is expressed during helminth infection. A targeted lipid analysis of 
macrophage- derived eicosanoids identified prostacyclin (PGI2) as a candidate ligand to 
mediate PPARS- dependent transcription in NeMCD during helminth infection in vivo. 
Finally, we integrate flow cytometry and a microarray gene expression profiling in a time 
series of macrophages elicited in response to the parasitic nematode Litomosoides 
sigmodontis. We capitalize on the discordant kinetics of alternative activation and 
proliferation in this model to define gene expression signatures associated with 
proliferation and AAMCp. Based upon this analysis we present a working model for IL -4- 
dependent macrophage proliferation in vivo and characterize candidate receptors 
mediating this process. We also demonstrate in vivo that AAMCp increase mitochondrial 
mass in response to L. sigmodontis infection. 
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1 INTRODUCTION 
Li OVERVIEW OF THESIS 
Macrophages are workhorses of the innate immune system and serve as both sentinels to 
detect disease, mediate inflammatory responses via the production of cytokines, and also 
clear invading pathogens via phagocytosis (Taylor et al., 2005). It is clear that macrophages 
play a role in the response to helminth infection, a paraphyletic grouping of parasitic 
nematodes, trematodes and cestodes. In response to helminth infections, activated T -cells 
produce IL -4 which stimulates macrophages to undergo alternative activation (Kopf et al., 
1993; Stein et al., 1992). Alternatively activated macrophages (AAMcD) are associated with 
the induction of a distinct gene expression repertoire, and are characterized by up- 
regulated expression of genes including Arg -1, YM1 and RELMa (Loke et al., 2002). IL -4 has 
also recently been described to induce macrophage proliferate in vivo, and helminth 
infection is associated with a large expansion of the resident tissue macrophage population 
(Jenkins et al., 2011). 
Although macrophages proliferate and undergo unique changes in gene expression in 
response to IL -4 in vivo, we are unaware of the role(s) of AAMN in helminth infection. 
Furthermore, IL -4 does not induce macrophage proliferation in vitro, and the molecular 
mechanisms driving IL -4- dependent macrophage proliferation remain uncharacterized. In 
this thesis I apply transcriptomics approaches to address these issues. Firstly, we perform 
an RNA -Seq analysis of AAMO elicited with the parasitic nematode Brugia malayi in both 
WT and IL -4Ra /- mice. This study provided us with an unprecedented depth and quality of 
transcriptomic information for in vivo -polarized AAMO, and has allowed us to define IL- 
4Ra- dependent gene expression profiles, metabolic pathways, and transcriptional 
regulatory mechanisms underpinning AAMO in vivo. Secondly, we integrate flow cytometry 
and microarray data in a time course analysis of the helminth infection Litomosoides 
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sigmodontis (Allen et al., 2008). The experiment that we present has allowed us to 
delineate transcriptional repertoires associated with macrophage proliferation and 
alternative activation by capitalizing on the discordant kinetics of these processes during 
the response to L. sigmodontis infection. I present hypotheses regarding AAMO function 
and regulation during filarial nematode infections, and present a working model for IL -4- 
dependent macrophage proliferation in vivo. My introduction begins with an overview of 
the innate immune system and macrophage biology, and is followed by an overview of the 
transcriptomic technologies and data analysis techniques used in this thesis. 
1.2 MACROPHAGES AND THE INNATE IMMUNE SYSTEM 
1.2.1 THE INNATE IMMUNE SYSTEM 
A challenge faced by all animals is the requirement for protection from an invading parasitic 
challenge. The innate immune system evolved to identify and eliminate offending foreign 
materials. The mammalian innate immune system is composed of multiple overlapping 
cellular and humoral components that interact to oversee the removal or control of a 
pathogen and the restoration of homeostasis. Any immune response has to be both specific 
and appropriate, while at the same time minimizing damage to surrounding host tissue. 
Broadly speaking, the response to all pathogens involves the same set of processes. Non - 
self- antigen is first recognised by tissue -resident immune cells or stromal cells based upon 
the presence of pathogen associated molecular patterns (PAMPS). PAMPS are generic 
chemical moieties that are non -self but are reliably associated with unwanted intruders 
(Janeway, 1989). These include, for example, lipopolysaccharide (LPS), a major constituent 
of the surface of gram- negative bacteria. PAMPS are detected by resident tissue immune 
sentinels and stromal cells by pattern recognition receptors (PRRs). PRRs are ubiquitously 
13 
represented around the body and include, but are not restricted to, receptors of the toll 
like receptor (TLR), nod -like receptor (NOD) and C -type lectin families (Cambi and Figdor, 
2003; Kanneganti et al., 2007; Kawai and Akira, 2010). 
When accompanied by a 'danger signal' PRR ligation leads to the initiation of an 
inflammatory response. The type of non -self detected, and both the nature and severity of 
the accompanying 'danger signal' provides crucial information to prompt an appropriate 
response (Gallucci and Matzinger, 2001). An appropriate response is mediated via the 
production of a cocktail of chemokines, cytokines and small molecule inflammatory 
mediators. These 'immune effectors' shape the subsequent cellular recruitment and 
activation profile. Chemotactic cytokines, chemokines, operate via endocrine and paracrine 
mechanisms to bring about the recruitment of leukocytes to sites of inflammation. Effector 
cell subsets such as neutrophils, eosinophils and monocytes are mobilized into the blood 
from distant sites such as the bone marrow (BM) and spleen via the interaction between 
circulating chemokines and cytokines and their cell surface receptors (Moser et al., 2004). 
Effector cells are subsequently recruited to sites of inflammation through paracrine 
functions of immune effector molecules. This inflammatory cascade leads to the 
modulation of integrin and adhesin expression on vascular epithelial cells, facilitating the 
recruitment of blood -borne immune cells to an afflicted area (Ley et al., 2007). At the 
infection site cytokines dictate the polarization and subsequent activity of both recruited 
and resident immune cells, which ordinarily leads to the coordinated destruction and 
clearance of invading pathogens and /or recruitment of successor waves of inflammatory 
components. The activities of the innate immune system occur in conjunction with an 
adaptive arm of immunity, which is initiated by the innate immune system and serves to 
direct innate immune function. The adaptive immune system is educated to recognise 
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specific pathogenic antigens via prior exposure, and accelerates the response to secondary 
exposure via the activity of helper T -cell, and antibody- mediated B -cell responses. 
1.2.2 COMPLEMENT IN INNATE IMMUNITY 
The cellular players of innate immunity system operate alongside humoral components, 
most notably the complement pathway. The complement system is a highly conserved 
pathway of proteases that circulate in the blood in their inactive forms. The central 
component of the complement cascade C3 is cleaved and activated by upstream proteases 
belonging to either the classical, alternative or mannose binding lectin (MBL) complement 
pathways (Gasque, 2004). C3 is cleaved by a 'C3 convertase' protease to release the C3b 
sub -unit, C3b binds covalently to the invading foreign body, and initiates a cascade of 
proteolytic cleavage events that culminate in the formation of the 'membrane attack 
complex' (MAC), reviewed in (Walport, 2001). This pore- forming protein assemblage is 
microbicidal, and MAC formation is accompanied by the production of multiple opsonins 
that promote phagocytosis, the primary function of the complement system. In addition to 
the opsonisation -promoting intermediaries of the MAC, peptide cleavage products of the 
complement pathway also act as cytokines and chemokines in their own right (Carroll, 
2004). 
Over 30 proteins are involved in the activation and regulation of the complement cascade, 
and a comprehensive overview is beyond the scope of this introduction, for the inclined I 
would recommend the following two reviews (Carroll, 2004; Walport, 2001). Three 
pathways lead to the formation of the C3 convertase complexes to activate the 
complement cascade. The first to be discovered (but last to arise in evolutionary terms) is 
the classical, Cl, pathway. This is induced by the recognition of antigen -bound antibody 
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complexes by a complex of Clq C1r and Cis proteins. Secondly, the mannose- binding lectin 
(MBL) pathway is involved in the identification of polysaccharides and is activated by the 
interaction of carbohydrate- engaged mannose- binding lectin (Mbl1 or Mb12) or ficolin (Fcna 
or Fcnb) proteins (Gasque, 2004). Lastly, the alternative pathway, is constitutively active in 
blood plasma and serves primarily as a positive feedback loop to amplify C3 conversion 
initiated by either the Cl or MBL pathways. 
1.2.3 MACROPHAGES 
Macrophages are the workhorses of the innate immune system. These professional 
phagocytes are found in all body tissues and play crucial roles in both the maintenance of 
homeostasis and in the initiation and resolution of inflammatory responses. They 
abundantly express PRRs, including TLRs and, thus are poised to detect invading pathogens 
and form a first line of defence against disease (Taylor et al., 2005). They also express 
complement receptors and Fc -gamma receptors (FcyR) to facilitate the uptake of 
complement- and antibody -bound particles respectively (Aderem and Underhill, 1999). 
Upon stimulation by invading microbial pathogens, macrophages phagocytose and destroy 
bacteria via the production of nitric oxide (NO). In parallel they produce inflammatory 
cytokines and chemokines such as TNFa, IL6, IL12, CCL2 and CCL5 and up- regulate 
expression of major histocompatibility complex (MHC) genes (Ogawa et al., 2005). Thus 
macrophages detect, engulf and destroy invading pathogens whilst acting to instruct and 
direct both adaptive and innate immune responses. As professional phagocytes 
macrophages are much more than innate immune cells. They are essential for the clearance 
of apoptotic cells and instruct regeneration following injury (Mantovani et al., 2013; 
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Mukundan et al., 2009) and this endows macrophages with an essential role in the 
development and in the maintenance of homeostasis. 
Macrophages are myeloid- derived cells and until recently most tissue macrophages (with 
the exception of microglia and Langerhans cells) were believed to originate solely from 
bone marrow -derived monocytes. A seminal publication from the Geissmann laboratory 
has recently overturned this dogma, showing that populations of tissue -resident 
macrophages arise from embryonic yolk sac precursors (Schulz et al., 2012). All 
macrophages are dependent on either colony stimulating factor 1 (CSF -1, Csfl, (Cecchini et 
al., 1994)) or IL -34 for their development (Wang et al., 2012). Both CSF -1 and IL -34 act 
through the CSF -1 receptor (CD115, Csflr) to drive the proliferation, maturation and 
survival of macrophages and their precursors (Hume and MacDonald, 2012). Typically 
mouse macrophages can be defined and easily distinguished by flow cytometry (FACS) 
through the expression of the surface markers CD11b, CD115 and F4/80, however, surface 
marker expression profiles do change depending upon the tissue analysed (Gautier et al., 
2012). In many tissues, including the serous cavities, which are the focus of this thesis, 
macrophages can be identified using FACS on the basis of surface F4/80 expression in 
conjunction with scatter profiles to determine cell size. 
In vivo macrophage populations inhabiting different tissues show a tremendous degree of 
diversity both transcriptionally and functionally (Gautier et al., 2012; Qian and Pollard, 
2010). This likely reflects a combination of differences in the developmental histories and 
micro -environmental cues received by different macrophage populations. The extent to 
which macrophage heterogeneity is explained by the irreversible terminal differentiation of 
'mature' CSF -1- derived macrophages within tissues, or reflects a reversible phenotypic 
plasticity remains unresolved. Understanding the diversity of macrophage populations in 
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vivo, and their developmental and functional relationships represents one of the major 
challenges in myeloid cell biology today (Hashimoto et al., 2011). 
t2.4 HELMINTH INFECTION AND TH2 IMMUNITY 
Helminths are a polyphyletic group of metazoan parasites that includes members of the 
phyla Nematoda and Platyhelminthes (Classes Trematoda and Cestoda). Although 
polyphyletic, 'helminth' provides a convenient nomenclature as these parasites elicit 
broadly similar immune responses in their mammalian hosts (Allen and Maizels, 2011). It is 
estimated that one third of the global population are infected by helminths (Hotez et al., 
2008) with the most common being the gastro -intestinal infections of hookworm and 
roundworm (Hall et al., 2008). Helminths are also the causative agents of multiple diseases 
including elephantiasis (lymphatic filariasis), river blindness (onchocerciasis) and 
schistosomiasis (Chitsulo et al., 2000; Davies, 1994; Evans et al., 1993). A notable feature of 
helminth parasites are their lifecycles, which typically involve a juvenile developmental 
stage occurring within an intermediate non -vertebrate host (Allen and Maizels, 2011). This 
intermediate host serves as a vector for the transmission of the parasite between 
mammalian hosts. 
Numerous metazoan parasites of rodents have been developed that collectively model the 
range of helminth diseases afflicting humans, and other hosts of veterinary and agricultural 
importance. Mouse models for gut -dwelling nematode parasites include Heligmosomoides 
polygyrus and Nippostrongylus braziliensis (Maizels et al., 2009). The human parasitic liver 
fluke Schistosoma monsoni readily infects mice, and is used in rodents as a model for itself 
(Pearce and MacDonald, 2002). Filarial nematodes, the focus of attention in the Allen 
laboratory and within this thesis, are also modelled by a human parasite, Brugia malayi 
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(McSorley and Maizels, 2012). The infective L3 stage of B. malayi, the stage transmitted 
from the arthropod vector to the mammalian host, does not readily transit from L3 to adult 
worm within mice. However the Mongolian Jird, Meriones unguiculatus, is able to serve as 
an intermediary for this process. Adult B. malayi are extracted from the peritoneal cavity of 
the Jird, and are subsequently implanted into the peritoneal cavity of mice. This is the B. 
malayi model of lymphatic filariasis and is an effective tool to study immune responses to 
the adult stage of infection as well as their accompanying microfilarial output (Lawrence et 
al., 1994). 
A more recently developed model for lymphatic filariasis and Onchocerciasis is 
Litomosoides sigmodontis. This natural parasite of the cotton rat, Sigmodon hispidius, has 
the advantage of developing from the infective L3 to adult worm within mice (Allen et al., 
2008). Furthermore, depending on the host mouse strain, L. sigmodontis may undergo a 
complete life cycle to produce microfilariae. The transmission stage is reached in the 
susceptible BALB /c strain, but adult L. sigmodontis are killed prior to the onset of sexual 
maturity ("j day 50 P.I) in the resistant C57BL/6 strain (Le Goff et al., 2002). Thus, L. 
sigmodontis serves as a model to study both the initiation of immune responses to filarial 
nematode infections, as well as immune mechanisms of resistance and susceptibility. 
Helminths have coevolved with their hosts, show remarkable host specificity and in some 
cases they can live within their hosts for many years (Plotkin et al., 2008). This is 
accomplished via the evasion and active suppression of the host immune system. Helminths 
are masters of both these processes (McSorley and Maizels, 2012). Helminth 
immunosuppression has evolved to counteract protective host responses (which are 
typically Th2 in nature) and is characterized by the emergence of mast cells, eosinophils, 
basophils and alternatively activated macrophages (AAMO, see below). Th2 type responses 
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are defined by the production of the cytokines IL -3, IL -4, IL -5, IL -9, IL -10 and IL -13 which 
drive the above innate -type responses and require the activity of CD4+ Th2 cells (Allen and 
Maizels, 2011). 
Th1 response- inducing microbes can easily be engulfed by phagocytes and destroyed via 
the production of proinflammatory intermediates. However, this is not an appropriate 
strategy to deal with the threat of invading metazoan parasites, although Th1 inflammatory 
responses may effectively kill helminths, these parasites are far too large to be engulfed by 
phagocytes. It is proposed that collateral tissue damage would bear too greater cost on 
host fitness for Th1 -type anti -helminthic immunity to represent an evolutionarily stable 
strategy (Allen and Wynn, 2011). Rather Th2 immunity, in addition to protecting against 
worm infection, is proposed to facilitate tissue repair, indeed, IL -4 and AAMCD facilitate 
effective wound healing following colonic punch biopsy (Seno et al., 2009). 
The robust induction of Th2 immunity in helminth infection requires the activity of CD4 +T - 
cells, however the initial 'danger signals' associated with infection, and required to induce 
the adaptive response, remain elusive. Helminths themselves may be adorned with PAMPS 
which betray their identity to their hosts, and the identification and characterization of 
immunogenic helminth products is underway (Hewitson et al., 2008). It is also proposed 
that damage itself may serve as the danger signal to initiate the innate immune reaction 
that initiates the Th2 response. Indeed IL -33, a cytokine released by dying epithelial cells, 
augments Th2 responses, in particular alternative macrophage activation (Kurowska- 
Stolarska et al., 2009). 
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1.2.5 AA M CD 
The Th2 cytokines IL -4 and IL -13 polarize macrophages towards a state of 'alternative 
activation' (AAMc). In contrast to classically activated macrophages (CAMS) induced by 
microbial stimulation, AAMO are potently induced during helminth infections and allergic 
inflammation, but may also be found in diverse pathological and physiological settings such 
as during cancer and in the adipose tissue of lean individuals (Allen and Maizels, 2011; 
Gordon and Martinez, 2010; Movahedi et al., 2010; Odegaard and Chawla, 2011). 
The IL -4Ra chain serves as a common receptor subunit for both IL -4 and IL -13 (Schnyder et 
al., 1996), and is absolutely required for the induction of AAMO. In this thesis we follow 
Siamon Gordon's definition of alternative activation, which is defined as the IL- 4/IL -13- 
dependent component of macrophage activation (Gordon, 2003). Signalling via either of 
these cytokines promotes phosphorylation of the IL -4Ra subunit, leading to the activation 
of the transcription factor STAT6 (Stütz et al., 2003). STAT6 drives alternative activation 
leading to the up- regulation of numerous genes including ARG1 (arginase 1, Arg1), YM1 
(Chi313, chitinase 3 like 3) and RELMa (Retnla, resistin like alpha)(Stütz et al., 2003; Welch 
et al., 2002). YM1 and RELMa were originally described as induced in AAMO in response to 
helminth infection (Loke et al., 2002), and both of these genes serve as excellent markers to 
define in vivo -derived AAMm using FACS (Jenkins et al., 2011). 
IL -4 has recently been shown to act as a potent macrophage mitogen in vivo (Jenkins et al., 
2011). In response to IL -4, tissue resident macrophages proliferate and accumulate in the 
absence of a significant influx of inflammatory macrophages from the bloodstream. This 
finding has forced a rethink in our understanding of hematopoietic system development, 
showing that mature tissue -resident macrophages can proliferate in response to a 
polarizing stimulus. Furthermore, recent unpublished data from the Allen laboratory have 
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shown that this process is independent of the canonical macrophage mitogen CSF -1 (S 
Jenkins, unpublished data). Importantly IL -4 does not induce macrophage proliferation in 
vitro, and so the precise molecular mechanisms governing IL -4- dependent macrophage 
proliferation remain uncharacterized. This gap in our understanding poses a significant 
unanswered question in macrophage biology and in chapter 7 I develop working model for 
IL -4a- dependent macrophage proliferation based upon microarray time series data. 
At the cellular and organismal level AAMO are widely considered to be anti -inflammatory 
(Gordon and Martinez, 2010).1L-4-stimulated macrophages show an impaired ability to 
produce pro -inflammatory cytokines (Loke et al., 2002), and the induction of Arg -1 by 
AAMO forms the basis of a functional antagonism between the CAMW and AAMO 
phenotypes (Modolell et al., 1995). ARG1 competes with the CAMcP- induced gene iNOS 
(inducible nitric oxide synthase) for a common substrate, arginine, which is required by 
CAMO to produce nitrosative intermediaries essential for microbial killing. Cell non - 
autonomous anti -inflammatory mechanisms of AAMm include their ability to suppress 
effector T -cell proliferation (Liu et al., 2003; Loke et al., 2000a), and promotion of 
regulatory T -cell profiles (Broadhurst et al., 2012). 
AAMO also contribute to pathology and are a major constituent of inflammation in multiple 
models of allergic inflammation (Martinez et al., 2009). AAMcD -like tumour -associated 
macrophages (TAM) also correlate with a poor prognosis in multiple cancer models 
(Ghassabeh et al., 2006; Mantovani et al., 2002). TAM contribute to cancer progression 
both directly and indirectly by promoting tumour growth, and vascularization as well as 
aiding metastasis (Qian and Pollard, 2010). TAM however encompass a range of 
macrophage phenotypes induced by multiple potential stimuli including IL- 4/1L-13, IL -10 or 
glucocorticoids, and, as such, TAM possess a more diverse range of activation states than 
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the strictly IL -4- dependent AAMCD (Mantovani et al., 2004). However, in spite of this it is 
generally accepted that TAMs are anti -inflammatory, and that the range of TAM 
phenotypes are broadly AAMCD-like (Van Ginderachter et al., 2006). It will be of interest to 
determine whether the apparent convergence in function of AAMCD -like TAM are driven by 
the processes regulated downstream of the initial polarization stimulus. One such 
downstream process, and a major proposed physiological role of AAMCD, is the promotion 
of wound healing and the resolution of inflammation (Allen and Wynn, 2011). AAMCD 
compete with fibroblasts and T -cells during inflammatory responses for extracellular 
arginine (Pesce et al., 2009). This serves to limit fibrosis by restricting L- proline availability, 
a catabolite of arginine and prerequisite for collagen synthesis. It is the anti -inflammatory 
properties of AAMCD that are postulated to couple with their pro -angiogenic and tissue 
remodelling abilities to facilitate wound repair and tissue regeneration (Martinez et al., 
2009). 
Macrophages display a broad range of activation states and have the potential to exert 
both beneficial and detrimental effects on host physiology. Furthermore, the complexity 
and range of macrophage activation phenotypes observed in vivo is far greater than can be 
recapitulated in vitro. It is thus essential to perform studies of macrophage function in vivo 
to understand their roles during homeostasis and in the response to infection. Although 
AAMCD and key marker genes have been characterized in multiple helminth infection 
settings (Jenkins and Allen, 2010), the role(s) of these cells in helminth infection remains 
elusive. Defining these roles in helminth infection is the central research theme of the Allen 
laboratory, and uncovering new genes and molecular pathways associated with AAMCD 
during helminth infection is a key aim in this thesis. 
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1.2.6 MACROPHAGE FUNCTION AND METABOLISM 
There is an increasing appreciation that immune processes in general, and macrophages in 
particular, are intimately integrated with physiological programmes of systemic metabolism 
(Chawla et al., 2011; Liu et al., 2012). The polar regimes of macrophage activation, CAMm 
and AAMO, are associated with obese and lean adipose tissue respectively (Lumeng et al., 
2007). Furthermore, these macrophage phenotypes play causative roles in the induction 
and alleviation of insulin resistance, the hallmark of type -2 diabetes. CAMO utilize 
glycolysis to sustain their activation programme (Tannahill et al., 2013), and CAMO derived 
pro -inflammatory cytokines induce systemic insulin resistance (Xu et al., 2003). This occurs 
via the activity of pro -inflammatory cytokines on the major metabolic tissues; adipose, 
muscle and liver (Olefsky and Glass, 2010). Ultimately this serves to increase circulating 
glucose concentrations, providing a resource for energetically demanding T- helper cell 
proliferation and innate immune activity. This sets up a positive feedback loop whereby 
inflammation facilitates the dysregulation of glucose metabolism, driving inflammation. It is 
chronic inflammation that underpins the progression of diseases associated with the 
metabolic syndrome including cancer, atherosclerosis and type -2 diabetes (Biswas and 
Mantovani, 2010; Reilly and Rader, 2003). 
AAMcD exert opposing metabolic effects to CAMO have been shown to improve insulin 
sensitivity by controlling the activities of metabolic tissues (Biswas and Mantovani, 2012). 
Notably, in vitro studies have established a requirement for the oxidative phosphorylation 
of lipids, rather than glycolysis, in AAMO as a means to meet their energetic requirements 
(Vats et al., 2006). The biochemistry of oxidative metabolism is performed within the 
mitochondria, and macrophages increase mitochondrial mass in response to IL -4 
stimulation in vitro (Odegaard et al., 2007). IL -4 stimulates AAMO to undergo mitochondrial 
biogenesis via the activity of the ligand- dependent transcription factors PPARy and PPARy, 
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members of nuclear receptor transcription factor superfamily, and their co- activator 
protein PCG -lb (Ppargclb, (Vats et al., 2006). Emerging evidence from a variety of in vitro 
studies is suggestive of an intimate cell autonomous relationship between alternative 
activation and oxidative metabolism. IL -4 leads to the production of PPAR ligands and also 
induces mRNA expression of PPARy and PGC -lb in a STATE- dependent manner (Huang et 
al., 1999a; Odegaard et al., 2007). In turn, the PPAR response element (PPRE) transcription 
factor binding site is necessary for IL -4- dependent induction of Arg -1 expression and PPAR 
ligation suppresses inflammatory gene expression in macrophages (Odegaard et al., 2007; 
Ogawa et al., 2005). The IL -4- dependent expression of key AMMO genes is also disrupted in 
PPARy -/- bone -marrow derived macrophages (Odegaard et al., 2007). The relevance of these 
findings to AAMD in the context of helminth infection remains to be determined. 
In this thesis I set out to improve our understanding of the role of AAMcD in helminth 
infection, and in order to do this I have chosen to apply the transcriptomic approaches 
discussed below. These approaches have allowed us to interrogate genome -wide gene 
expression profiles purified macrophage populations, and have been used to address the 
following outstanding question which form the aims of this thesis: - 
What IL -4Ra- dependent molecular pathways and components of macrophage activation 
are elicited in response to helminth infection? 
Do in vivo elicited AAMm up- regulate mitochondrial metabolism during helminth infection? 
What is the relationship between IL -4Ra- dependent alternative activation, and IL -4- 
dependent macrophage proliferation in vivo? 
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1.3 TRANSCRIPTOMIC ANALYSIS OF GENE EXPRESSION 
1.3.1 EXPRESSION PROFILING AS A MEANS OF CELLULAR PHENOTYPING 
mRNA transcripts within a cell reflect the intermediate state between the genomic 
information and the final functional protein product. The mouse genome contains 23,158 
protein coding genes (Ensembl v70, accessed 24th February 2013), approximately 45% of 
which are expressed in each cell at any one time (Ramsköld et al., 2009). Roughly 8,000 
genes, 75% of all expressed genes, are expressed by every cell ( Ramsköld et al., 2009) yet 
the dynamic range of transcript expression varies by greater than 5 orders of magnitude 
(Wang et al., 2009). The quantitative assessment of the entire population of mRNA 
molecules within a cell, or population of cells, thus provides a proxy for functional state. 
The identification of differences in genome -wide expression profiles between treatments 
and /or conditions thus provides a means to functionally characterize phenotypic changes 
arising from a treatment. 
Several methods have been developed to facilitate the detection and quantification of 
mRNA in cells and tissues. The most mature of these technologies is microarray expression 
profiling, several variants of which exist. However, more recently, advances in second 
generation sequencing technology have led to the development of direct RNA sequencing 
(RNA -Seq) which has begun to supersede microarray technology. Both of these 
technologies are used in this thesis and a specific overview of the methods used to 
generate workable data from each follows. Although microarrays and RNA -Seq are different 
technologies that require analysis with different statistical approaches, the fundamental 
principles of data analysis are identical. Both require a library preparation step to convert 
RNA into a form that can be measured by the technology. Next, estimates of gene 
expression are obtained, although this may be a multi -step process. Finally, after 
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normalization of the primary data, differential expression analysis is used to identify 
differentially expressed genes. 
1.3.2 ILLUMINA BEADARRAY TECHNOLOGY 
Microarray technology is the best -established and most mature method for the 
quantification and analysis of transcriptomic data. Microarrays use a complementary 
hybridization approach to allow the simultaneous detection and quantification of 
thousands of genes (Duggan et al., 1999). Many different solutions to this hybridization 
approach exist and I made use of Illumina BeadArray technology in this thesis (Kuhn et al., 
2004). 
The BeadArray works by randomly placing beads coated with oligonucleotide sequences 
complementary to portions of mRNA transcripts in the mouse genome into wells on a 
silicon array. Each bead contains an individual oligonucleotide sequence (probe) present at 
approximately 700,000 copies per bead. This provides roughly 3 orders of magnitude 
dynamic range when probes are hybridized to samples. Attached to each probe is a shorter 
artificial sequence used to locate the randomly positioned bead by a process of sequential 
hybridization (Gunderson et al., 2004). 
Libraries for analysis on an array are prepared using a PCR based approach. mRNA is 
converted into double- stranded cDNA that is then used as a template for in vitro 
transcription to produce many copies of biotinylated copy -RNA (cRNA). cRNA is hybridized 
to the Illumina arrays and signal is detected by developing the arrays with streptavidin- 
conjugated Cy3 dye (Kuhn et al., 2004). The Mouse WG -6 v2.0 (Ref6) array platform 
contains comprehensive transcript annotations for the mouse with 45,281 transcripts 
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represented. Each oligonucleotide probe is present on average 30 times in each array 
platform. Given the random positioning of each probe within the array, this ensures that at 
least 5 copies of each probe are present (Kuhn et al., 2004). This provides significant 
advantages over 'printed' array technologies where probes are located at pre- defined 
coordinates on a chip because systematic artefacts arising from the influence of 
neighbouring probes are eliminated with this approach. Furthermore, the redundancy in 
probe existence on each array improves the precision of expression estimation. 
Data analysis for microarray experiments requires the normalization of observed signal 
intensities across all samples within an experiment and their transformation to remove any 
relationship between signal intensity and variance (enforcing homoscedasticity). This 
process allows the application of traditional parametric -based statistical tools and is also an 
important part of RNA -Seq data analysis, discussed later. 
1.3.3 NORMALIZATION AND DIFFERENTIAL EXPRESSION ANALYSIS FOR 
ILLUMINA BEADARRAYS 
While many methods for microarray data analysis exist, standard protocols have emerged 
to deal with each array technology (Ritchie et al., 2011), these provide the flexibility to 
ensure an appropriate analysis pipeline for a given experimental design. Data processing for 
Illumina BeadArrays is a two -step process and takes into account the redundancy in probe 
numbers on each array chip. The robust spline normalization method (RSN) (Lin et al., 2008) 
calculates the average expression of each probe in an array after the removal of outliers. 
Following this, signal intensities are normalized both within and between arrays 
simultaneously using the variance -stabilizing normalization (VSN) method (Huber et al., 
2002a). This normalization procedure ensures that the signal intensity distribution between 
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arrays in an experiment is roughly equal, and that the variance in expression for all 
expressed genes is roughly the same across the entire distribution of gene expression 
levels. 
Normalized microarray data of the kind described above can be analysed using parametric 
methods such as linear regression analysis and t- tests. These are the most frequently used 
approaches for microarray analysis, and by far the most widely used software package for 
this is limma (Smyth, 2004) implemented in the Bioconductor environment (Gentleman et 
al., 2004). The limma package supports generalized linear modelling (GLM) for microarray 
data in an easy to understand and accessible manner. The flexibility allowed by a GLM 
approach is that it can incorporate anything from the most trivial to complicated 
experimental designs. Additionally, limma supports multiple methods for the correction of 
multiple testing, an important consideration for the elimination of false -positive results in 
high- throughput data analysis. For both microarray and RNA -Seq analyses presented in this 
thesis, the Benjamini- Hochberg method to correct for multiple testing is used (Benjamini 
and Hochberg, 1995). This method controls the type 1 false discovery rate, the likelihood a 
gene is erroneously classified as differentially expressed, and is typically the default method 
used by bioinformaticians in this kind of analysis (Dudoit et al., 2003). 
1.3.4 ILLUMINA SEQUENCING TECHNOLOGY & RNA -SEQ 
An increasingly preferred method for genome -wide expression profiling is direct highly 
parallelized sequencing of RNA (RNA -Seq). This technological advancement has been made 
possible over the past five years with the development of second -generation sequencing 
technologies, in particular Illumina sequencing (Mardis, 2008). Illumina technology uses a 
sequencing -by- synthesis approach and allows for the massively parallel sequencing of short 
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reads of DNA. A brief introduction to the method is given below (for a detailed overview of 
the technology see (Mardis, 2008)). 
Illumina sequencing begins with an adapter- modified DNA library containing size -selected 
fragments of DNA with specific sequencing adapters ligated to the ends of each fragment. 
The fragments of this library are annealed to a glass flow cell containing oligonucleotides 
complementary to the sequencing adapters. Once annealed, the individual molecules of 
DNA are amplified to form the clusters that are sequenced. Hundreds of thousands of 
clusters are formed on each slide, each of which is sequenced in parallel. This is achieved by 
sequentially washing the flow cell with modified oligonucleotides. Each base is conjugated 
to one of four fluorescent dyes, and contains a 3' -OH group to ensure only one base can be 
added to a cluster at a time. The base incorporated into each cluster is identified by the 
fluorescence signal measured after each incorporation cycle, following each incorporation 
step the dye and blocking 3' -OH group are chemically washed off prior to the next cycle. 
Sophisticated optics ensures that clusters are reproducibly identified over sequential cycles. 
Over the course of this PhD project (2009 -2013) the specifications of Illumina sequencing 
have improved dramatically, both in terms of throughput and sequence read length. We 
performed Illumina sequencing during project between 2009 and 2010. At this time, a 
single lane of sequencing data generated on an Illumina GAllx produced 10 -15 million 50 
base paired -end reads per sequencing run. Illumina sequencing can be applied to gene 
profiling. Sequencing libraries are produced from randomly sheared purified mRNA 
obtained by poly -A selection. A size selected (^200bp) fragment of sequencing adapter - 
ligated cDNA is amplified and sequenced using Illumina technology as described above. 
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The short reads during an RNA -Seq experiment represent a random sub sample from the 
entire population of fragmented mRNA molecules present in the library. Reads are mapped 
to the reference genome using specialized tools designed to map millions of reads with high 
fidelity extremely quickly using a Burrows -Wheeler transformation (Langmead et al., 2009). 
The number of reads that map to a gene reflect the steady state expression level of the 
gene's constituent transcripts in the parent population. Expression levels are thus 
quantified by counting reads within exons of known genes based on available annotations. 
RNA -Seq has several advantages over microarray technology. Although minor biases in 
RNA -Seq library generation arise from the differential binding of random hexamer primers 
during cDNA synthesis (Hansen et al., 2010), RNA -Seq has substantially higher 
reproducibility and lower and inter -laboratory variability than microarray technology ('t 
Hoen et al., 2008). Dynamic range is limited only by the depth of sequencing, with a single 
lane typically providing 5 -6 orders of magnitude. This is two orders of magnitude greater 
than microarray technology and is enough to quantify all biologically relevant transcripts 
within a homogenous population of cells (Marioni et al., 2008). Because reads map to the 
genome it is possible to both detect new transcripts and novel splice junctions. 
1.3.5 RNA -SEQ READ MAPPING AND DIFFERENTIAL EXPRESSION 
ANALYSIS 
Dedicated read mapping software for RNA -Seq, TopHat (Trapnell et al., 2009) has been 
produced. TopHat maps reads quickly with the aid of the Burrows -Wheeler based 
algorithms while at the same time supporting mapping at splice junctions and searching for 
de novo splice sites. There are considerations for accurate gene expression quantification in 
RNA -Seq experiments. Sequences within mammalian genomes are repetitive as many genes 
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contain paralogues or conserved signalling domains. This means that not all 50 -100 base 
stretches of DNA are unique within genes and that RNA -Seq reads may map equally well to 
more than a single location on the genome. These so called multi- mapping reads must be 
discounted prior to gene expression estimation as it is not possible to know which gene 
these sequences arose from, this ultimately leads to incorrect expression estimation. 
RNA -Seq data require normalization prior to the identification of differentially expressed 
genes. The principal inter -library adjustment required for RNA -Seq data analysis is for 
sequencing depth. To do this DESeq, the dedicated RNA -Seq analysis program used in this 
thesis, calculates an effective library size for each sequenced lane based on the median 
read count per gene (Anders and Huber, 2010). This effective library size is used to adjust 
for the differences in sequencing depth. 
RNA -Seq data are fundamentally different to microarray data and require handling with 
statistical models that make appropriate distributional assumptions. Owing to the count - 
based nature of RNA -Seq data, gene expression levels are naively expected to follow a 
Poisson distribution (Marioni et al., 2008). However it was quickly realised that Poisson 
statistics capture only the count -based component of RNA -Seq data and fails to account for 
biological variability (Robinson et al., 2010). DESeq and other RNA -Seq analysis pipelines 
(Robinson, McCarthy, and Smyth 2010) utilize negative binomial distributions, this model is 
an over -dispersed Poisson distribution allowing for the incorporation of 'extra variance' and 
biological variability itself is estimated from the data and incorporated into the statistical 
procedure. The early implementations of DESeq that are utilized in this thesis relied solely 
on pairwise comparisons however more recent versions support multi -factorial 
experimental designs. 
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1.3.6 PATHWAY ANALYSIS AND TRANSCRIPTIONAL REGULATION 
The usual purpose of a genome -wide expression profiling experiment is to generate 
testable hypotheses for functional follow -up experiments. Thoughtful experimental design 
is the most valuable consideration to aid the identification of the contrasts of interest. Once 
significance values have been assigned to a list of genes multiple approaches may be used 
to gain biological insight. 
The most intuitive approach to analysing transcriptomic data is to look for changes in the 
expression of genes, or gene families, whose change in expression will yield directly 
interpretable information. For example in this thesis (discussed below) we explicitly search 
for changes in the expression profiles of chemokines, cytokines and their receptors. Genes 
belonging to families, or with a particular classification, can be identified using Gene 
Ontology (GO) terms (Ashburner et al., 2000). Genes are assigned GO terms belonging to 
one of three ontologies, defining the 'molecular function', biological process' and 'cellular 
component' to which a gene belongs. This provides easy access to gene family and 
biological pathway information. The grouping of genes into pre- defined biological pathways 
'gene sets' is the starting point for Gene Set Enrichment Analysis (GSEA) and over- 
representation analysis. The philosophy underpinning both GSEA and over -representation 
analysis is that the identification of co- ordinately regulated sets of genes with a common 
function provides insight into cellular processes occurring in response to treatment. 
While both approaches are conceptually similar, they rely on different statistical methods, 
and provide different qualities of data. GSEA is based on a ranked list of expressed genes 
and identifies gene sets that are biased towards the extreme ends of the list (i.e. gene sets 
that are correlated either positively or negatively with a phenotype). An enrichment score 
is calculated for each gene set and a P -value assigned using a permutation -based method 
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(Subramanian et al., 2005). Over -representation analysis on the other hand takes a binary 
approach to identify gene sets whose members are more present than would be expected 
by chance in a list of differentially expressed genes, given a list of background genes. P- 
values in this approach are assigned using an exact approach based on the hypergeometric 
distribution (Cordero et al., 2007). In addition to the Gene Ontology several databases 
contain curated biological pathway information. Amongst the most widely used are 
Reactome (Vastrik et al., 2007) and KEGG (Kanehisa and Goto, 2000) both of which contain 
detail cellular metabolic and signalling pathways. 
In a conceptually similar manner to GSEA, transcriptomic data can be combined with 
genome sequence information to provide insight into mechanisms of transcriptional 
regulation. These methods correlate differential gene expression with presence or absence 
patterns of transcription factor binding sites (TFBS) in gene regulatory regions. TFBS 
libraries such as JASPAR (Bryne et al., 2008) define the relative affinities of transcription 
factors to cognate DNA sequences, alternatively TF binding occupancy may be determined 
directly using chromatin immunoprecipitation followed by high throughput sequencing 
(ChIP -Seq) (Valouev et al., 2008). The presence of TFBS within regulatory regions is then 
tested using either hypergeometric methods (Heinz et al., 2010) or approaches that take 
into account the relative affinity of a transcription factor to a TFBS (Frith et al., 2004). 
Defining a gene's regulatory regions presents a challenge. One naive approach is to define a 
promoter as a short sequence (typically -500 bp) flanking a gene's transcription start site 
(TSS). Alternatively, regulatory regions defined using ChIP -Seq against epigenetic markers of 
promoter and enhancer regions may be used provided data is available for a similar cell 
type to the one under investigation (Heinz et al., 2010). 
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1.4 OUTLINE OF THESIS 
In this thesis transcriptomics approaches are taken to define IL -4Ra- dependent 
components of macrophage activation and proliferation during helminth infection. In 
chapter 5 RNA -Seq is used to define the transcriptomic profile of FACS -purified AAM 
induced using the B. malayi implant model. I compare B. malayi- induced macrophage gene 
expression profiles against inflammatory -like thioglycollate elicited macrophages to define 
changes in gene expression resulting from the presence of the nematode and the 
associated Th2 environment. These data are interpreted alongside profiling of B. malayi - 
elicited macrophages from IL- 4Ra -/- mice, which are unable to alternatively activate, in 
order to identify IL -4Ra- dependent changes in gene expression. Together these data permit 
identification of IL -4Ra -dependent changes in gene expression whilst controlling for 
additional effects of B. malayi. Using this model I confirm the anti -inflammatory phenotype 
of AAMO and validate the mitochondrial phenotype associated with AAMO in vivo. 
Furthermore I discover that PPARy, required for AAMO in vitro, is expressed at a low level 
by B. malayi- elicited AAMm in vivo, although PPARS is expressed. I validate the role for 
PPAR transcription factors in AAMm in vivo by analysing TFBS in macrophage promoters. 
Gene promoter regions are defined using a novel method for transcription start site 
identification with RNA -Seq data. The algorithm, TSS- Predictor, is discussed in Chapter 6. I 
have been able to put forward a putative mechanism for PPARS- dependent transcriptional 
regulation in AAMm. Using GSEA I identified differential regulation of arachidonic acid 
metabolism, a source of PPAR ligands, associated with AAMm. In collaboration with Philip 
Whitfield and Ben Maskrey at The University of the Highlands and Islands I went on to 
characterize AAMCD- derived eicosanoids and identified the PPARS ligand PGI2 as 
abundantly produced in a B. ma /ayi- dependent manner. 
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In chapter 7 of this thesis I present a time course of the macrophage response to L. 
sigmodontis infection. This more natural parasite model than B. malayi extends our RNA - 
Seq analysis from a single time point to capture macrophage gene expression profiles 
induced early during the response to helminth infection. I use a novel approach to gene 
expression analysis by integrating gene expression profiling with FACS -based 
measurements of alternative activation and proliferation. With this approach I define 
macrophage gene signatures associated with alternative activation and proliferation. An 
analysis of cis -regulatory elements in promoter regions is performed and, surprisingly, no 
STAT6 signature was found in the promoters of proliferation- associated genes induced in 
response to IL -4. Using the data obtained from this analysis and our current understanding 
of IL -4Ra- dependent macrophage proliferation I propose a model to explain these 
observations. Using this model I identify candidate mediators of IL -4- dependent 
macrophage proliferation in vivo. 
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2 THE BIOLOGY OF NEMATODE- AND IL -4Ra- 
DEPENDENT MURINE MACROPHAGE POLARIZATION 
IN VIVO AS DEFINED BY RNA -SEQ AND TARGETED 
LIPIDOMICS 
This chapter contains the unedited version of (Thomas et al., 2012) published in Blood. 
Supplementary information for this chapter can be found in Appendix la and 
supplementary tables can be found in Appendix lb. 
2.1 ABSTRACT 
Alternatively activated macrophages (AAMO) are a major component of the response to 
helminth infection however their functions remain poorly defined. To better understand 
the helminth -induced AAM D phenotype we performed a systems -level analysis of in vivo 
derived AAMO using an established mouse model. With next -generation RNA sequencing 
(RNA -Seq) we characterized the transcriptomes of peritoneal macrophages from BALB /c 
and IL- 4Ra- /- mice elicited by the nematode Brugia malayi, or via intra- peritoneal 
thioglycollate injection. We defined expression profiles of AAMm- associated cytokines, 
chemokines and their receptors, providing evidence that AAMO contribute towards 
recruitment and maintenance of eosinophilia. Pathway analysis highlighted complement as 
a potential AAMO- effector function. Up- regulated mitochondrial genes support in vitro 
evidence associating mitochondrial metabolism with alternative activation. We mapped 
macrophage transcription start sites (TSS), defining over -represented cis -regulatory motifs 
within AAMO- associated promoters. These included the binding site for PPAR transcription 
factors, which maintain mitochondrial metabolism. Surprisingly PPARy, implicated in the 
maintenance of AAMm, was down -regulated upon infection. PPARÒ expression however 
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was maintained. To explain how PPAR- mediated transcriptional activation could be 
maintained we used lipidomics to quantify AAMO- derived eicosanoids, potential PPAR 
ligands. We identified the PPARS ligand PGI2 as the most abundant AAMO- derived 
eicosanoid and propose a PGI2 -PPARS axis maintains AAMcD during B. malayi implantation. 
2.2 INTRODUCTION 
Macrophages display enormous functional diversity determined by signals from their 
immediate environment. IFNy stimulation induces classical activation, an essential 
prerequisite for microbial infection control, whereas IL- 4/1L-13 exposure polarizes 
macrophages towards alternative activation (Gordon and Martinez, 2010). Alternatively 
activated macrophages (AAM(D) are now implicated in the promotion of a wide range of 
diseases including cancer (Mantovani et al., 2002), allergy (Gordon and Martinez, 2010) and 
fibrosis (Gordon and Martinez, 2010); but also in protection against helminth infection 
(Allen and Maizels, 2011), diabetes (Odegaard and Chawla, 2011) and obesity (Odegaard 
and Chawla, 2011). 
Despite the flurry of interest in AAMm we remain remarkably ignorant of their physiological 
role(s), partly because classical and alternative activation represent polar- regions in a 
landscape of activation phenotypes sculpted by multiple factors. Different cellular 
developmental histories (Jenkins et al., 2011), micro -environmental cues and factor - 
dependent polarization (Hashimoto et al., 2011) vastly increase the complexity of 
macrophage phenotypes in vivo. IL- 4/1L-13 induce canonical alternative activation via IL- 
4Ra- dependent phosphorylation of STAT6, driving the transcription of a diverse repertoire 
of genes including Argl (Arginase -1, ARG1), Chi313 (Chitinase 3 -like 3, YM1) and Retnla 
(resistin like alpha, RELMa, FIZZ -1). Because exposure to helminths almost universally 
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induces potent Th2 responses, alternative activation of McD is characteristic of these 
infections (Loke et al., 2002). Indeed, Chi313 and Retnla were described as AAMcD markers 
associated with challenge by the parasitic nematode Brugia malayi (Loke et al., 2002). 
An emerging paradigm suggests that cytokine- mediated alterations in cellular metabolism 
determine cellular life- history (van der Windt et al., 2012) and effector functions (Infantino 
et al., 2011). For example, a switch from glucose- dependency to mitochondria) metabolism 
oversees the ability of effector CD8+ T -cells to commit to a memory phenotype (van der 
Windt et al., 2012). In this context, it is interesting to note that in vitro studies suggest that 
classically activated macrophages (CAM() and AAMO are associated with different 
metabolic profiles. CAMN require aerobic glycolysis (Rodríguez -Prados et al., 2010), while 
AAMm couple lipid oxidation with oxidative phosphorylation (Odegaard and Chawla, 2011). 
Cooperative interactions between STAT6, PPARy and PGC-lb are considered necessary 
(Odegaard and Chawla, 2011; Szanto et al., 2010)' to induce these metabolic changes in 
AAMD. In vivo confirmation of this observation is required, and an improved understanding 
of the role for mitochondria] metabolism in alternative activation may yield key insights 
into the effector functions of these cells. 
Previous transcriptomic analyses of AAMO have used in vitro generated cells while in vivo 
studies of Th2 environments have analysed whole tissue (Sandler et al., 2003; Vats et al., 
2006)'. This leaves a gap in our understanding of AAMcD function during infection. 
Previously we identified abundantly expressed genes in in vivo -derived AAM(D using an 
expressed sequence tag approach (Loke et al., 2002). This provided valuable insight into 
markers expressed by these cells, but lacked the power to critically assess molecular 
pathways associated with alternative activation in vivo. Here, using second -generation 
Illumina sequencing and mass spectrometry, we combined transcriptomics and lipidomics 
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to gain a global overview of macrophage IL -4Ra- dependent transcription and 
transcriptional regulation in vivo. 
We compared nematode -elicited macrophages (NeM(D) and inflammatory -like 
thioglycollate- elicited macrophages (ThioMCD) from both wild type (WT) and IL -4Ra1- mice. 
We sought to define physiological functions of in vivo -derived AAMO, and have focused on 
understanding the macrophage response to filarial nematode infection. We defined 
macrophages as F4/80 positive cells with a negative gating strategy to exclude 
contaminants. This definition likely includes macrophage sub -populations that contribute 
differentially towards the overall response, however this comparison allowed us to focus on 
the most relevant changes in macrophage physiology to filarial nematode challenge. The 
contrast between WT -NeMN and WT- ThioMCD identified differential gene expression due 
to the presence of the nematode, or differences in cell origin. Comparing WT -NeM(D and IL- 
4Ra- / --NeMCD revealed IL -4Ra- dependent components of macrophage activation during 
helminth infection. We followed Siamon Gordon's definition of alternative activation as the 
IL- 4/1-13- dependent component of macrophage activation (Gordon and Martinez, 2010). 
IL -4Ra deficiency ablates both IL -4 and IL -13- dependent signalling (Gordon and Martinez, 
2010). Thus, co- ordinately differentially expressed (DE) genes in WT -NeMq (i.e. in vivo 
generated AAMcD) relative to both WT- ThioMCD and IL- 4Ra " -NeMCD are, by definition, 
those relevant to alternative activation during helminth infection. 
Illumina RNA sequencing (RNA -Seq) provided >5 orders of magnitude dynamic range 
between the most abundant and lowly expressed genes, delivering the most extensive 
characterization of in vivo -polarized macrophage populations to date. We establish a 
putative role for AAMcD in eosinophil recruitment and the complement response during 
helminth infection. Macrophage transcription start sites (TSSs) were mapped, and, by 
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characterizing overrepresented cis -regulatory elements in AAMm promoters, we confirm 
PPAR- dependent transcription as a major facilitator of alternative activation in vivo. 
Pathway analysis supported these findings by identifying AAMcD- dependent alterations in 
lipid and mitochondrial metabolism, key targets of PPAR transcription factors. Finally, liquid 
chromatography tandem mass spectrometry (LC- MS /MS) was used to define the B. malayi- 
induced repertoire of endogenous eicosanoids, allowing us to propose a mechanism for 
PPARB- mediated alternative activation. We thus provide global mechanistic insights into 
the function and regulation of helminth- elicited AAMO and identify putative effector 
molecules involved in the maintenance and regulation of alternative activation in vivo. 
2.3 METHODS 
2.3.1 MICE 
BALB /c and IL- 4Ral- mice bred on the BALB /c background were used in the RNA -Seq 
experiments. All mice were 8 -10 weeks old at the start of the experiments, and were bred 
in house. All work was conducted in accordance with the Animals (Scientific Procedures) 
Act of 1986. 
2.3.2 ELICITATION OF MACROPHAGE POPULATIONS FOR RNA -SEQ 
Adult Brugia malayi were retrieved from the peritoneal cavity of infected Mongolian Jirds 
obtained from TRS laboratories (Athens, GA). B. malayi were washed five times by serial 
passage into 50 ml RPMI supplemented with 1% Penicillin /Streptomycin (P /S) and 1% L- 
gluta mine. 
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NeMcp were obtained by surgically implanting 9 male BALB /c and 9 male IL- 4Ra- /- mice each 
with 4 female and 1 male B. malayi adults intraperitoneally. Similarly, ThioMc were 
obtained by intraperitoneal administration of 700 µl 4% Brewer's modified thioglycollate 
medium in PBS (w /v) (BD Pharmingen) into 9 male BALB /c and 9 male IL -4R«1 mice. 21 
days post -implantation, or 3 days post -thioglycollate injection, peritoneal exudate cells 
(PEC) were retrieved by 10 * 1 ml peritoneal lavage with ice -cold RPM' supplemented with 
1% P /S, 1% L- glutamine and 5% Fetal Calf Serum (FCS). 
2.3.3 FLOW CYTOMETRY 
All reactions were quenched between all staining steps by the addition of 1 ml FACS buffer 
(PBS + 0.5% BSA, 2 mM EDTA) followed by centrifugation at 1200 rpm for 5 min, removal of 
supernatant and brief re- suspension of cells by vortexing. All incubations are carried out on 
ice and in the dark unless otherwise stated. 
2.3.4 PURIFICATION OF MACROPHAGES FOR RNA -SEQ 
Prior to RNA sequencing Mm were purified by flow cytometry. 1*107 PEC cells were 
transferred in 1 ml to FACS tubes and stained with 50 µl Live /Dead -Aqua (Invitrogen, 1/500 
dilution in PBS) for 10 min at room temperature. Cells were blocked on ice for 20 min with 
300 µl blocking buffer (FACS buffer + 1/300 0.8 mg /ml aCD16/32 + 1/32 mouse serum) 
before staining with F4/80- biotin (1/100, BioLegend), SiglecF -PE (1/100, eBiosciences), 
B220 -PE (1/100, eBiosciences), CD4 -FITC (1/100, eBiosciences) in 300 pl FACS buffer for 20 
min. Finally, cells were incubated with 300 µl streptavidin conjugated -APC (1/200, 
eBiosciences) for 20 min, washed twice with 1 ml FACS buffer and resuspended in 300 pl 
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FACS buffer before sorting. Martin Waterfall at the Ashworth Laboratories, University of 
Edinburgh central flow facility performed flow sorting. Immediately after sorting cells were 
washed in 1ml PBS and stored at -80 °C in 700 ill Qiazol (Qiagen) prior to RNA extraction. 
2.3.5 INTRACELLULAR CYTOKINE STAINING FOR RELM 
Intracellular staining for RELMa was performed to validate the activation status of B. 
ma /ayi- implanted BALB /c and IL- 4Ra -/- mice. 5 *105 PEC were treated with 10 µl each 
Live /Dead Aqua and blocked with 50 µ.l blocking buffer as described above. Cell surface 
staining was performed with 50 [II F4/80- biotin (1/100, BioLegend), SiglecF -PE (1/100, 
eBiosciences), B220 -PE (1/100, eBiosciences), CD3 -AF700 (1/300, BioLegend) in FACS buffer 
for 20 min. Secondary staining was performed with streptavidin conjugated -APC (1/200, 
eBiosciences), 50 µl incubation for 20 min prior to fixation with 2% PFA at room 
temperature for 10 min. Intracellular staining was performed by washing cells with 
PermWash (BD Biosciences) before incubation with rabbit anti -RELMa (1.5 µg /ml, 
Peprotech) or rabbit -IGG isotype (1.5 µg /mI, Molecular Probes) in PermWash for 45 min. 
Secondary staining was performed using 50 µl anti -Rabbit -AF488 (1/300, Molecular Probes) 
and cells were resuspended in 100 µl FACS buffer prior to acquisition on a FACS Canto. 
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2.3.6 RNA -SEQ LIBRARY PREPARATION AND SEQUENCING 
RNA was extracted using the Qiagen miRNeasy kit according to the manufacturer's 
instructions and quality assessed using an Agilent Bioanalyzer (RNA Nano 6000). All samples 
had RIN scores > 8. RNA concentration was quantified using a Q -Bit fluorimeter (Invitrogen). 
RNA -Seq libraries were prepared using the Illumina paired -end RNA -Seq library preparation 
kit in accordance with the manufacturer's guidelines. All reagents are supplied as a part of 
the Illumina kit unless otherwise stated. We prepared three biological replicates for each 
condition. 9 mice were used per group with each library being derived from 2 lug total RNA 
obtained by pooling 0.66 µg from 3 individuals. Poly -Adenylated mRNA was enriched using 
Sera -Mag Magnetic Oligo(dT) Beads and eluted into 16 p,l Tris -HCI. Purified mRNA was then 
fragmented by incubating at 94 °C for 5 min using the supplied fragmentation buffer which 
utilizes divalent cations to catalyse RNA fragmentation. Following mRNA fragmentation first 
strand cDNA is synthesized using the SuperScript reverse transcriptase and buffer 
(Invitrogen) and random hexamer primers in a 50 min, 42 °C incubation. Double stranded 
cDNA is then synthesized using DNA Polymerase I and GEX second strand buffer. Following 
clean -up using the QlAquick PCR purification kit (Qiagen) cDNA was eluted into 50 iul 
Qiagen EB buffer and 'blunt- ended' using Klenow polymerase to remove 3' overhangs and 
to fill -in 5' overhangs. Following another clean -up step (QlAquick) 3' ends are adenylated 
using the supplied Klenow exonuclease and Illumina sequencing primers ligated using a T4 
DNA ligase, with a further QlAquick clean -up step prior to ligation. cDNA was then eluted 
into 101u1 Qiagen EB buffer and 200 bp fragments are size selected using a 2% agarose gel is 
prepared with lx TAE buffer (BioRad) and Certified Low -Range ultra agarose (BioRad). 10 ul 
cDNA was run alongside 2 lul 100bp DNA ladder (Invitrogen) at 120 v for 1 hour. A 200 bp 
+/- 20 bp slice of gel was then excised and cDNA was extracted using the QlAquick gel 
extraction kit (Qiagen). Finally, the excised cDNA library is amplified by PCR using the high- 
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fidelity Phusion DNA polymerase, primers specific to the Illumina sequencing adapters, and 
18 cycles of a 30 s 65 °C annealing phase and a 30 s 72 °C elongation phase. Each RNA -Seq 
library was then validated on a 2% agarose gel as above and sequenced on a single lane of 
an Illumina GAllx at the GenePool genomics facility in Edinburgh, yielding 51 base, paired - 
end reads. 
2.3.7 GENE EXPRESSION QUANTIFICATION: READ MAPPING AND 
DIFFERENTIAL EXPRESSION ANALYSIS 
Illumina sequencing yielded between 11 and 30 million paired -end reads per lane. Reads 
were mapped to the mouse reference genome (mm9) using TopHat (Trapnell, Pachter, and 
Salzberg 2009) (version 1.1.13) and gene expression levels quantified by counting uniquely 
mapping reads within Ensembl (v58) gene predictions using the intersection -nonempty 
function of HTSeq -count (version 0.4.7). Raw data and gene expression count tables are 
available at SRA (accession ERP001255) and ArrayExpress (accession E -MTAB -995). Data 
quality assessments (QA) and differential expression analyses were performed using the 
R /Bioconductor package DESeq (version 1.4.1, Anders and Huber 2010). Variance outliers 
were removed to minimize false -positives, see below for more details. 
2.3.8 IDENTIFICATION OF TECHNICAL ARTEFACT BASED UPON RESIDUAL 
VARIANCES 
In the course of exploratory data analysis and QA we investigated the expression 
characteristics of genes with large residual variances (> 20) after DE analysis with DESeq. 
We identified 190 such protein coding genes (0.83% of the total), > 90% of which were 
differentially expressed in at least 1 comparison. Hierarchical clustering revealed a 
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tendency towards higher gene expression amongst this subset of genes between samples 
BTG3, 4Ne1 and 4Ne2 and the remaining samples (Figure Al -52). This discrepancy did not 
affect the overall clustering of samples according to their biological conditions (Figure Al- 
s3). However, the results do indicate an underlying technical artefact, and were excluded 
from downstream analysis. 
2.3.9 HIERARCHICAL AGGLOMERATIVE CLUSTERING AND 
CLASSIFICATION OF IMMUNE EFFECTOR GENES 
Hierarchical agglomerative clustering was performed on all genes considered DE between 
WT -NeMO and either IL- 4Ra- / --NeMo or WT- ThioM0. A Euclidean distance metric was 
calculated between all selected genes using mean -centred variance -stabilized values. 
Variance stabilization was performed using the transformation provided in DESeq. The 
resulting matrix was subject to hierarchical agglomerative clustering using Ward's method, 
and subsequently sub -divided into 20 clusters in the R environment. 
Chemokines, chemokine receptors, cytokines and cytokine receptors (GO identifiers 
GO:0042379, GO:0004950, GO:0005125 and GO:0004896 respectively) were identified 
using the Bioconductor package 'GO.db', and those present in the differential expression 
clusters above were identified for further analysis. 
2.3.10 GENE -SET ENRICHMENT ANALYSIS 
To obtain p- values and t- statistics for gene set enrichment analysis (GSEA), raw data were 
variance stabilized using the transformation within DESeq. Differential expression was then 
reanalysed using limma (version 3.6.9, Smyth 2011) after non -specific filtering to enforce 
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homoscedasticity (variance stabilized value < 2, Figure A1-s4). The effect of this procedure 
is to remove systematic biases in the data that ordinarily provide greater statistical power 
to longer and more highly expressed genes (Young et al. 2010). GSEA on biochemical and 
metabolic pathways as defined by Kyoto Encyclopaedia of Genes and Genomes (KEGG, 
(Kanehisa and Goto, 2000)) was performed using the method described in Jiang and 
Gentleman (2007). Briefly, KEGG pathways were assigned a score, defined as the mean 
directed t- statistic for all expressed genes within the pathway. Disease pathways and those 
containing < 5 genes were excluded from analysis. 
2.3.11 IDENTIFICATION OF TRANSCRIPTION START SITES USING RNA - 
SEQ DATA 
We have devised a protocol to identify transcription start sites (TSS) accurately using RNA - 
Seq data, this has now been converted into an application for use by the wider research 
community. For a detailed overview of the algorithm and how it works see Chapter 7. TSS 
prediction and promoter region analysis presented in this chapter was performed with a 
preliminary version of this algorithm, described in brief below. 
METHOD. Accurate identification of transcription start sites is aided by deep sequencing. 
To maximise the depth of coverage in our experiment we merged reads from all 12 libraries 
into a single lane and mapped to the mouse reference genome with TopHat (Trapnell et al., 
2009) using the default parameters (allowing multi- mapping reads). Aligned reads were 
then assembled using the reference -guided transcript assembler Cufflinks (Version 0.9.3, 
(Trapnell et al., 2010)), without the aid of the existing transcript annotations, to aid the 
discovery of novel transcripts (genes, exons or splice junctions). Cufflinks assembles 
overlapping sections of mapped reads into transcribed fragments, called 'transfrags'. These 
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ab initio defined transcripts were subsequently related to known gene models (Ensembl 
v58) using Cuffcompare from the Cufflinks suite. 
TSS prediction operates by revising Cufflinks 'transfrag' predictions to more accurately 
identify the TSS. We selected the longest Cufflinks transfrag associated with each Ensembl 
GID (provided it was on the same strand as the reference gene) and calculated the per -base 
coverage of mapped reads using Samtools (Li et al., 2009). The observed per -base coverage 
obtained from Samtools and expected coverage for each transfrag provided by Cufflinks 
were used to trim transfrags to X% of the expected coverage using custom scripts. The 
trimming strategy and value of X were empirically optimized using chromosome 2 as a test 
dataset. 
OPTIMIZATION OF TRIMMING CONDITIONS. Two trimming policies were tested, forward 
and reverse trimming. Forward trimming begins at the outermost base in an annotation 
and iterates towards the 3' end of the transcript, removing one base at a time until 
condition X is met. Reverse trimming begins at the base adjacent to the donor splice site of 
the first exon and works towards the 5' end of the transcript, one base at a time, until 
coverage drops below X; all upstream annotation for the gene is then discarded. For both 
forward and reverse trimming, if threshold X is not met in exon 1 then the process is 
repeated consecutively for downstream exons until it is. Trimmed annotations are then 
output in GTF format. 
To identify optimal cutoff conditions we identified the longest Cufflinks transfrag for each 
reference gene (as implemented in Prep4Trim.p1) and retained the 50% most abundant 
transfrags. Using chromosome 2 as a subset, MADs between predicted and nearest 
annotated TSS were determined at 1 %, 5 %, 10 %, 20 %, 30 %, 40 %, 50% and 60% of the 
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expected expression for each gene (Figure A1-s5). This optimality criterion assumes that at 
least one of the Ensembl- predicted TSS is correct, which may not always be the case. The 
empirically determined optimal trimming condition was 10% of the expected coverage with 
the reverse -trimming protocol as this provided the minimal MAD value of 32 bp. 
DETERMINATION OF OPTIMAL GENE EXPRESSION CUT -OFF. With optimal trimming 
conditions defined we wanted to rationally define the minimum gene expression level 
required to accurately predict TSS. A trade -off exists here between maximising the number 
of promoters for further analysis and introducing false positive TSS predictions resulting 
from the incomplete assembly of lowly expressed genes. 
In order to determine this cutoff we identified TSS for all expressed genes defined by 
Cufflinks transfrags. Using a similar MAD scoring method to above we allocated genes into 
one of 20 bins based upon their expression (i.e. 0 -5 %, 6 -10% ... 95 -100 %) and, for each bin, 
calculated the MAD from the nearest Ensembl TSS (Figure Al -56). From this we included the 
80% most abundant genes as they show minimal deviation from the expected MAD. 
POST -FILTERING. We tested whether our method allowed us to identify novel promoters 
in our dataset. We noted that the majority of the TSS a long distance from the nearest 
Ensembl TSS appeared to result from erroneously selecting Cufflinks transfrag for trimming. 
Thus, to improve the accuracy of TSS identification we disregarded TSS greater than 500 bp 
from the nearest Ensembl TSS for the associated gene. Finally, as we required multiple - 
mapping reads for TSS identification we also removed TSS predictions associated with 
genes that contained > 30% of multi- mapping reads. Genome -wide this method allowed us 
to predict 7,817 high- confidence macrophage TSS. 
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2.3.12 CLOVER ANALYSIS OF OVER- REPRESENTED TRANSCRIPTION 
FACTOR BINDING SITES 
Promoter regions proximal to the identified TSS, 300 bp upstream and 100 bp downstream, 
were extracted from the mouse genome (mm9) using BEDToolsfastaFromBed. 
Overrepresented cis -regulatory motifs were identified using Clover (version 2010 -02 -19 
(Frith et al., 2004)) with position weight matrices (PWMs) of transcription factor binding 
sites (TFBSs) defined by the Jaspar non -redundant vertebrate set (Bryne et al., 2008). 
Overrepresentation in macrophage promoters was assessed by comparing all macrophage 
promoters to all mouse promoters (Ensembl v58). Similarly, AAMO promoters were 
assessed by comparing the intersection of genes upregulated in WT -NeMm relative to both 
WT- ThioM0 and IL- 4Ra-t- -NeMm against all remaining macrophage promoters. P- values 
were determined by permutation test using 1000 iterations. The number of occurrences of 
a motif within AAMO associated promoters were counted using the online tool RSAT 
matrix -scan with the default parameter set (Thomas -Chollier et al., 2011). 
2.3.13 ELICITATION, CHARACTERIZATION AND ISOLATION OF 
MACROPHAGE POPULATIONS FOR LIPIDOMICS 
Macrophages for the lipidomic study were elicited using exactly the same protocol as 
described above for RNA -Seq, only 5 mice were used in each group, and we omitted the IL- 
4Ra thioglycollate group. The first 2 ml of peritoneal lavage culture supernatant was 
retained and stored at -80 °C prior to preparation for mass spectrometric analysis. 5 *105 
PEC from B. ma /ayi- implanted mice were retained for flow cytometric cell phenotyping. 
FACS was performed using the above protocol, our staining panel included, Live /Dead -Aqua 
(1/500), CD4 -FITC (1/200), BioLegend), F4 /80 -PE (1/200, eBiosciences), Gr1 -PerCP (1/200, 
BioLegend), CD19 -APC (1/300, eBiosciences), eosinophils were determined as F4/80 
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intermediate, SSC high. Samples were fixed for 10 min in 2% PFA prior to acquisition on a 
FACS Canto. Mm were adherence purified by plating the remaining PEC into 6 well plates 
for 4 h at 37 °C, 5% CO2. Non -adherent cells were removed by washing twice with 1 ml 
warm culture media (RPMI + 1% L -glut + 1% Pen /Strep + 5% FCS). After 12 hours culture in 
1 ml culture media, both adherent macrophages and culture supernatant were collected 
together and stored at -80 °C prior to preparation for mass spectrometric analysis. 
2.3.14 ISOLATION AND MASS SPECTROMETRIC ANALYSIS OF EICOSANOIDS 
Samples were thawed on ice to which 2 volumes of ice -cold methanol containing the 
deuterated internal standards 15- HETE -d8, LTB4 -d4, PGE2 -d4 and 8 -iso Prostaglandin F2a- 
d4 were added to give final concentrations of 2 ng /sample for cell culture samples and 4 
ng /sample for peritoneal lavage samples. Following protein precipitation, samples were 
centrifuged (600 g, 10 min, 4 °C) and the supernatant then diluted to a final concentration 
of 10% methanol. Samples were acidified to pH 3.5 with 2M HCI and immediately applied to 
a 6 cc 500 mg C18 SPE Cartridge (Waters) which had been prepared by passing through 2 
column volumes of methanol, and 2 volumes of H20. Samples were washed with 5 ml H20, 
2x 5 ml hexane and eluted with 2x 3 ml ethyl acetate. Eluants were dried under a stream of 
N2 and resuspended in 100 µl of 50:50 HPLC buffer A (H20 + 0.02% acetic acid):buffer B 
(methanol + 0.02% acetic acid) and stored at -80 °C until analysis. Eicosanoids were 
separated by injecting 10 µl sample onto a reverse phase HPLC column (Hypersil Gold C18 
column; 3 µm x 2.1 x 50 mm; Thermo Scientific) maintained at 40 °C with a gradient from 
50% B to 65 at 14 min, increasing to 100% B at 20 min, held at 100% B until 22 mins then 
recycled to 50% B at 23 mins until 25 mins at a flow rate of 300 µL /min. 6 -keto PGF1a was 
chromatographed on a shorter gradient to obtain optimal peak shape using 60 -90% B over 
51 
2 min, increased to 100% B at 10 min, then recycled back to 60% B at 11 min and held until 
15 min at a flow rate of 400 µl /min. The eluted eicosanoids were detected using an online 
tandem mass spectrometer (MS /MS) (TSQ Quantum Ultra; Thermo Scientific) operating in 
negative ion mode with a HESI source using the selected reaction monitoring (SRM) scan 
mode with argon as the collision gas. Electrospray voltage was -2.5 kV with a vaporizer 
temperature of 350 °C and capillary temperature of 250 °C. Optimal collision energies and 
tube lens voltages were optimized individually for each analyte. The analytes and Q1 /Q3 
transitions were as follows; 15- HETE -d8 (327 >226); LTB4 -d4 (339 >197); PGE2 -d4 (355 >193); 
8 -Iso PGF2a -d4 (357 >197); 5- OxoETE (317 >203); 15 -HETE (319 >175); 5 -HETE (319 >115); 12- 
HETE (319 >179); LTB4 (335 >195); 6 -keto PGF1a (369 >163); Thromboxane B2 (369 >169); 
PGF2a (353 >193); 20- hydroxy LTB4 (351 >195); 13,14 -dihydro -15 -keto PGE2 (351 >235) 
13,14 -dihydro -15 -keto PGD2 (351 >207); PGD2 (351 >233); PGE2 (351 >189) and 8 -iso PGF2a 
(353 >193). Data was acquired and peak area integrated using the software (LCquan v2.6; 
Thermo Scientific). Amounts were quantified by reference to standard curves run in 
parallel, with extraction efficiency and recovery normalized by reference to the appropriate 
internal standard. Mass spectrometry and determination of eicosanoid concentrations was 
performed by Ben Maskrey at UHI (University of the Highlands and Islands, Inverness). 
52 
2.4 RESULTS 
2.4.1 GENERATION OF AAMO AND DIFFERENTIAL EXPRESSION 
ANALYSIS 
We generated NeMcD and ThioMcD by implanting BALB /c and IL -4Ra mice with the 
nematode B. malayi, or via intraperitoneal administration of thioglycollate to elicit a 
population of non -polarized, inflammatory -like macrophages. IL -4 stimulation increases 
F4/80 surface expression on macrophages (Jenkins et al., 2011). In order to enrich for 
AAMO in the implant setting, we collected the brightest F4/80 positive macrophage 
population in each condition (see Figure Al -sl and Table Al- ST -1). Macrophage purity was 
maximized by exclusion of dead cells, doublets, B -cells (6220 +), eosinophils (SiglecF and 
CD4+ T -cells using negative gating (Figure 2 -1a). On average 47% of WT -NeMO were RELMa 
positive, consistent with 30 -60% positivity typically seen following B. malayi implant (Figure 
2- 1b,c). RNA -Seq libraries yielded between 11 and 30 million 51 base paired -end reads. 
Gene expression was quantified by mapping reads to the mouse reference genome using 
TopHat (Trapnell et al., 2009). 52 -70% of reads mapped uniquely to the genome, with 7.7- 
25 million within exons of known genes (Ensembl v58, Table 2 -1). Between 12,853 and 
13,520 (56 -59 %) protein coding genes were expressed in each group, with 12,039 of these 
common to all four populations (Figure 2 -2a). We validated sample purity by assessing the 
expression of lineage- restricted marker genes for potential contaminants; eosinophils, 
neutrophils and B -cells (Table A1- ST -2). With this approach we confirmed negligible 
contamination of neutrophils or eosinophils, however a low level of Cd19 expression was 
observed in IL- 4Ra-'-- NeMO. 
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Figure 2 -1. Flow cytometric acquisition of macrophages, and confirmation of alternative 
activation in WT B. malayi -implanted macrophages. 
A) Gating strategy used to obtain pure macrophage populations as shown with one 
representative WT B. malayi infected individual. After the removal of dead cells B220, 
SiglecF and CD4 positive cells were excluded. F4/80 high cells were then selected and 
doublets removed based upon FSC -W /FSC -A scatter (Forward scatter -width /forward 
scatter -area). 
B) Intracellular cytokine staining for RELMa expression in thioglycollate- elicited 
macrophages (top) and B. malayi- elicited macrophages (bottom). The scatter profile and 
macrophage gates on the left refer to one representative WT B. malayi infected 
individual. 
C) Bar chart showing percentage of RELMa positive macrophages from analysis b) n =9 
per group (p < 0.001 * * *). 
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Figure 2 -2 Overall gene expression and differential expression analysis. 
A) Number of expressed genes in macrophage populations where expressed is 
considered as at least 1 read mapping to a gene in all 3 replicates of a condition. 
B) Unsupervised, hierarchical clustering of individual lanes demonstrating discrete 
clustering of biological replicates. 
C) Summary of DE genes (p < 0.01) in each pairwise comparison showing the total 
number of DE genes (inner), and a breakdown showing the direction of differential 
expression for both moderately (log 2 fold change -±2 -4) and highly (Log 2 fold change > 
4) DE genes. 
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Hierarchical clustering of global gene expression profiles grouped RNA -Seq libraries 
according to biological condition, reaffirming the quality and reproducibility of our analysis 
(Figure 2 -2b). Following differential expression analysis we identified substantial 
transcriptional differences between the macrophage populations in the three key 
comparisons (Figure 2 -2c). Using a p -value cutoff of 0.01 after correction for multiple 
testing (Benjamini- Hochberg method), we identified 4,571 DE genes between WT -NeMc 
and WT- ThioMm, 4,561 DE genes between WT -NeMm and IL- 4- Rat- -NeMO, and 3,271 DE 
genes between WT- ThioMo and IL- 4Ra- /-- ThioMm (Figure 2 -2c). A list of all genes discussed 
in this chapter and associated p- values are provided in supplementary Table A1-ST -3. We 
observed a higher number of DE genes between WT -NeMO and IL- 4Rá' --NeMcD than 
between WT- ThioMcD and IL- 4Ra " -- ThioMm (Figure 2 -2c). Additionally, the magnitudes of 
these differences were much greater in the infection setting (Figure Al -s7). Furthermore, a 
similar range of differential expression was observed between WT -NeM0 and WT- ThioMo 
as for WT -NeMO and IL- 4Ra- '- -NeMcD. Thus, as expected, IL -4Ra- dependent signalling 
drove major alterations in the macrophage transcriptional profile in response to Th2- 
inducing immune stimuli. 
We interrogated the expression profiles of DE genes in order to identify those explicitly 
associated with alternative activation. All DE genes from the WT -NeM(U vs. WT- ThioMo 
and WT -NeMO vs. IL- 4Ra"- -NeM(A comparisons (4,571 and 4,561 respectively) were 
grouped according to their expression profile using hierarchical agglomerative clustering. 
The resulting tree was sub -divided into 20 clusters, and the expression profile of genes in 
each cluster was assessed (Figure Al -58). We identified five clusters with increased 
expression levels in WT -NeM(b relative to WT- ThioMo and IL -4Ra "-- NeM(p. These were 
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classified as AAMCD -up (Figure 2 -3, Table A1- ST -4). Similarly, five clusters were identified 
with converse expression profiles, and classified as AAMCD -down. In total 1,658 genes 
AAMCD -up genes and 1,735 AAMCD -down genes were identified (Figure 2 -3). Importantly 
we can state that expression of genes in AAMCD -up and AAM(D -down clusters is IL -4Ra- 
dependent. However, as the IL- 4Ra '- mice lack IL -4Ra expression on all cells we cannot say 
whether these effects are cell- autonomous, and in some cases may reflect other changes 
such as Th2 cell activation. 
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Figure 2 -3. Expression profile and GO enrichment of differentially expressed AAMm- 
associated gene sets. The expression profiles of gene sets positively and negatively 
associated with alternative activation (AAM D -up and AAMcD- down). All statistically 
significant genes (p <0.01) between WT -NeMcD and WT- ThioMm, and WT -NeMcD and IL- 
-/- 4ra -NeMcD, were clustered using hierarchical agglomerative clustering. Each gene 
within an expression cluster is plotted in blue and the mean expression for all genes 
within each cluster is overlaid in black. The figure in each panel represents the total 
number of genes in that cluster. 
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2.4.2 DIFFERENTIAL EXPRESSION OF IMMUNE EFFECTORS 
We reasoned that a descriptive, knowledge- based, assessment of immunologically relevant 
GO terms (encompassing cytokines, chemokines and their receptors; GO terms 
GO:0005125, GO:0008009, GO:0004896 and GO:0004950 respectively; hereafter called 
immune effectors) would provide insight into AAMm function and regulation. Immune 
effectors that were present in AAMO -up and AAMm -down clusters were defined as AAMO- 
associated. Using this criterion we identified AAMO- association for expression of 16 
cytokines, 11 cytokine receptors, 10 chemokines and 8 chemokine receptors (Figure 2 -4). 
Below we discuss the function of key AAM(D- associated immune effectors, providing insight 
into the IL -4Ra- dependent facets of the macrophage response to filarial nematode 
infection in vivo, and defining candidate genes for future investigations. 
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effector genes, cytokines, chemokines and their respective receptors (GO:0005125, 
GO:0008009, GO:0004896 and GO:0004950 respectively), in AAMD- associated clusters 
were identified based upon gene ontology annotations. Hierarchical clustering analysis 
reveals a unique expression profile of AAMcD- associated immune effectors. 
62 
CHEMOKINE AND CHEMOKINE RECEPTOR EXPRESSION PROFILES. The AAMc chemokine 
expression profile (Figure 2 -4) was consistent with macrophage- mediated maintenance of 
the cellular milieu in the peritoneal cavity of B. malayi- implanted mice, which is composed 
primarily of B- cells, macrophages and eosinophils (Loke et al., 2007). All assayed 
macrophage populations abundantly and constitutively expressed Cc16 and Cc19 (Table Al- 
ST-5), which may serve to maintain macrophage populations within the peritoneal cavity 
(Romagnani, 2002). In the AAMO -up clusters we identified the eosinophil chemoattractants 
Cc124 and Cc18 (Romagnani, 2002), as abundantly and moderately expressed respectively. 
Cxc112 and Cxcl13 were also identified as AAMO- associated, however were expressed at 
much lower levels. Consistent with an anti- or non -inflammatory phenotype of AAMO 
(Gordon and Martinez, 2010), the AAM(D -down clusters contained Cc13 (Mip1a), Cc14, Cc12 
(MCP -1), Cc17 (MCP -3) and Cxcl14, all of which are involved in acute phase inflammation, 
attracting primarily monocytes and neutrophils (Mantovani et al., 2004). 
Interestingly, AAMcD -up clusters were devoid of chemokine receptors with the exception of 
Cxcr7 (Figure 2 -4). Cxcr7 responds to the stromal- derived Cxcl12, affecting both migration 
and differentiation in monocytes (Sánchez -Martín et al., 2011). Ccr1 (MIP -1 a receptor, 
Table A1-ST -5) was also highly expressed by macrophages, but not classified as AAMm- 
associated. Therefore, Cxcr7 and /or Ccrl may be key determinants of nematode -induced 
AAMO localization(Mantovani et al., 2004; Sánchez -Martín et al., 2011)'. A large number of 
chemokine receptors were present in the AAMO -down clusters. These included Ccr2, Cxcr1, 
Cxcr2, Cxcr3, CcrS and CcrI2 implying that AAM(D are impaired in their capacity to respond 
to numerous chemokines. This suggests that WT -NeMm do not migrate to prime lymphatic 
T -cell responses, in spite of high MHCII expression and functional antigen presentation 
(Loke et al., 2000b; Mylonas et al., 2009). 
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CYTOKINE AND CYTOKINE RECEPTOR EXPRESSION PROFILES. Cytokine receptor expression 
was typically maintained or enhanced in NeMCD. AAMCD -up clusters contained the IL -33 
receptor, 111r11 (ST -2) and the IL -27 receptor subunit 1127ra (WSX -1), both of which have 
previously been characterized as AAMCD- associated (Kurowska -Stolarska et al., 2009; 
Rückerl et al., 2006). AAMCD -up clusters also included Gfra2 (GDNF family receptor alpha -2), 
involved in neuronal survival and differentiation (Jing et al., 1997), and the leptin receptor 
(Lepr). Leptin is an adipokine involved in energy homeostasis with broad, pleiotropic 
effects. There is no described role for leptin in Th2 immunity, however, macrophages of 
Lepr deficient mice express higher levels of inflammatory cytokines (Li et al., 2006) 
suggesting the possibility that the leptin receptor contributes to the anti -inflammatory 
profile of AAMCD. 
With regard to cytokines WT -NeMCD produced significantly more 116, Wnt2 and Bmp6 than 
WT- ThioMCD or IL- 4Ra-1-- NeMCD. Bmp6 is pleiotropic, suppressing B -cell proliferation 
(Kersten et al., 2005) and promoting macrophage IL -6 production (Lee et al., 2010). Wnt2 
has no defined role in macrophage physiology, although Wnts do influence immune cell 
fate decisions (Staal et al., 2008). Thus, Wnt2 and Bmp6 represent promising novel 
candidates for future investigations of Th2 immunity. 
AAMCD are described as broadly anti -inflammatory (Gordon and Martinez, 2010), in part 
due to their production of IL -10. Surprisingly, in the chronic setting of our experiment, WT- 
NeMCD did not transcribe any 1110 (table A1- ST -5). Nonetheless, AAMCD -down clusters 
contained genes for many pro -inflammatory cytokines. Amongst these were Tnf, Lif, 111b 
and 1116 (Cruikshank et al., 2000; Rosado and Rodriguez -Sosa, 2011; Tofaris et al., 2002). 
Additionally, the expression of the macrophage activating factor Tnfsf9 (Kim et al., 2009) 
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and the IL -27 and IL -35 subunit Ebi3 were lowered in AAMO. In summary, AAMO expressed 
greater levels of immune effectors associated with eosinophil recruitment and survival, and 
lower levels of numerous pro -inflammatory agents. 
2.4.3 KEGG PATHWAY ANALYSIS 
To assess whether metabolic changes in macrophages previously observed during IL -4 
treatment in vitro also occur in vivo, we applied gene set enrichment analysis (GSEA) using 
the KEGG pathway database alongside modifications for RNA -Seq data (see methods 
section). By considering the relative expression of all genes, rather than only DE genes, 
GSEA provides a sensitive metric for identifying differences in biochemical and cell 
signalling pathways. 
THE COMPLEMENT AND COAGULATION CASCADE. Unexpectedly, the complement and 
coagulation cascade (KEGG pathway mmu04610) was the most differentially regulated 
pathway between WT -NeM0 and WT- ThioMcD (Table A1- ST -6). The most striking feature of 
complement expression in AAM(D was transcript abundance (Figure 2 -5). For example, C3 
and C4 attracted over 100,000 reads each, making them amongst the most abundant 
NeMcD- associated transcripts. NeMO showed up- regulation of C1q complex genes (C1ga, 
Clqb and Clqc), and striking over -expression of MBL pathway constituents specifically 
FicolinA (FcnA), Cfb and Cfp (Figure A1-S9). This suggests a role for FicolinA- dependent 
complement activity in the response to helminth infection. 
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Figure 2 -5. Complement components are abundantly expressed in an alternative 
activation- dependent manner. The expression of genes in the complement and 
coagulation cascade (KEGG pathway mmu:04610). For reference the median, and 90`h 
percentiles of expression for all expressed genes are included (solid and dashed red 
lines respectively). Additionally, as highly expressed marker genes Chi313 (YM1) and 
Retnla (RELMa) are included for reference. 
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MITOCHONDRIAL METABOLISM. Twenty -three of the twenty -seven most differentially 
regulated pathways between WT -NeMm and WT- ThioMm were metabolic (Figure Al -s10, 
Table A1- ST -6). A similar trend was observed between WT -NeMm and IL- 4Ra4- -NeMm, 
supporting a model wherein a shift in metabolic phenotype is a cardinal feature of 
alternative activation (Odegaard and Chawla, 2011) (Figure Al -s10). The second most 
perturbed KEGG pathway between WT -NeMc and WT- ThioMo was the tricarboxylic acid 
(TCA) cycle (Table Al- ST -6). Indeed, the majority of expressed TCA cycle genes were 
expressed at a higher level in WT -NeMm relative to both WT- ThioM(D and IL- 4Ra- /- -NeMc 
(Figure 2 -6a, Figure A1-s11). A similar pattern of gene expression was also observed for 
genes involved in oxidative phosphorylation (Figure 2 -6b). Taken together these findings 
are consistent with previous studies showing that IL -4 induces expansion of the 
mitochondria) compartment in macrophages in vitro (Odegaard et al., 2007). 
PPARy and PGC -lb, key regulators of mitochondrial metabolism have been described as 
required for alternative macrophage activation in vitro (Odegaard et al., 2007; Vats et al., 
2006). Accordingly, the metabolic profile we observe could be explained by transcriptional 
activity of PPAR family members (PPARa, PPARy and PPARS). However, during B. malayi 
infection, macrophage- specific PPARyi- mice show no impairment in alternative activation 
(Dominik Rückerl, unpublished data). Furthermore, although Ppargclb (PGC -1b) expression 
was augmented in an IL -4Ra- and infection -dependent manner, Pparg (PPARy) levels were 
substantially lower in NeMm than ThioMCD (Figure 2 -6c). Ppara ( PPARa) was not expressed 
by any of the assayed macrophage populations (Table A1- ST -5). Only Ppord (PPARÒ) 
expression was sustained in NeMcP, yet it was not up- regulated (Figure 2 -6c). This suggests 
that during helminth infection, PPARS may compensate, either partially, or completely, for 
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reduced PPARy in NeMm. Alternatively, PPAR- independent transcription may maintain 
mitochondrial metabolism in NeMcD. 
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Figure 2 -6. AAM D up- regulate mitochondrial tricarboxlyic acid (TCA) cycle genes and 
show evidence of PPAR- dependent transcription in vivo. 
A) Schematic of the TCA cycle showing DE genes in WT -NeMc relative to WT- ThioMcD 
(blue border = up- regulated, yellow border = down -regulated). Additionally, genes up- 
regulated in WT -NeMm relative to IL -4Ra-/ -NeMcD are depicted with a red asterix. 
B) Heatmap showing relative expression of mitochondrial electron transport chain (ETC) 
components between WT-NeMD, IL -4Ra-/ -NeMcD and WT- ThioMc. The majority of ETC 
components are most highly expressed in WT- NeM(1). 
C) The expression levels of transcripts encoding for PPARy, PPARS and the co- activator 
protein PGC-lb shows that WT -NeMm express high levels of PPARS and PGC-lb, but not 
PPARy. 
D) Confirmation of the accuracy of transcription start site (TSS) prediction. The density 
plot shows the distances from the predicted TSS for each gene to nearest annotated 
Ensembl TSS (median absolute deviation = 32bp). 
E) Consensus motifs for the 3 over- represented transcription factor binding sites in 
AAMD- associated promoter regions identified using clover (p <0.01), comparison of 
AAMm- associated promoters (TSS -400, +100 bp) against non -AAMm- associated 
macrophage promoters. 
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2.4.4 TSS IDENTIFICATION AND PROMOTER REGION ANALYSIS 
To address whether PPARs facilitate transcription of IL -4Ra- dependent genes in vivo we 
analysed transcription factor binding sites (TFBSs) in the promoters of AAMCD- associated 
genes. We developed and optimized a method to accurately identify TSSs using RNA -Seq 
data (Figure 2 -6d). Briefly, transcripts were defined using Cufflinks (Trapnell et al., 2010), 
and TSSs identified based upon expected gene expression and the observed sequencing 
read depth at each position in the gene. Proximal promoter sequences (300 bp upstream 
and 100 bp downstream of each TSS) were obtained from 7,817 high- confidence TSSs, and 
analysed for over -represented TFBSs. 
We validated our method by identifying overrepresented TFBSs in our promoters relative to 
all mouse promoters using Clover (Frith et al., 2004), and comparing the found set with the 
macrophage lineage restricted TFBSs identified by Hume et al (2010). In our data we 
identified 54 motifs that were present significantly more often than expected (p -value < 
0.01). Hume et al ( 2010) used a different library of TFBS motifs and identified 27 significant 
motifs, 23 of which were represented in the library we used. Our analysis identified 18 of 
these (78 %) as overrepresented in our macrophage promoters, reinforcing the findings of 
the previous study and confirming the accuracy of our predictions. 
Promoters were categorized according to the expression characteristics of their parent 
genes. We identified 682 AAMc- associated promoters, derived from genes upregulated in 
WT -NeMc relative to both WT- ThioM( and IL -4Ra l- -NeMO. The remaining 7,135 
promoters were classified as generic macrophage promoters. We compared AAMC - 
associated promoters to the generic set, and identified only three over -represented TFBS 
motifs: MZF1, ZNF354c and PPARG:RXRA (also known as PPAR response element, PPRE), 
(Table 2 -2 and Figure 2 -6e). We used the Regulatory Sequence Analysis Toolkit (Thomas- 
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Chollier et al., 2011) to count the number of instances of each motif within our set of 682 
AAM4- associated promoters and found that 113 (17 %) contained high- confidence PPRE 
elements. Because the MZF1_1 -4 and ZNF354c consensus motifs are very short we could 
not quantify these at the default significance threshold (p < 1e-5). The observation of an 
abundant and over- represented PPRE identifies PPAR- mediated transcription as significant 
component of AAMO- associated transcriptional regulation in vivo. 
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Jaspar Motif Clover P -value 
MZF1_1 -4 Zinc -coordinating 0 
PPARG::RXRA Zinc -coordinating 0.004 
ZNF354C Zinc- coordinating 0.006 
Table 2 -2. The three statistically over -represented position weight matrices in AAMm- 
associated promoters relative to all macrophage promoters. Clover P -value determined 
by permutation test over 1000 iterations. 
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2.4.5 ANALYSIS AND QUANTIFICATION OF NEMoiD- DERIVED EICOSANOIDS 
GO and KEGG gene set enrichment analysis identified augmented mitochondrial and 
metabolic gene expression, specifically the TCA cycle, as infection and IL -4Ra- dependent 
processes (Figure 2- 6a,b). Our analysis of AAMCD- associated cis -regulatory features further 
supported a role for PPAR involvement (Figure 2 -6e). Together these strongly suggest that 
PPAR- mediated transcription is a driving component of the AAMCD phenotype in vivo. 
PPARy and oxidative phosphorylation are described as necessary for alternative activation 
(Odegaard and Chawla, 2011), yet NeMCD Pparg expression was low (Figure 2 -6c). As PPARS 
is the major PPAR driving TCA cycle flux in adipocytes (Roberts et al., 2011) we 
hypothesized that it may compensate for PPARy in NeMCD. The PPAR family are ligand- 
dependent transcription factors. Thus, although Ppard was not DE we explored the 
possibility that increased ligand availability might modulate PPARS- dependent transcription 
in NeMCD. 
KEGG pathway analysis identified arachidonic acid (AA) metabolism, a known source of 
PPAR ligands, as up- regulated in WT-NeMCD (Table A1- ST -6). Products of the AA enzyme 
cascade, eicosanoids, comprise a wide variety of pro- and anti -inflammatory mediators, 
including the prostaglandins, leukotrienes and lipoxins. We characterized a broad range of 
these compounds produced by NeMCD and ThioMCD using LC -MS /MS in an independent, 
homologous experiment (lacking the IL- 4Ra('. thioglycollate group). Individual eicosanoids 
(for a full list of species see supplementary methods) were measured in peritoneal lavage 
fluid and ex vivo in 12 -hour cultures of adherence purified macrophages. Ex vivo cultures 
showed that NeMCD produced significantly more eicosanoids than ThioMCD (Figure 2 -7a) 
irrespective of IL -4Ra expression. This cannot be attributed to enhanced activity of the AA- 
liberating phospholipase A2 enzymes as Plat transcripts were expressed in ThioMCD at a 
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comparable level to NeMcD (Figure A1-s12). This suggests IL -4Ra- independent effects of B. 
malayi drive AA catabolism. 
Principal component analysis (PCA) of eicosanoid profiles from cultured macrophages 
showed that the three treatment groups formed distinct clusters (Figure 2 -7b). IL- 4Ra- /-- 
NeMw produced high levels of pro -inflammatory PGE2 and downstream metabolites that 
promote acute phase inflammation (Trebino et al., 2003). WT -NeMm were characterized by 
production of the 12 /15- lipoxygenase- derived hydroxyeicosatetraenoic acid (HETE) 
metabolites, predominantly 12 -HETE (Figure 2 -7c). Interestingly, by far the most abundant 
cox -derivative in WT -NeMm was 6- keto- PGF1a, the auto -oxidation product of the PPARÒ 
agonist prostacyclin (PG12, Lim and Dey, 2002, Figure 2 -7d). 
Integrating the lipidomic profiles and gene expression data allowed us to better understand 
the relationship between transcriptional profiles and metabolic phenotype. We plotted 
gene expression and metabolite data onto a pathway map of the enzymatic cascade, 
relating AA catabolism to metabolite production (Dennis et al., 2010). Alterations in 
synthase gene expression showed high concordance with the relative abundances of 
daughter metabolites (Figure 2 -7e), with one notable exception. Despite robust expression 
of Gpxl, Alox5 and Lta4h we were unable to detect any 5- lipoxygenase derived 
metabolites, 5 -HETE 5- OxoETE, LTB4 or, 20 -OH LTB4 (Figure A1-s13). Thus peritoneal 
macrophages were primed to produce leukotrienes but did not. Substrate competition for 
AA or higher -level control of leukotriene biosynthesis may explain this observation. In 
summary, eicosanoid production by macrophages is stimulated in response to B. malayi. 
Rather than affecting total eicosanoid production, IL -4Ra- dependent signalling modulated 
the architecture of the downstream enzymatic cascade, leading to a more anti - 
inflammatory eicosanoid profile. 
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Heterotypic interactions contribute towards the eicosanoid profile in vivo. To discern the 
relative contributions of macrophage and non -macrophage derived eicosanoids, we 
measured AA products in peritoneal lavage from the mice in the same experiment (Figure 
A1-s13). PCA plots (Figure 2 -7f) showed no distinction between WTthioglycollate -injected 
and IL- 4Ra-i -B. malayi- implanted mice. The WT B. malayi- implanted individuals however 
clustered distinctly, showing that the response to B. malayi implantation generated a 
unique, IL -4Ra- dependent, eicosanoid environment. This also implies that B. malayi is not a 
major source of total peritoneal eicosanoids in this model. WT- implanted mice had 
increased HETE, PGD2 and TxB2 concentrations (Figure 2 -7g), the latter two of which are 
eosinophil chemoattractants (Arima and Fukuda, 2011; Ishizuka et al., 1998)'. It is unlikely 
that the PGD2 was macrophage- derived as low levels were produced in AAM(p ex vivo 
cultures. TxB2 concentrations correlated with, and may be explained by, the increase in 
macrophage numbers associated with infection in a WT environment (Figure A1-s14a, b). 
We have therefore identified a distinct lipid effector profile in the response to helminth 
infection. While the activity of 5- lipoxygenase did not contribute towards this profile, the 
actions of cyclooxygenase and 15- lipoxygenase did. 
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Figure 2 -7 Characterization of AAMcD- derived eicosanoids. 
A) Quantification of arachidonic acid (AA) metabolites in 12h cultures of purified 
macrophages (upper) and in peritoneal lavages (lower). 
B) PCA scores plot for 12h cultures of purified macrophages. 
C) PCA loading plot for b) showing how individual eicosanoids contribute towards the 
primary and secondary principal (x and y respectively) axes. 
D) Pie chart showing the breakdown in the production of cyclooxygenase metabolites 
between WT -NeMc and IL -4Ra -' -NeMcD. 
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Figure 2 -7 Characterization of AAMc- derived eicosanoids. 
E) Schematic of the AA cascade reproduced using Vanted. Genes are shown in square 
boxes with red text, measured metabolites are in rounded boxes with black text. Black 
arrows indicate enzymatic reactions, red arrows auto oxidation. Relative expression 
values (normalized such that the total over all 3 conditions =1) are beneath the 
associated gene /metabolite. WT B. malayi (left box) IL- 4Ra-'- B. malayi implanted 
(centre) and WT- Thioglycollate (right). 
F +G) PCA scores and loading plot as in b) and c) for the peritoneal lavages. 
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2.5 DISCUSSION 
We have characterized the phenotype of B. malayi- elicited AAMN using RNA -Seq and a 
targeted lipid analysis. Together these reveal the effects of IL -4Ra dependent signalling on 
macrophage physiology in a chronic Th2 environment. Our findings strongly support the 
emerging paradigm that alternative activation and inflammation are associated with 
wholesale alterations in metabolism (Odegaard and Chawla, 2011). Further, GSEA and a 
detailed analysis of AAM4- associated chemokine and cytokine expression provide intriguing 
clues as to the physiological role(s) of AAMcD in vivo. 
One of the more unexpected findings of our analysis was that, collectively, macrophage 
complement genes were amongst the most abundantly expressed and differentially 
regulated in the response to helminth challenge, and may represent a previously 
unrecognised effector axis of AAMO. A requirement for complement in anti -helminthic 
immunity has previously been demonstrated, as C3 mediates clearance during both 
Strongyloides stercorallis (Kerepesi et al., 2006) and Schistosoma mansoni infection (La 
Flamme et al., 2003). In the context of B. malayi, complement interacts with microfilariae 
(Carter et al., 2007) and may contribute towards their clearance. Here we identify AAMm- 
derived FicolinA as a candidate for further study into the regulation of the complement 
response to filarial nematode infection. 
We also identified IL -4Ra- dependent expression of cytokines not currently associated with 
AAMQ) physiology including Bmp6 and Wnt2. Intriguingly Bmp6 has been associated with 
increased MCP iNOS activity, suggesting that it may curtail alternative activation (Hong et 
al., 2009). Wnt2 is a highly abundant AAMcD- derived cytokine with no identified role in 
macrophage biology. Wnt2 does however affect hematopoietic lineage commitment 
(Wang et al., 2007), and our AAMm -up clusters contained Cdhl (E- cadherin), an AAMO 
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marker in both humans and mice (Van den Bossche et al., 2009). Given the known 
convergence between cadherin and Wnt pathways, further work to elucidate the role of 
Wnt2 in macrophage biology is warranted. We have observed IL -4Ra and infection 
dependent production of cytokines, chemokines and eicosanoids suggesting that NeMD aid 
in the orchestration and maintenance of the immune environment. Specifically, NeMcD 
potentially regulate eosinophil recruitment via multiple, redundant, mechanisms. Reese et 
al (2007) previously demonstrated chitin -induced eosinophilia as an AAMO- dependent 
process, but whether they fulfil this role in the more complex environment of live parasite 
infection is unclear. We show here that WT -NeMcD transcribe eosinophil chemotactic 
factors in vivo. Cc18 (Romagnani, 2002) and Cc124 (Mantovani et al., 2004) operate as Ccr3 
ligands, while TxA2, the bioactive precursor of TxB2, induces eosinophilia by affecting 
vascular epithelial integrin expression. Our data are therefore consistent with AAMO- 
mediated recruitment and maintenance of eosinophilia during helminth infection. 
Interestingly, in contrast to the work by Reese et al (2007) our proposed mechanism for 
eosinophil recruitment is LTB4- independent. Our findings may differ because Reese et al 
used an acute stimulus, whilst we employ a chronic model of helminth infection. 
Nevertheless, our data suggest cooperative interactions between AAMc- derived protein 
and lipid mediators ensure robust, tightly regulated eosinophil recruitment to sites of 
infection. 
IL -4Ra- dependent signalling led to reduced expression of multiple pro -inflammatory 
cytokines and chemokines, supporting a model wherein AAM$ are anti- or non - 
inflammatory. Macrophage PPAR activity augments alternative activation and reduces the 
expression of pro -inflammatory cytokines (Odegaard and Chawla, 2011). Indeed 
thiazolidenediones, anti -diabetic PPARy agonists, improve insulin sensitivity in obese white 
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adipose tissue (WAT) partly by curtailing CAM) (Odegaard and Chawla, 2011). Global 
similarities can be drawn between our surveyed NeMm and the beneficial AAMCD in WAT of 
lean individuals, these include enhanced oxidative metabolism and low pro -inflammatory 
cytokine expression (Odegaard and Chawla, 2011). By assaying TFBS in NeMN promoters 
we provide compelling evidence that PPAR- mediated transcription is an important facet of 
the macrophage response to helminth infection in vivo. WAT AAMm and NeMcp are 
however distinct subsets. WAT AAMm express PPARy, 1110 and Cd36 (Liang et al., 2004), 
while Cd36 and PPARy were down -regulated, and 1110 was not expressed, in NeMO (Table 
A1- ST -1). This is consistent with alveolar AAMm failing to express IL -10 in response to 
Nippostrongylus braziliensis (Chen et al., 2012). However, the observation that N. 
braziliensis infected mice show improved glucose tolerance (Shapiro et al., 2011) 
demonstrates that the physiological consequences of modulating alternative activation, 
either in the response to infectious disease, or during homeostasis, imparts similarities that 
are greater than the observed differences between WAT AAM(D and NeM P. This is perhaps 
not surprising as alternative activation in both these disparate environments is STAT6- 
dependent. An improved understanding of the influence of context -specific (i.e. 
tissue /infection model) cues in fine -tuning AAM(p polarization is required to fully 
appreciate the functional diversity of AAMCD phenotypes. 
We observed low PPARy expression in NeMm, consistent with a recent report of PPARy 
expression profiles in different macrophage subsets (Gautier et al., 2012b). Analysis of 
AAMm- associated cis -regulatory regions suggested a role for PPARs in WT -NeMcD, and we 
therefore sought a mechanism for PPAR- dependent transcription during B. malayi 
infection. By profiling macrophage- derived eicosanoids we found that nematode- but not 
thioglycollate- elicited macrophages abundantly produced the PPARy ligand PGI2. Due to 
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the low expression of PPARy in NeMm, and constitutive PPAR expression, macrophage 
PG12 production provides a feasible and testable explanation for the maintenance of PPAR- 
dependent transcription in NeMm. However it should be noted that because NeMcp do 
express PPARy we cannot rule out a role for both these transcription factors during 
alternative activation. We have shown that macrophage eicosanoid generation is IL -4Ra 
independent in this system. This suggests that the liberation of PPAR ligands is B. malayi- 
mediated, and is perhaps achieved via a pathogen associated molecular pattern- dependent 
mechanism. IL -4Ra- dependent signalling did however alter the expression of AA catabolic 
enzymes, enhancing the production of anti -inflammatory HETEs (Allen and Maizels, 2011). 
Hence, extracellular cues (i.e. IL- 4/1L-13) manipulated the architecture of the enzymatic 
cascade, reorganizing the eicosanoid landscape. Ultimately this reduced pro -inflammatory 
eicosanoid production, and increased the synthesis PGI2 and anti -inflammatory HETEs. We 
propose a model in which the presence of a 'danger signal' is coupled with cytokine- 
dependent structural reorganization, providing both an initiator and higher order specificity 
that contribute towards sustaining the NeMcl) phenotype in vivo. 
We have defined the phenotype of IL -4Ra- stimulated AAMm in vivo during the response to 
a nematode infection. All of the data we present are supportive of anti -inflammatory roles 
for AAMN in this setting. To summarize, WT -NeMO broadly down -regulated the expression 
of numerous pro -inflammatory cytokines and chemokines. The eicosanoid environment 
generated by NeMm is defined by enhanced production of anti -inflammatory HETE 
metabolites, and also the abundant production of the PPARÒ ligand PG12. We infer that 
NeMO have a decreased migratory capacity, due to the down -regulation of multiple 
chemokines, and therefore are unlikely to prime lymphatic T -cell responses. Our study has 
also identified the production of complement as a major component of the macrophage 
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response to filarial nematode challenge. While complement may aid in the recognition and 
clearance of either adult B. malayi or microfilariae, it is also has extensive immuno- 
regulatory functions (Schmidt and Gessner, 2005). For example, complement C5a interacts 
with surface Fc receptors to modulate inflammation (Schmidt and Gessner, 2005). In this 
context our WT -NeMm strongly up- regulated expression of the regulatory Fcgr2b (Table 
A1- ST -1). Thus the complement -Fc receptor axis induced by AAMN in the response to 
nematode challenge may be an additional anti -inflammatory feature of IL -4Ra- dependent 
macrophage activation. 
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3 TSS- PREDICTOR: IDENTIFICATION OF CIS - 
REGULATORY REGIONS WITH RNA -SEQ DATA 
3.1 INTRODUCTION 
Eukaryotic transcriptional regulation leads to the generation of multiple transcriptional 
isoforms from individual genes arising from regulated changes in exonic splicing and 
promoter usage. Differential promoter usage leads to the production of mRNA isoforms 
with multiple transcription start sites (TSS). The identification of these TSS provides a useful 
starting point to analyse mechanisms of differential gene expression. By defining cis- acting 
transcription factors laying in promoter sequences proximal to TSS it is possible to gain key 
insight into the processes governing cellular responses to developmental and 
environmental cues (Suzuki et al., 2009). 
Second -generation sequencing technologies have catalysed a shift in our ability to 
investigate transcriptomes. Deep sequencing of cDNA (RNA -Seq) is increasingly superseding 
microarray technology as the tool of choice for transcriptomic profiling, primarily due to the 
greatly improved sensitivity and dynamic range offered by RNA -Seq (Wang et al., 2009). 
Methods have been developed to exploit new opportunities offered by RNA -Seq including 
facilitated transcript discovery (Trapnell et al., 2010), alternative splicing (Shen et al., 2012), 
RNA editing and SNP calling (Li et al., 2009). RNA -Seq also has the potential to identify 
major TSS usage for genes. However, TSS identification is hampered by the fact that 
multiple TSSs exist for individual genes. As a consequence of this dedicated methods for 
TSS identification from RNA -Seq data do not currently exist. 
Over the past decade multiple large consortia, including the FANTOM and ENCODE 
projects, have contributed significantly towards the functional annotation of high quality 
genomes such as human and mouse (Carninci et al., 2005; Consortium, 2004). A major 
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component of the annotation effort has been the high- throughput deployment of CAGE 
(cap analysis gene expression) technology to map TSS at base -resolution genome wide. 
CAGE works by capturing and sequencing the first 20 bases of mRNA transcripts from the 5' 
end (Shiraki et al., 2003). These sequenced 'tags' and then mapped to the reference 
genome and counted, providing expression profiling and TSS mapping simultaneously. This 
work has led to the generation of near, if not complete, maps of TSS usage genome wide 
(Carninci et al., 2005). In this chapter I present TSS- Predictor, a pipeline that leverages high 
quality gene annotations to predict major TSS usage for genes from RNA -Seq experiments. 
TSS -Predictor achieves this by revising gene predictions produced by the reference -guided 
transcript assembler Cufflinks (Trapnell et al., 2010). Cufflinks assembles overlapping 
sections of mapped reads into transcribed fragments, called 'transfrags' which are then 
related to known gene models. In principle this is sufficient to allow TSS identification as, 
for each gene, the most abundant set of Cuffcompare transcripts sharing a common TSS 
ought to reflect the primary TSS. 
Anecdotal evidence gained from visualizing reads mapped to the reference genome 
alongside Cufflinks and Ensembl gene predictions indicated that Cufflinks tended to 
systematically predict TSS upstream of the true TSS, for an example see Fiure 3 -5 (p 95). I 
was therefore not satisfied with Cufflinks TSS predictions and devised a strategy to improve 
on these. This is now implemented in the publicly available program TSS- Predictor. TSS - 
Predictor is an embodiment of the method developed in Chapter 2. Significant 
improvements have been made in the usability of the program, and several steps that were 
previously performed manually, such as the selection of transfrags for trimming, are now 
automated. Figures are also automatically generated to help the user assess the success of 
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TSS trimming, and an optimization step can be performed to identify the optimal 
parameters for TSS identification. 
In this chapter I first describe the scripts in the TSS- Predictor pipeline, explaining how the 
algorithm works and how the two main programs, TSS- Optimizer.pl and TSS- Predictor.pl, 
can be used to generate high -quality TSS predictions from RNA -Seq data. Using the RNA - 
Seq dataset generated in chapter 2 it is shown that TSS- Predictor improves TSS inferences 
from Cufflinks. Finally I present the public interface for the TSS- Predictor project (tss- 
predictor.bio.ed.ac.uk). This website contains links to the project download page and 
extensive help documentation including a walkthrough example for generating TSS 
predictions from raw FASTQ data. 
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3.2 METHODS 
3.2.1 DATA INPUT AND PRE -PROCESSING 
Prior to using TSS- Predictor transcript models must be predicted from the data. Sequence 
reads are mapped to a reference genome using TopHat allowing for multiple- mapping 
reads. Reads that map uniquely to the genome are desirable for expression quantification 
because biases are introduced by multiple- mapping reads (Mortazavi et al., 2008). However 
this restricts the 'mappability' of certain repetitive regions of the genome that may include 
highly conserved signalling motifs, interaction domains, and closely related genes (Koehler 
et al., 2011). Effective transcript assembly demands coverage across the length of a gene 
and thus requires the use of multiply mapping reads (Trapnell et al. 2010). Mapped reads 
are next assembled using Cufflinks and assigned to reference genes using Cuffcompare 
from the Cufflinks suite. In the working example presented in this chapter mouse 
macrophage RNA -Seq data generated in Chapter 2 were mapped to the mouse mm9 
reference genome and assigned to the Ensembl v67 reference annotation set. 
3.2.2 THE TSS- PREDICTOR ALGORITHM. 
Below I describe the function of the individual scripts in the TSS- Predictor program. For an 
overview of how these are linked to produce the final TSS- Predictor program see Figure 3 -1. 
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Figure 3 -1. Overview of the TSS- Predictor algorithm. Rectangles represent scripts or 
programs. Diamonds depict data files, green diamonds are input files from external 
sources whereas blue diamonds are produced by TSS= Predictor. The red solid line shows 
the portions of the script covered by TSS- Predictor.pl and the red dashed line shows 
portions of the script covered by TSS -Optimizer.pl 
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3.2.2.1 GETCOVERAGE.PL. 
The first step in the TSS- Predictor pipeline (see Figure 3 -1) is the calculation of per -base 
read coverage at each transcribed location on the genome. This is achieved using BEDTools 
applications (Quinlan and Hall 2010). The user provides the 'combined.gtf file produced by 
Cufflinks Cuffcompare, which contains the exon information for all 'transfrags' produced by 
Cufflinks including their locations, linking them to reference annotations where applicable. 
GetCoverage.pl uses BEDTools mergeBed to 'flatten' all predicted gene models into a list of 
features that are deemed to be transcribed. GetCoverage.pl next accesses the BAM file 
produced by TopHat which contains the positions of all sequenced reads aligning to the 
reference genome. The BEDTools feature intersectBed is used to identify all mapped reads 
overlapping transcribed regions. This data is then passed to genomeCoverageBed which 
counts the number of observed reads overlapping each transcribed base on the reference 
genome. The output of GetCoverage.pl is a three -column file containing the chromosome, 
position and observed sequencing depth. 
3.2.2.2 PREP4TRIM.PL. 
The second step in TSS- Predictor is the selection of a representative Cufflinks 'transfrag' for 
each reference gene. The user provides Prep4Trim.pl with the reference annotation set 
used by Cufflinks Cuffcompare (Ensembl v67 annotations) and two Cufflinks output files. 
The 'transcripts.gtf' annotation file of transfrags produced by Cufflinks, and the 
Cuffcompare `gtf.tmap' file containing additional information for to each transfrag including 
the transcript per -base expression level and the Ensembl transcript ID to which each 
transfrag is linked. Prep4Trim.pl assigns cufflinks transfrags to reference gene using the 
primary reference annotations, and calculates expected per -base coverage for each 
90 
reference gene by summing length -normalized per -base coverage estimates for all 
transfrags linked to the gene as described in Figure 3 -2. 
The longest Cufflinks transfrag, on the same strand, is selected for each reference gene. 
Prep4Trim.pl produces two files - 'trim.combined.gtf and 'trim.gtf.tmap'. 
'Trim.combined.gtf' is a reduced version of the Cufflinks 'combined.gtf file and contains 
only the set of longest transfrags selected for trimming. `Trim.gtf.tmap' is an amended 
version of the `gtf.tmap' output. This contains a mapping between Cufflinks transfrags that 
are to be trimmed and the reference gene, as well as the amended coverage estimate for 
the gene. All other fields in ' trim.gtf.tmap' file are transfrag level information generated by 
Cuffcompare. 
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Figure 3 -2. Per -gene coverage calculation. Each expressed reference gene (G) is 
composed of n transfrags (T), each with coverage (C) and length (L). Thus, CT, is the 
coverage for the 
ith transfrag of gene G, and LTi is the length of the ith transfrag for gene 
G. 
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3.2.2.3 TRIM_CUFFLINKS_GTF.PL 
Trim_Cufflinks_GTF.pI parses the expected gene -level coverage information from the 
'trim.gtf.tmaP' file and transfrag information from 'trim.combined.gtf' produced by 
Prep4Trim.pl. Using the per -base coverage information calculated by GetCoverage.pl each 
selected isotig is trimmed at the position where the observed expression drops below a 
pre- defined fraction of the expected coverage for the gene (X). The estimation of a credible 
value for Xis described below. 
To do this Trim_Cufflinks_GTF.pI iterates, one base at a time, from the last base (3') in the 
first exon of each selected transfrag 5' towards the first base, provided that the observed 
coverage at that base is > X * CG. The annotation is trimmed once the per -base coverage of 
the selected transfrag drops below X * CG. If the observed expression of the final base in the 
first exon is less than X * CG then the second exon is examined, so on and so forth. Figure 3- 
3 provides a graphical representation of the trimming policy implemented by 
Trim_Cufflinks GTF.pI as well as the tendency for Cufflinks to overestimate transcript 
length. 
Trim_Cufflinks GTF.pI generates an 'isotigs.trimmed.gtf' file that contains revised 
transcription start site predictions for each isotig. An additional variable "contain_tss" is 
added to the 9th field of the GTF file to identify exons predicted to contain transcription 
start sites. 
93 
Per -base 
read 
coverage 
TopHat 
mapped 
reads 
Gene tracks 
E 
.e,.,aoo .. 
bb, 
.0,03S(400 s. oo.me,i .00 .. 
E 
i 
. 
. 
. 
i 
. 
{ 
. 
. 
Expected coverage 
Iterate outwards 
Cutoff (x) 
Imi Cufflink's prediction 
Ensembl genes 
Proximal promoter 
prediction 
Figure 3 -3. Overview of TSS- predictor's reverse -trimming policy as described in section 
4.2.2. The top section shows a histogram of per -base read coverage. In the lower panel 
it can be seen that the Cufflinks gene prediction (black) overestimates the true gene 
primary TSS by including a few spurious reads in the gene annotation. The true TSS is 
marked by a precipitous drop in read coverage around the Ensembl- defined TSS (blue). 
The promoter region defined by TSS -predictor (default value 300bp upstream, 100bp 
downstream of TSS) predictions provides a substantial improvement on the cufflinks 
predictions. 
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3.2.2.4 GET -TSS.PL AND GETDISTANCES.PL. 
These are the final scripts in the main TSS- Predictor and TSS- Optimizer pipelines. Get -TSS.pl 
parses the 'isotigs.trimmed.gtf file and reports transcription start sites based on the 
presence of the "contain_tss = yes" flag in the 9th fields of the GTF file. By default Get - 
TSS.pl reports a one base feature identifying the TSS, however to extract promoter 
sequences of arbitrary length the flags ' -u' and ' -d' may be set, this produces a BED file 
containing upstream and downstream regions ' -u' and ' -d' bases from the TSS. BED format 
TSS predictions contain chromosome, start position, end position, reference gene and 
strand information. GetDistances.pl generates a tab -delimited text file containing the 
reference gene, chromosome, predicted transcription start site, nearest reference 
transcript, nearest reference transcription start site and the distance between the two 
predictions. 
3.2.2.5 TSS - OPTIMIZER. PL 
This script is a wrapper for the main TSS prediction algorithm and is used to estimate the 
cutoff fraction (X). TSS -Optimizer.pl takes one chromosome, defined by the user and 
predicts transcription start sites over a range of cutoff fractions specified by the ' -s' start, '- 
e' end and ' -i' increment flags. TSS- Optimizer.pl reports, for each gene at each cutoff 
fraction, the distance between the predicted TSS and nearest annotated TSS for the same 
gene. TSS- Optimizer also R scripts to produce a graph showing the median absolute 
deviation (MAD) between the predicted and nearest annotated transcription start sites at 
each cutoff fraction. The cutoff fraction (X) that gives the lowest MAD is determined as 
optimal for use with TSS- Predictor. 
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A number of files are produced by TSS- Optimizer.pl. Firstly, a reduced version of the 
'.coverage' file is created for the chromosome of interest. This simple step substantially 
reduces the time taken to iterate over each coverage cutoff. TSS- Optimizer.pl produces 
multiple copies of 'isotigs.trimmed.gtf, 'distances.txt' and 'tss.prediction.bed', one for each 
cutoff fraction interrogated. Finally a matrix file 'CutoffDistances.txt' containing distance 
information for each gene at each coverage cutoff is produced. 
The most informative output of TSS- Optimizer.pl is the graph 'Optimizer- MADPIot.jpg'. This 
bar chart, produced by the R script'MADPIot.R', shows the MAD between TSS predictions 
and nearest annotated TSS over all cutoff fractions assessed. The cutoff fraction yielding 
the lowest MAD is shown in red and should be given to 'TSS- Predictor.pl' to determine TSS 
usage genome wide. The actual MAD calculated by TSS- Optimizer contains no post -filtering 
and is therefore typically much greater than the value obtained in the final predictions. 
3.2.2.6 TSS -PREDICTOR.PL 
TSS- Predictr.pl identifies TSS from RNA -Seq data genome -wide. Similar to TSS- Optimizer.pl 
this script acts as a wrapper for Prep4Trim.pl, Trim_Cufflinks_GTF.pI, Get- TSS.pI and 
GetDistances.pl. Accordingly, the user provides TSS- Predictor.pl with the reference 
annotations, the cufflinks directory, Cuffcompare prefix and path to the 'cuffcompare.tmap' 
file, the cutoff fraction (X) determined using TSS- Optimizer.pl and the number of bases 
upstream and downstream of the TSS prediction to report. A BED format 
'tss.prediction.bed' file is produced alongside the 'distances.txt' file produced by 
GetDistances.pl. An essential step for obtaining high quality TSS predictions is filtering the 
data. The two strategies for filtering we implement are depth -based and distance -based 
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filtering. While filtering is performed using the `SelectTSS.pI'script, figures are produced by 
'TSS- Predictor.pl' to aid the selection of appropriate cutoff conditions. 
3.2.2.7 SelectTSS.pl 
This script is used to filter the dataset after running TSS -Predictor.pl. The user provides 
either an expression, or distance based cutoff using the flags ' -e' or ' -d'. Select.tss.pl reports 
a BED file containing only those genes with expression greater than the specified cutoff, or 
predicted TSS less than the specified distance from the nearest annotated TSS for the gene. 
If both ' -e' and ' -d' are specified then both criteria must be met for a gene to be reported. 
Additionally the user may specify whether to report the predicted TSS, or the TSS of the 
closest reference transcript using the flag ' -r'. When a high quality reference annotation set 
us used, high quality macrophage TSS are obtained after removing both lowly expressed 
genes and TSS predictions a 'large' distance from the nearest annotated TSS. As the 
promoter regions surrounding TSS used for cis -regulatory analysis are typically quite small 
(500 -1000 bp), TSS predictions further than the centre of the desired promoter region to 
the nearest annotated TSS are typically removed (500 bp). 
3.2.3 USING TSS -PREDICTOR WITH MACROPHAGE RNA -SEQ DATA 
TSS- Predictor was applied to our macrophage RNA -Seq dataset to demonstrate the 
identification of high -quality TSS predictions. All 12 RNA -Seq libraries were mapped to the 
reference genome with TopHat using default parameters to permit multi- mapping reads. In 
order to obtain deep sequencing coverage for transcript discovery and TSS prediction, all 
mapped read files were merged and sorted by chromosome using SAMTools, aligned reads 
were then assembled using Cufflinks (Trapnell et al. 2010). Ensembl reference annotations 
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were downloaded from the Ensembl FTP site and converted from NCBMI37 to UCSC mm9 
format using Ensembl2UCSC.p1, available at the TSS- Predictor GitHub page. After the 
creation of a '.coverage' file with GetCoverage.pl, TSS- Optimizer.pl was run with the default 
parameters, using chromosome 1 as a subsample. TSS -Optimizer.pl predicts TSS for cutoff 
(X) values between and 1% and 20% of the expected coverage for the gene in 1% 
increments. TSS- Predictor.pl was then run at a cutoff of 4% to identify TSS -usage genome- 
wide as informed by the TSS -Optimizer.pl MAD plot. Finally, to generate a list of high - 
quality TSS predictions, genes with TSS greater than 500bp from the nearest annotated TSS, 
and with a per -base expression less than 65 were disregarded using SelectTSS.pl. 
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3.3 RESULTS 
3.3.1 TSS- PREDICTOR AND VALIDATION WITH MACROPHAGE- RNA -SEQ 
DATA 
3.3.1.1 TSS -PREDICTOR APPLICATION. The utility of the TSS prediction method devised 
for chapter 2 has been extended into an application, TSS- Predictor, which may be used by 
the wider research community. A detailed overview of the algorithm, script by script, is 
provided above. Below I present a working example of TSS- Predictor, Appendix 2 contains a 
list of the software versions used in this example. Extensive help documentation for the 
program including a walkthrough example of how to generate high -quality TSS- Predictions 
from raw sequence data using our macrophage RNA -Seq dataset is available on the website 
and is included in Appendix 3. Here we review the outputs of the various stages of the TSS - 
Predictor algorithm and describe how they inform user choice to obtain high quality 
predictions. 
3.3.1.2 TRANSCRIPTION START SITE PREDICTION WITH TSS -PREDICTOR. Following read 
mapping and transcript assembly with Cufflinks, a '.coverage' file was generated and the 
optimal cutoff fraction determined to be 4% (0.04) using TSS- Optimizer.pl (Figure 3 -4). The 
lowest value highlighted in red in Figure 3 -4 is chosen as the optimal coverage cutoff and 
should be provided to TSS- Predictor.pl in the next step of the TSS- Prediction process. 
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Figure 3 -4. Optimizer -MADplot produced by TSS- Optimizer.pl. The trimming cutoff condition that generates the minimum MAD between TSS predictions and the nearest 
annotated TSS is shown in red (0.04, 4 %) and should be used during TSS- Predictor. 
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Following the identification of the optimal cutoff fraction TSS were predicted genome -wide 
using TSS- Predictor.pl. As described in the methods section, TSS- Predictor.pl identifies TSS 
usage genome -wide for all expressed reference gene, i.e. those that have been assigned to 
at least one cufflinks transfrag. Low abundance transcripts are likely to assemble incorrectly 
due to incomplete coverage across the length of the gene. SelectTSS.pl is designed to filter 
potentially incorrect TSS predictions by removing lowly expressed genes, but this required 
user input. TSS- Predictor.pl assists user decision making by providing a graphical overview 
of the MAD for genes binned by expression level (by calling the R script TSSCutoffs.R). 
Genes are binned according to their expression level, and the MAD between TSS 
predictions and the nearest annotated TSS is calculated for each bin (Figure 3 -5). The 
median expression level of the first bin (lowest expression) with a MAD less than the MAD 
for the entire dataset is taken as the expression cutoff for depth -based filtering (Figure 3 -5). 
An additional approach to obtaining high -quality TSS predictions is to disregard predictions 
that lie a large distance away from the nearest annotated TSS. This assumes that the 
annotation set provided to TSS- Predictor is of high quality. Figure 3 -6 shows that the 
majority of TSS predictions are within 500bp of the nearest annotated TSS. Anecdotal 
evidence from our RNA -Seq dataset suggested that highly expressed genes with TSS 
predictions >500 bases from the nearest predicted TSS tended to arise from incorrect 
transcript assembly, or selection of an incorrect Cufflinks transfrag for trimming. It is 
possible however that identifying abundant TSS a large distance from the nearest 
annotated TSS provides a strategy to define novel TSS usage, thus the selection of a 
distance -based cutoff can be suppressed. To generate our high -quality TSS predictions here 
I remove TSS belonging to both lowly expressed genes (per -base coverage <65) and whose 
distance is greater than 500bp from the nearest annotated TSS for the gene. 
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Figure 3 -5. MAD -expression plot produced by TSS- Predictor.pl, each point shows the 
median MAD for genes within each bin, grouped by per -base expression level. The 
dashed line shows the MAD for all TSS predictions over the entire dataset. Error bars 
depict the interquartile range within each bin. 
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Figure 3 -6. The expression cutoff plot produced by TSS -Predictor.pl (x -axis is truncated 
at + /- 6000bp and the y -axis at the median per -base coverage of the bin with the most 
abundant coverage) the horizontal red line shows the effect of removing lowly - 
expressed genes with the approach outlined in Section 4.2.2 and depicted in Figure 4 -4. 
The value for the horizontal dashed red line is the median expression level of the first 
bin with a lower MAD than the population MAD shown in Figure 4 -5 and is reported to 
the screen by Tss- Predictor.pl. In this instance the advised per -base coverage cutoff is 
65.09. The vertical red line depicts a 500bp window either side of the nearest annotated 
TSS. The numbers within the embedded table reflect the number of genes in each 
quadrant of the plot. Note these do not accurately reflect the data shown due to the 
truncation of the axes. 
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3.3.1.3 VALIDATION OF TSS- PREDICTOR ACCURACY. To validate the improvement 
provided by TSS- Predictor over Cufflinks we calculated the distances between TSS defined 
by Cufflinks, and those defined by TSS- Predictor. Assuming that one of the TSS annotations 
in the reference annotation set is correct, I define TSS -prediction accuracy as the absolute 
distance between the predicted TSS and the nearest annotated TSS for the associated gene. 
Distances were calculated between TSS- Predictor -defined TSS and the nearest annotated 
TSS for the gene. Similarly, these same distances were calculated for the original Cufflinks 
predictions. Cufflinks predictions were then grouped according to whether more than one 
Cufflinks gene prediction was generated for each Ensembl gene. Figure 3 -7 shows the 
distances for TSS- Predictor -defined TSS and Cufflinks- defined TSS for all genes with TSS < 
500bp from the nearest annotated TSS. We can learn a number of things from this figure:- 
A similar number of Cufflinks genes and TSS- Predictor genes have distances <500bp when 
Cufflinks transfrag -Ensembl gene mapping is Ito 1. 
Very few genes have this relationship when Cufflinks transfrag -Ensembl mapping is X >1. 
TSS predictor substantially increases the number and accuracy of predictions less than 
100bp from the nearest annotated TSS. 
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Figure 3 -7. TSS- Predictor predictions are closer to the nearest annotated TSS for the 
gene than Cufflinks predictions. Cufflinks A = Cufflinks gene:EnsGene 1:1 mapping, most 
abundant transfrag. Cufflinks B = Cufflinks gene:EnsGene 1:1 mapping, longest Cufflinks 
transfrag. Cufflinks C = Cufflinks gene:EnsGene >1:1 mapping, most abundant transfrag. 
Cufflinks D = Cufflinks gene:EnsGene >1:1 mapping, longest Cufflinks transfrag. 
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3.3.1.4 TSS- PREDICTOR WEBPAGE. 
The TSS- Predictor project is hosted from URL http : / /tss- predictor.bio.ed.ac.uk (Figure 3 -8). 
The website contains links to the GitHub page https: / /github.com /GrahamThomas /TSS- 
Predictor, where the code can be downloaded. Help documentation (Appendix 3) and links 
to files from the walkthrough example are also provided. 
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3.4 DISCUSSION 
This chapter presents TSS- Predictor, a novel approach for TSS identification using RNA -Seq 
data. The method was originally designed for TSS prediction in a macrophage RNA -Seq 
project (Thomas et al., 2012a) and is here generalized for use with RNA -Seq datasets 
provided the reference genome and accompanying annotations are of high quality. 
Implemented in Perl and R, TSS- Predictor also makes use of BEDTools (as such it is designed 
for use on Unix operating systems and requires a command line for usage). TSS -Predictor is 
trivial to use for those with basic command line experience. Automated scripts produce 
figures to guide user decisions necessary for the production of high -quality TSS predictions. 
The website http : / /tss- predictor.bio.ed.ac.uk provides links to the download page for the 
project and hosts example files as well as extensive help documentation. This includes a 
step -by -step guide on the production of TSS predictions from raw Illumina RNA -Seq data. 
The output BED data format is a de facto standard, and is compatible with many other 
applications for downstream analysis of identified cis -regulatory regions. 
We have demonstrated the utility of TSS- Predictor with the original RNA -Seq dataset for 
which it was designed. Prior to publication, future work will require further testing, and 
validation on a range of mouse and human RNA -Seq datasets downloaded from public 
repositories. In addition to this TSS- Predictor will also be incorporated into the online 
bioinformatics workbench GeneProf (Halbritter et al., 2012). GeneProf provides web -based 
access to command line bioinformatics tools, allowing biologists access to sophisticated 
tools for systems biology research. By incorporating TSS- Predictor into this service we will 
widely increase its accessibility within the research community. 
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4 TIME SERIES ANALYSIS OF MACROPHAGE 
ACTIVATION IN RESPONSE TO L. SIGMODONTIS 
INFECTION 
4.1 INTRODUCTION 
In chapter 2, we defined the phenotype of helminth- elicited AAMO using B. malayi- elicited 
macrophages purified from BALB /c mice 21 days post implantation. This is by far the most 
comprehensive profiling of NeMO performed to date, uncovering both IL -4Ra- dependent 
and IL- 4Ra- independent components of the macrophage activation programme. 
Nonetheless, the experimental strategy we devised has drawbacks that limit the scope of 
conclusions. Firstly, because we assayed the macrophage response to one nematode 
species we are unable to state whether our findings are generally applicable to NeMCO 
phenotypes, or if they reflect a specific component of the response to B. malayi in BALB /c 
mice. Secondly our experiment was performed at a single time -point 21 days post- infection. 
We decided to use this time point because natural helminth infections are typically chronic, 
and this would reflect the fully established macrophage response. Furthermore, due to the 
surgical implant procedure it was necessary to allow sufficient time for complete recovery 
to ensure analysis of helminth- dependent macrophage phenotypes. We also cannot make 
any claims regarding temporal profiles of gene expression during NeMcD induction from our 
RNA -Seq analysis. Our final concern regarded the use of recruited, thioglycollate- elicited, 
macrophages as a control group when we know AAMO can be derived from the resident 
population (Jenkins et al., 2011). 
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The Litomosoides sigmodontis infection model provides a solution to the problems outlined 
above. L. sigmodontis, a natural parasite of the cotton rat, is competent to complete its life 
cycle in the mouse (Hoffmann et al., 2000a). Infective larval L3's are delivered sub- 
cutaneously, these migrate via the lymphatic's into the pleural cavity at 3 -4 days post - 
infection whereupon they undergo two moults, eventually reaching sexual maturity and 
producing microfilarae 50 -60 days post- infection in the susceptible BALB /c mouse strain 
(Hoffmann et al., 2000a). However, most mouse strains such as C57BL/6 are resistant to L. 
sigmodontis infection. Resistance correlates with earlier a significant expansion of pleural 
cavity leukocytes between day 10 and day 30, and adult worms are killed prior to the 
production of microfilarae (Babayan et al., 2003). Thus, L. sigmodontis infection in C57BL/6 
mice is a model to understand the immunological traits conferring resistance to filarial 
nematode infection. 
Owing to the physiologically relevant migration into, and establishment of infection in, the 
pleural cavity, this provides an excellent model for a temporal analysis of the NeMO 
phenotype. The infection site also differs between the B. malayi and L. sigmodontis models. 
Thus, with the choice of an appropriate host mouse strain we are able to decouple the 
strain, site, and species -specific components of the macrophage response to B. malayi 
infection presented in Chapter 2 from those that genuinely reflect the physiological 
response to nematode infection. 
It has recently been reported that IL -4 induces both AAMO and proliferation in vivo (Jenkins 
et al., 2011), however only alternative activation but not proliferation can be replicated in 
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vitro. During L. sigmodontis infection macrophages accumulate in the pleural cavity 
between day 8 and day 15 P.I. This accumulation is IL -4- dependent and results from 
proliferation of the resident macrophage population rather than recruitment from the 
periphery (Jenkins et al., 2011). An open question of biological significance is how can IL -4 
support macrophage proliferation in vivo but not in vitro? Related to this question is a 
paradox concerning the mechanisms of IL -4- dependent macrophage proliferation. Our 
RNA -Seq analysis confirmed in vivo, observations previously reported in vitro, that IL -4 
induces mitochondrial metabolism in AAM0 (Odegaard et al., 2007), Indeed, A Chawla and 
colleagues have stated that alternative macrophage activation requires enhanced 
mitochondrial metabolism (Vats et al., 2006). The prevailing dogma regarding mechanisms 
of cellular proliferation is the requirement for aerobic metabolism, also known as the 
Warburg effect (Vander Heiden et al., 2009). It therefore seems counterintuitive that 
AAMO both up- regulate mitochondrial metabolism and proliferate in response to IL -4 in 
vivo, and one immediate outstanding question is whether the two processes can occur 
concurrently. 
In this chapter we present the first transcriptomic time series analysis of highly purified 
alternatively activated macrophages until the establishment of adult L. sigmodontis, day 28 
post infection (Hoffmann et al., 2000a). We make use of cDNA microarrays for 
transcriptomic profiling owing to the lower requirement for input RNA as compared to 
RNA -Seq libraries. The time series covers both the induction phase of alternative activation 
as well as the macrophage proliferative burst and has, as a starting point, naive tissue - 
resident pleural cavity macrophages. A novel approach to data analysis is presented in 
which we integrate a FACS -based phenotypic analysis of alternative activation and 
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proliferation with genome -wide expression profiling. Linear modelling and principal 
component analysis (PCA) are applied to this dataset allowing us to delineate the 
transcriptional phenotypes associated with the macrophage alternative activation and 
proliferation regimes. 
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4,2 METHODS 
4.2.1 LITOMOSOIDES INFECTIONS 
35 male C57BL/6 mice, aged 10 weeks, were each infected with 30 L. sigmodontis L3s 
suspended in 100 pl RPMI by sub -cutaneous injection. On days 0, 4, 6, 8, 11, 14, 18 and 28, 
5 mice were each sacrificed by terminal anaesthesia (100 pl Domitor /Vetalar 1:1 sub -cut) 
followed by CO2 after bleeding of the brachial artery. Day 0 mice served as naïve controls. 
10 x 1 ml pleural cavity lavages (RPMI + 5% FCS + 2 mM EDTA + 1% penicillin /streptomycin) 
were taken and retained for flow sorting. 
4.2.2 MACROPHAGE PURIFICATION. 
Pleural lavage cells were made up to 10 x 107/ ml and treated with 1 ml RBC lysis buffer 
(Sigma). 2OOk cells were retained for intracellular staining with the proliferation markers 
Ki67 and YM1 and the remaining cells retained for flow sorting. Surface staining volumes 
were calculated based on the number of cells available such that block and surface staining 
was performed in a final volume of 30 pl /million cells. 
Cells were sorted on an Aria (BD) by Martin Waterfall at the flow cytometry facility at 
Ashworth Laboratories. F4 /80 -Hi resident tissue macrophages were purified on the basis of 
F4/80 -APC (F4/8O- biotin, 1:100; Strep -APC, 1:300) and MHCII -PacBl positivity. 
We excluded dead cells using Live /Dead -Aqua staining and removed cell doublets with FSC- 
A/FSC-W doublet gate. Negative gating was also used to exclude B -Cells (CD19 -PE, 1:100) 
and eosinophils (SiglecF -PE, 1:100). Primary and secondary antibody surface staining steps 
were performed for 25 min each. Sorted macrophages were stored in 700 pl Qiazol 
(Qiagen) prior to RNA extraction. 
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4.2.3 INTRACELLULAR STAINING 
Pleural cavity intracellular staining for YM1 and Ki67 expression was performed by Stephen 
Jenkins. 200k pleural cavity lavage cells were retained prior to FACS sorting (see section 
7.2.1). Cells were surface stained with F4 /80 -PeCy7 (1/200), CD11c -PE (1/200), CD19 -APC 
1/200) and MHCII -PacBI (1/400) at the indicated concentrations in a final volume of 50 µl 
for 25 min. Following this cells were washed twice in FACS buffer (5% FCS, 2 mM EDTA in 
PBS) and fixed overnight at 4 °C using Fixation /Permiabilization solution (eBiosciences). 
Intracellular staining was performed in BD Perm /Wash. Ki67 -FITC (7.5 µl /sample), YM1 -biot 
(1/50), Rabbit- anti -mouse -RELMa (1/75) were added to cells at the indicated 
concentrations in a final volume of 25 IA and incubated for 45 min on ice. Cells were 
washed twice with PermWash before incubation with anti -rabbit -PacBl (1/300) and strep- 
PerCP (1/300) in 25 µl for 30 min. Cells were washed twice in PermWash and resuspended 
in 80 µl FACS buffer before acquisition on a FACS Canto. Data were analysed by Stephen 
Jenkins using the FlowJo software. 
4.2.4 MICROARRAY LIBRARY PREP AND HYBRIDIZATIONS 
RNA was extracted from purified macrophages by phenol -chloroform extraction followed 
by clean -up over RNeasy MinElute columns (Qiagen) according to the manufacturer's 
instructions and eluted into a final volume of 15 pl. RNA extractions were performed in five 
batches of eight in order to maximise the speed of RNA extractions. Batches were created 
by extracting one biological replicate from each treatment group together, making the 
identification of batch effects tractable. RNA concentrations and integrity were assessed 
using an RNA -pico chip on the Agilent Bioanalyzer (Agilent Technologies). Samples had an 
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RNA integrity >8 and were suitable for microarray library preparation. Total RNA was 
prepared for hybridization onto Illumina mouse Ref6 -WG2 arrays by conversion into 
Biotinylated amplified RNA (cRNA) using the Illumina TotalPrep RNA amplification kit 
(Ambion) in accordance with the manufacturer's guidelines. cRNA libraries were deemed to 
be of sufficient quality if the fragment size distribution was 250 -5500 nucleotides, and if the 
final amount of cRNA was > 1.5 µg. Concentration and fragment length distribution were 
assayed on a Bioanalyzer RNA nano chip (Agilent Technologies) according to the 
manufacturer's instructions. We did not obtain sufficient cRNA for some libraries with a low 
starting cell number, however successful hybridizations were obtained for all 24 successful 
libraries are shown in Table 4 -1 (results section 7.3.1). Microarray hybridizations were 
performed onto MouseWG -6 v2 arrays (Illumina) at the Edinburgh Wellcome Trust Clinical 
research Facility. 
4.2.5 MICROARRAY NORMALIZATION, ARRAYQUALITYMETRICS 
VALIDATION AND DIFFERENTIAL EXPRESSION ANALYSIS 
MICROARRAY PRE -PROCESSING AND NORMALIZATION. 
Microarray data processing and analysis were performed in R. Raw data intensities were 
first normalized between arrays using the robust spline normalization method and 
homoscedasticity was enforced using the variance stabilizing transformation (Huber et al., 
2002b; Lin et al., 2008), both using the Bioconductor package Beadarray (Dunning et al., 
2007). Beadarray was used to convert data into a MIAME compliant ExpressionSetlllumina 
object for future submission to online gene expression repositories. Non -expressed probes 
were filtered prior to statistical analysis using Illumina's method implemented in the 
Beadarray package (Dunning et al., 2007), a detection score < 0.05 defined probes as non - 
expressed. These data were used for all subsequent analyses. The quality of normalized 
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data were assessed using arrayQualityMetrics (Kauffmann et al., 2009), all hybridizations 
were confirmed to be of high quality. For the arrayQualityMetrics report see Appendix 4. 
TRANSFORMATION OF FACS DATA FOR STATISTICAL ANALYSES. 
Percentage values of YM1 and Ki67h' positivity for each sample, as determined by flow 
cytometry, were imported into R and tested for normality using the Shapiro -Wilk Normality 
Test (R function shapiro.test). %YM1 positive data were found to satisfy the assumption of 
normality (P<0.01), however %Ki67h' frequencies did not. Square root transformation of 
%Ki67h' frequencies yielded normally distributed values suitable for statistical modelling. 
PRINCIPAL COMPONENT ANALYSIS AND LINEAR MODELLING. 
Principal component analysis of normalized gene expression data were performed using the 
base R function 'prcomp'. Differential expression analysis of microarray data was 
performed using the limma package (Smyth). A simple linear model was fit to 
simultaneously incorporate %YM1 positive and transformed %Ki67h' positive values. P- 
values were calculated based on the significance of the correlation of probe expression 
relative to each independent variable (YM1 or root -transformed Ki67h'), and corrected for 
multiple testing using the Benjamini- Hochberg method. We selected a significance cutoff 
based on the log -odds ratio of differential expression (B). This Bayesian estimator is more 
conservative than the parametric approach (Smyth). A B value cutoff of 4.6 was chosen 
corresponding to a <1% likelihood that a correlation between dependent and independent 
variables has occurred by chance. 
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4.2.6 KEGG GSEA (BROAD METHOD) 
Gene Set Enrichment Analysis (GSEA) on microarray data was performed using the Broad 
method (Subramanian et al., 2005) using the downloadable Java applet (version 2.0.10). 
Mouse WG Ref 6 array annotations and KEGG pathway annotations (v3.0) were obtained 
from the Broad Institute MsigDB (Liberzon et al., 2011). Genes were ranked for GSEA 
according to the Pearson's correlation coefficient between gene expression profile and 
%YM1 positive, or root transformed %Ki67h' levels. The most abundantly expressed probe 
for each gene was considered in this analysis. P- values for each gene set were calculated by 
1000 permutations of sample labels. A nominal P -value of 0.05 and FDR of 25% were used 
for significance cut -offs as suggested by the authors of the program (Subramanian et al., 
2005). 
4.2.7 ORDEREDLIST ANALYSIS 
The Bioconductor package OrderedList (Lottaz et al., 2006) was used to identify similarities 
in gene expression patterns between microarray and RNA -Seq experiments by comparing 
ranked lists of gene expression using the default parameters. Microarray data were ordered 
according to the significance of the correlation of gene expression with respect to YM1 
level, taking into account the direction of the correlation (most significant upregulated < 
Not DE > most significant down -regulated). This list of genes was compared against two 
similar rankings of genes from the RNA -Seq experiment (see chapter2), firstly WT- Infected 
vs. WT- Thioglycollate and secondly, WT- Infected vs. IL -4Rá1- infected. P- values were taken 
from the differential expression test performed on the RNA -Seq data in limma for use in 
GSEA in chapter 2. 
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4.2.8 HEATMAPS AND FIGURES 
Heatmaps were drawn using the heatmap.2 function in the gplots package (Warnes et al., 
2009) and all other graphics in R were produced using ggplot2, Prism (GraphPad) or 
automatically using the GSEA software. 
4.2.9 CIS -REGULATORY ANALYSIS WITH HOMER 
To identify over -represented TFBS we first assigned macrophage TSS defined in Chapter 2 
to expressed genes identified on Illumina microarrays using NCB! gene IDs. TSS were next 
assigned as AAMQ -associated or Ki67h1- associated if the parent gene was deemed 
significantly correlated with respect to the appropriate covariate in the limma analysis 
(above). Promoter regions were defined for these TSS by downloading a BED file of 
H3K4Me3 peaks from the lab website (http: / /biowhat.ucsd.edu /homer /data /ucsc /sheinz- 
10-05-28/ ThioMac- H3K4me3.alignment.mm8.bed.gz, Heinz et al. 2010). ChIP -Seq peaks 
were merged using BEDTools slop and merge respectively. All ChIP -Seq peaks within ±1 kb 
of a gene TSS were identified and retained using BEDTools intersect. The resulting file was 
used for motif enrichment analysis using Homer (Heinz et al., 2010). Default parameters 
were run with Homer's findMotifsGenome.pl script and the mouse mm9 genome was 
provided at the reference. Background sequences for overrepresentation analysis were 
selected by Homer to be of equal length and similar GC content to each test sequence. 
118 
4.3 RESULTS 
4.3.1 ACTIVATION AND PROLIFERATION KINETICS OF MACROPHAGES IN 
RESPONSE TO L. SIGMODONTIS INFECTION 
In order to study the kinetics of macrophage proliferation and alternative activation in the 
context of parasite infection we infected C57BL /6 with 30 L. sigmodontis L3 larvae each. We 
have previously defined YM1 as an IL -4Ra- dependent marker of alternative activation in 
macrophages (Loke et al., 2002) and Ki67h' expression as a surrogate for actively 
proliferating cells by FACS (Jenkins et al., 2011). At each time point, days 0 (naïve), 4, 6, 8, 
11, 14, 18 and 28, we measured alternative activation and proliferation by FACS using YM1 
and Ki67 respectively. 
L. sigmodontis enter the pleural cavity at day 4 P.I. after migrating through the lymphatic 
vasculature (Hoffmann et al., 2000a). Consistent with previous observations from our lab (S 
Jenkins - unpublished) there was a notable difference in the kinetics of proliferation vs. 
alternative activation in the macrophage compartment. An increase in proliferation was 
observed by day 6, yet we did not begin to see enhanced YM1 expression until clay 8 (Figure 
4 -1). We have taken advantage of this discordant response to discriminate between genes 
involved in macrophage proliferation and alternative activation in response to L. 
sigmodontis infection in vivo. In this experiment a subsample of cells (200k) from each 
mouse were used for flow cytometric phenotyping while the remainder were retained for 
microarray expression profiling. The microarray expression profiles reflect the average 
expression of each gene over the entire population of F4 /80hi macrophages analysed, 
whereas the flow cytometry data provides information on the frequency of proliferating 
and alternatively activated cells within the sample as a whole. Because we have paired (i.e. 
flow and microarray) data for each mouse this experimental design allows us to correlate 
119 
population -level FACS data against gene expression values to explicitly identify expression 
profiles associated with each phenotype. 
Our macrophage sorting strategy was similar to that performed during our RNA -Seq 
analysis of B. ma /ayi- elicited macrophages. Cell doublets were excluded based on scatter 
profiles, dead cells were disregarded by Live /Dead -Aqua staining and eosinophils (SiglecF +), 
B -cells (CD19 +), and T -cells (CD3 +) removed based on negative gating for PE. F4/80 and 
MHCII were used to sort the F4/80 brightest macrophage population over our time course. 
Figure 4 -2 shows representative sorts at each time point. RNA was extracted from the 
sorted macrophage populations and microarray libraries were prepared (See methods 
section). We ensured the highest possible standard in our data acquisition, and with the 
exception of 2 libraries collected at day 8 all assayed samples were sorted to >85% purity 
(average 94.5% excluding day 8) and had RIN (RNA integrity) values >8 (Table 4 -1). 
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Figure 4 -1. The frequency of %VM1 positive (solid line) and %Ki67h1 (dashed line) pleural 
cavity F4/80 "1 resident tissue macrophages during time series of L. sigmodontis infection 
in this chapter. YM1 serves as a marker of AAMcD and Ki67h1 macropahges are deemed to 
be those in cell cycle as previuously publeihed by Jenkins et al (2011). Error bars 
represent SEM with 5 mice per time point. 
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Microarray libraries were prepared as describe in the methods section and hybridized to 
Illumina Whole Genome Mouse Ref6 arrays to quantitate mRNA expression levels. Due to 
the low numbers of macrophages present at early time points (Table 4 -1 and Figure 4 -3) we 
had limited success obtaining microarray libraries of sufficient concentration and quality for 
hybridization. Consequently data were only available for one naïve individual, two mice at 
day 4, and we obtained no successful libraries from day 6 post -infection. In total 24 
successful libraries and hybridizations were performed (see Table 4 -1). The viability of a 
large number of microarray experiments is undermined by the inadvertent 'aliasing' of 
technical and biological variability. For example, if one performs independent RNA 
extractions on biological replicates then there is no way of discriminating between changes 
in gene expression due to treatment and those due to RNA extraction. Throughout this 
experiment it was ensured that any potential technical artefacts could be identified during 
data QC. RNA was extracted using a balanced -block design where a single replicate from 
each time point were extracted together, small RNA extraction groups also expedited each 
isolation, maximizing RNA quality. Microarray libraries were prepared in a single batch to 
minimize technical variability at this critical stage. Finally samples were hybridized to arrays 
(each array takes 6 samples) in a manner that minimized the overlap between RNA 
extraction groups, day post infection and array number. 
Prior to statistical analysis of differential expression in microarray experiments, data are 
normalized both within- and between -arrays. Using the Bioconductor package beadarray 
(Dunning et al., 2007) we implemented an optimal pipeline for the normalization of 
Illumina microarray data (Lin et al., 2008). The robust spline normalization (RSN) method 
(Lin et al., 2008) was used to accurately define signal intensities for microarray probes, this 
is specifically designed to take advantage of the replicated and random probe distribution 
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on Illumina arrays (Lin et al., 2008). Raw signal intensities were then scaled using the VSN 
method (Huber et al., 2002b) which stabilizes the mean -variance relationship between 
signal intensities across the range of expression values both within and between arrays. 
This approach to data normalization allows the application of traditional parametric 
statistical techniques, such as linear modelling (Huber et al., 2002b; Smyth). After 
normalization, data QC was performed using the battery of analyses provided in the 
Bioconductor package arrayQualityMetrics (Kauffmann et al., 2009). This package performs 
three kinds of test for array data quality and highlights hybridizations that fail any one of 
these tests. All of the samples we analysed passed every test. Between array comparisons 
are made by assessing pairwise distances between arrays and using PCA, the distributions 
of normalized array intensities are assessed using box- and density -plots. Finally individual 
array quality is assessed by calculating Hoeffding's statistic (Da) for each array, this assesses 
systematic biases in relative expression (M) as a function of absolute expression (A) over 
each array, an indicator or microarray hybridization quality. A printout of the 
arrayQualityMetrics report for this project is included in Appendix 4. 
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Figure 4 -2. Sorting strategy for macrophage isolation during L. sigmodontis time- course. 
Cells were first identified based on FSC -A, SSC -A scatter profiles and cell -cell doublets 
excluded by FSC -A and FSC -W scatter profiles. Following this dead cells were excluded 
using Live /Dead -aqua staining and T- cells, B -cells and eosinophils excluded by negative 
gating for CD3 -PE, CD19 -PE and SiglecF -PE respectively. Finally macrophages were 
idneitified based upon F4 /80 -APC and MHCII -PacBI positivity. One representative mouse 
is shown for each time point. 
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Class Day Total 
Cells 
( *106) 
Total 
F4 /80hi 
( *106) 
% 
F4 /80hi 
Sorted 
F4 /80h' 
F4/80 
hi 
purity 
( %) 
Total 
RNA 
(I.tg) 
RIN Array 
No. 
Total 
cRNA 
Naive 0 0.82 0.223 27.2 56,105 97.8 2.28 9.6 2 2.28 
Infected 4 0.93 0.208 22.4 46,704 92.8 1.74 9.7 1 1.74 
Infected 4 1.50 0.585 39.0 86,593 89.2 1.60 9.1 3 1.60 
Infected 8 5.84 0.439 7.5 45,722 67.5 2.40 9.9 1 2.40 
Infected 8 1.78 0.285 16.0 52,745 65.7 4.16 9.5 2 4.16 
Infected 8 3.92 0.459 11.7 122,674 88.2 1.90 8.8 4 1.90 
Infected 8 2.58 0.490 19.0 78,722 89.2 2.78 9.1 3 2.78 
Infected 11 20.4 2.917 14.3 367,132 98.8 4.48 9.6 2 4.48 
Infected 11 13.8 2.636 19.1 656,723 93.6 5.26 9.6 3 5.26 
Infected 11 11.8 3.269 27.7 1,081,2 97.5 2.98 9.7 3 2.98 
81 
Infected 11 17.8 2.830 15.9 276,928 91.7 2.98 9.6 1 2.98 
Infected 11 14.6 2.073 14.2 211,033 96.2 2.32 9.5 4 2.32 
Infected 14 16.8 4.939 29.4 327,051 86.1 1.92 9.5 1 1.92 
Infected 14 17.8 4.948 27.8 347,283 93.1 2.32 9.8 4 2.32 
Infected 14 12.6 1.940 15.4 147,448 98.8 1.58 10 2 1.58 
Infected 18 11.8 2.631 22.3 265,261 92.6 3.00 9.2 4 3.00 
Infected 18 8.40 2.402 28.6 189,438 89.6 3.34 8.9 2 3.34 
Infected 18 16.8 5.796 34.5 589,505 96.3 2.74 9.9 3 2.74 
Infected 18 15.4 4.050 26.3 517,888 97.3 2.56 9.2 4 2.56 
Infected 18 24.6 11.193 45.5 1,433,7 96.5 5.02 9.6 1 5.02 
06 
Infected 28 69.5 20.781 29.9 610,803 98.0 2.38 9.4 4 2.38 
Infected 28 41.5 7.429 17.9 425,410 98.8 2.64 9.4 2 2.64 
Infected 28 61.5 9.963 16.2 315,393 97.2 4.12 9.5 3 4.12 
Infected 28 65.0 14.950 23.0 327,241 98.6 3.68 9.5 1 3.68 
Table 4 -1. Summary statistics for each successful cDNA sample profiled by microarray in 
this chapter. The tabl detailis the day post infection with L. sigmodontis, both the total 
number of pleural lavage calls and F4 /80h' macrophages and the number of sorted 
F4/80h1 macrophages, the final amount of RNA extracted and bioanlayzer RNA integrity 
(RIN). Additionally the array number the sample was profiled on and the final cRNA 
yield prior to array analysis. 
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Figure 4 -3. Increase in macrophage cell numbers in the response to L. sigmodontis 
infection. The total number of F4/801" tissue resident macrophages (solid line), and the 
number of FACS sorted F4/80h1 macrophages (dashed line) obtained from the pleural 
cavities of L. sigmodontis- infected mice for microarray profiling. Day 0 mice were naive. 
Error bars represent SEM with 5 mice per time point. 
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4.3.2 MICROARRAY PCA ANALYSIS - MACROPHAGE PROLIFERATION AND 
ALTERNATIVE ACTIVATION ARE CHARACTERIZED BY INDEPENDENT 
TRANSCRIPTIONAL PROFILES 
We performed principal component analysis (PCA) to understand the processes controlling 
the variability in macrophage gene expression during the expansion and activation 
response to L. sigmodontis infection. PCA is an unsupervised dimension reduction 
technique that groups genes into bins that explain the variability in a dataset. As an 
unsupervised technique, PCA is naive to experimental design and /or potential confounding 
artefacts. With an appropriate experimental design (such as discussed in section c.i in this 
chapter) PCA can be used to confirm data quality or identify potential confounding 
covariates. Each principal component (PC) is assigned an 'eigenvalue', which serves as a 
measure of the proportion of variability in the overall dataset that is explained by that 
component. The more variability explained by a principal component the higher the 
eigenvalue. Furthermore, a gene's 'loading' within each principal component defines the 
relative contribution of that gene to the principal component's eigenvalue. Thus, the PC 
explaining the greatest variability in a dataset is identified as having the largest eigenvalue, 
and the genes that contribute most within each PC are identified as having the largest 
loading. 
Our initial principal component analysis shows that the majority of variability, 61.9 %, in our 
dataset is explained by the first two principal components, accounting for 36.4% and 25.5% 
respectively (Figure 4 -4a). We wanted to understand if the variance observed in PC1 and 
PC2 can be explained by biology, rather than technical artefact. A plot of PC1 against PC2 
with samples coloured by day (Figure 4 -4b) shows a general tendency for gene expression 
profiles to cluster according to day post infection. Interestingly the naïve (Day 0) and two 
Day 4 samples cluster tightly together indicating no differences exist in the transcriptional 
profiles of these populations between at this early time points. Linear regression analysis of 
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gene expression profiles between day 0 and day 4 samples confirmed that day 4 samples 
were essentially naive. There was a greater degree of similarity between day 0 and mean 
day 4 gene expression (R= 0.989) than between the two independent biological replicates 
sampled at day 4 (R = 0.983, Figure7-5a,b). 
The overall tendency appears to be for a correlation between day P.I. and the first principal 
component. The frequency of YM1 positive macrophages as measured by FACS was used as 
a surrogate marker for AAMcD in this experiment. This is because we know that 
macrophage YM1 expression is IL -4Ra- dependent in this system. The percentage of YM1 
positive macrophages from our flow analysis were correlated against PC1 to explore 
whether PC1 captures a gene expression profile consistent with alternative activation 
(Figure 4 -4c). This is indeed the case and a linear regression of PC1 against %YM1 positive 
reveals a strong, highly significant, correlation between the two variables (R =0.78, 
P<0.0001). From this we can conclude that roughly a third (36.4 %) of the total variation in 
macrophage transcriptional activity during L. sigmodontis infection is associated with the 
alternative activation regime. Because the Ki67h' macrophage population represents 
actively proliferating cells (Jenkins et al., 2011), we performed a similar correlation analysis 
between %Ki67h' macrophages measured by FACS and the second PC (Figure 4 -4e and f). 
The results of this analysis revealed a similar, highly significant, correlation between Ki67h' 
levels and PC2 gene expression profiles (R =0.46, P <0.001). Similarly, roughly a quarter 
(25.5 %) of the total variation in macrophage gene expression in this dataset correlates with 
macrophage proliferation. Thus, approximately 60% of the total variability in gene 
expression can be attributed to either alternative activation or proliferation, which further 
validates the quality of the dataset in this analysis. Importantly, as by definition, there is no 
correlation between PC1 and PC2, these data show that the expression profiles associated 
128 
with proliferation and alternative activation are independent. Importantly, neither the 
correlation between YM1 and PC2, or Ki67h' and PC1 were significant (P= 0.1238 and 
P= 0.1289 respectively). This is surprising considering that both alternative activation and 
proliferation are predominantly IL -4- dependent in this model. 
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Figure 4 -4. Principal component analysis (PCA) of microarray data showing that the first 
principal component (PC) correlates with AAM D and that the second principal 
component correlates with macrophage proliferation. PCA was performed on all 
expressed genes in the microarray dataset. A) Scree plot showing the relative 
proportion of variance explained by each of the 10 largest principal components. Scatter 
plots of PC1 vs PC2 loadings coloured by b) day, c) %YM1 positivity and e) %Ki67" 
positivity as measured by FACS. D) Linear regression analysis of PC1 values against 
%YM1 positivity. F) Linear regression analysis of PC2 values against %Ki67hi positivity. 
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Figure 4 -5. F4/80h1 macropahges at day 4 post infection are transcriptionally 
indistinguishable from naive pleural cavity F4/80h1 macrophages. A) Linear regression of 
gene expression profiles of the two independent biological replicates sampled at day 4 
post infection (P.I.) showing a high degree of similarity between the two biological 
replicates. B) Linear regression analysis of mean gene expression of samples acquired at 
day 4 P.I. against the single successful day 0, naïve, microarray hybridization. 
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4.3.3 LINEAR MODELLING TO IDENTIFY GENE EXPRESSION ASSOCIATION 
WITH YM1 AND K167 
A generalized linear modelling (GLM) approach was taken to identify statistically significant 
changes in gene associated with %YM1 and %Kí67 "' macrophages as defined by FACS. Firstly 
we determined that the expression profiles of our explanatory (FACS) variables adhered to 
the requirements of linear modelling and were normally distributed. A Shapiro -Wilk 
normality test confirmed that YM1 was normally distributed (i.e. failed to reject the null 
hypothesis at our chosen cutoff of P<0.01, P= 0.02). The distribution of Ki67"' levels on the 
other hand were not Gaussian (P <0.001), this was corrected using a square root transform 
of %Ki67"' levels (P= 0.17). 
We confirmed the fit of our linear model by analysing residual errors after fitting the linear 
model. For successful linear modelling the explanatory data must provide a good fit to the 
observed data. This assumption requires that residual errors must be normally distributed 
after fitting the linear model. The analysis of residual errors from microarray experiments 
can identify systematic biases to help identify outlying patterns of gene expression. Firstly, 
to compare residuals between the many genes in a microarray experiment they must be 
normalized, and studentization is the method used for this (Oron et al., 2008). This 
approach involves dividing each residual for a gene by the standard deviation of the 
residuals for the gene. Hierarchical clustering of studentized residuals resulted in the 
production of a heatmap showing little, if any, structure (Figure 4 -6). This tells us that a 
linear model describing gene expression as a function of YM1 and Ki67"' captures the 
variation in the dataset well. If additional temporal features of alternative activation were 
detectable over the time course and interval range we have sampled we would expect to 
have observed systematic biases in the residual errors of the linear model. 
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A log -odds ratio of 4.6 was used as our significance cutoff, this corresponds to a < 1% 
chance of a correlation between our explanatory and response variables (FACS data and 
gene expression data) occurring by chance. The log -odds ratio calculated by limma provides 
a more accurate measure of significance when few samples are present, and is derived by 
borrowing information on the variance in gene expression of similarly expressed probes 
across all genes (Smyth, 2004). The B -value of 4.6 corresponds to adjusted P- values of 
1.1x105 for YM1 and 1.2x10 -4 for YM1 associated genes and is therefore more conservative 
than the parametric method. We identified 685 significant probes associated with YM1, and 
569 probes associated with Ki67. Multiple probes may map to a single gene, these results 
corresponded to a significant association of 500 genes with YM1, and 399 genes with Ki67 
(Figure 4 -7a). Supporting the findings of our principal component analysis, that there is 
little overlap in significance profiles associated with alternative activation and proliferation. 
Thirteen significant genes were shared between the two lists (Figure 4 -7a, b) including two 
genes, Ccbll and Cd209b, whose expression is positively associated with alternative 
activation, but negatively associated with proliferation. Notably the expression profile of 
these genes is down -regulated (relative to naïve Day 0 and Day 4) at day 11, the peak of IL- 
4- dependent proliferation and a time point with significant alternative activation. 
Nine of the 13 genes significantly associated with both YM1 and Ki67 were up- regulated 
during proliferation, and significantly down -regulated later during alternative activation 
(Figure 4 -7b). This list of genes includes the proliferation- associated gene Cdca4 (Hayashi et 
al., 2006), the histone cluster protein Hist2h2ab, and the nucleosome assembly protein 
Nap111 (Keck and Pemberton, 2012) and is suggestive of chromatin remodelling, perhaps 
reflecting a maturation phase post peak proliferation. Intriguingly, genes associated with 
cellular migration and adhesion Corola and Smtn and Sell (L- selectin, Cd621) are down- 
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regulated over the time series of L. sigmodontis infection (Gatfield et al., 2005; Grailer et 
al., 2009). Together, these data support our previous conclusion (Thomas et al., 2012a) that 
AAM are associated with a reduced migratory capacity. We also observe the reverse 
expression profile, where genes negatively correlate with proliferation and positively 
correlate with alternative activation. These include the cell- surface marker Cd209b (DC- 
SIGN, (Cheong et al., 2010) which is expressed at a lower level in Day 11 proliferating 
macrophages (the peak of IL -4- dependent proliferation) relative to both naive and later 
time points. If we assume that the F4 /80h' macrophage population we assayed during this 
time course is derived from a resident population, these data imply that additional changes 
occur in the macrophage phenotype post IL -4- dependent proliferation. Furthermore, 
Cd290b expression may reflect this maturation or terminal differentiation step in AAMm as 
it is described to do so in dendritic cells (Cheong et al., 2010). 
The distribution of statistically significant positive and negative correlations with YM1 is 
roughly equal with 269 positive and 231 negative genes; similarly, the distribution of fold 
changes is roughly equal (Figure 4 -8) showing that alternative activation is associated as 
much with up- regulation as down -regulation (Table 4 -2). Although the microarray analysis 
has identified a lower number of DE genes than the RNA -Seq analysis presented in chapter 
2, the same trend of roughly equal up- and down -regulated genes was observed between 
both WT- Infected and WT- Thioglycollate and WT- and IL- 4Ra4 -- infected groups. 
The DE profiles of Ki67- associated genes differ from YM1. Of the 399 statistically significant 
correlations 231 genes positively correlated, while only 80 genes negatively correlated with 
Ki67 (Table 4 -2). Furthermore there was a tendency for up- regulated genes to be more 
highly correlated with Ki67 than down -regulated genes were negatively correlated (if this 
was categorical we would say the fold changes are greater, Figure 4 -9). This implies that 
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commitment to proliferation is associated with the induction of genes associated with 
proliferation, rather than the repression of inhibitors of proliferation. 
We have identified substantial changes in dynamic gene expression associated with 
macrophage proliferation and alternative activation in the response to L. sigmodontis 
infection. Both PCA and linear modelling approaches support the concept that proliferation 
and alternative activation, while both IL -4- dependent are transcriptionally independent 
processes. 
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Figure 4 -6.No obvious transcriptional signature remains after accounting for gene 
expression associated with alternative activation (YM1) and proliferation (Ki67h1). 
Heatmap of internally studentized residual variances after fitting the linear model to 
describe gene expression as a function of %YM1 positive and %Ki67hi positive 
macrophages. Hierarchical clustering was performed using a eucledian distance metric. 
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Figure 4 -7.Few genes significantly associate with both alternative activation and 
proliferation. A) Venn diagram showing the number of genes significantly correlated 
with %YM1 positive and %Ki67h1 levels, and the overlap between the two. B) Gene 
expression profiles of those genes significantly correlated with both %YM1 positive and 
%Ki67h1 levels. 
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Table 4 -2. Genes that correlate significantly with either %YM1 positivity of Ki67hi levels 
as determined by FACS analysis showing the split between positive and negative 
correlation. 
138 
30 -! 
20 
Lyz1 
Apoe 
10- 
Fpr2 
-10 
Hsdllbl 
Emb , 
Htra3 
. 
qh 
. i 
Ccnd1 
ti 
Si 
Clec4d ! ; 
s .. . 
N S '.t 
ro; M
4: 
Anft%4dip 
SISr7046Q7 
Mrvi1 
' t A ti 'KC 
t Btbd11 arl2Fxyd6 
¡w~ ChchdlSO t t ppl Chi313 
.tf,r.t. Trim43aEar4 
, - ~ 
... 
s 
,ey 
Clec4g 
Ucp1 
Timd2 
Earl 
Chi314 
-0.04 0.00 0.04 0.08 
IogFC 
Figure 4 -8. Volcano plot showing the degree of correlation of gene expression with 
%YM1 positivity (y axis). Statistically significant 
genes are above the red dashed line (B =4.6). The top 30 most highly correlated, 
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Figure 4 -9. Volcano plot showing the degree of correlation of gene expression with 
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graph. 
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4.3.4 GSEA AND FOLLOW -UP OF K167- ASSOCIATED GENES HELPS 
DEFINE THE AAM(1) PROLIFERATION TRANSCRIPTIONAL PROFILE 
GSEA. 
We have inferred the expression of genes involved in macrophage proliferation using the 
frequency of Ki67h' macrophages measured by FACS as a surrogate for proliferation. As a 
starting point to better understand the regulatory processes underpinning macrophage 
proliferation in vivo we performed GSEA. GSEA was applied to Ki67h' associated genes as 
described in the methods section in order to identify differentially regulated KEGG 
pathways. Using significance cutoffs suggested by the GSEA authors (nominal P -value 0.05, 
FDR 25 %) fifteen KEGG pathways were positively correlated with Ki67h' levels, and none 
were significantly negatively correlated (Table 4 -3). 
Significant pathways broadly fall into two classes. The most numerous set of significant 
pathways relate to the structural aspects of the cell -cycle and include 'meiosis', 'mitosis' 
and 'DNA replication', as well as additional pathways associated with DNA processing, for 
example, 'DNA excision and repair' and 'homologous recombination'. A second set of 
pathways constitute metabolic processes supporting proliferation, in particular the 
production and processing of purine and pyrimidine nucleosides. This set includes 'purine 
metabolism', ` pyrimidine metabolism' and 'drug metabolism other enzymes'. This analysis 
confirms that our Ki67- associated gene expression signature is indeed a cell -cycle 
associated gene expression profile. 
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KEGG Pathway Gene 
Set 
Size 
ES NES Nominal 
p -val 
FDR 
q -val 
FWER 
p -val 
KEGG OOCYTE MEIOSIS 89 0.5 1.844 0.004 0.075 0.071 
KEGG CELL CYCLE 105 0.6 1.840 0.002 0.040 0.075 
KEGG DRUG METABOLISM OTHER 22 0.5 1.760 0.004 0.083 0.196 
ENZYMES 
KEGG PROGESTERONE MEDIATED 68 0.4 1.751 0.002 0.070 0.218 
OOCYTE MATURATION 
KEGG HOMOLOGOUS 22 0.7 1.730 0.025 0.074 0.264 
RECOMBINATION 
KEGG DNA REPLICATION 33 0.9 1.701 0.006 0.090 0.345 
KEGG NUCLEOTIDE EXCISION 43 0.6 1.670 0.039 0.110 0.436 
REPAIR 
KEGG SPLICEOSOME 89 0.6 1.670 0.029 0.097 0.437 
KEGG CYSTEINE AND METHIONINE 22 0.6 1.658 0.010 0.096 0.467 
METABOLISM 
KEGG PROTEASOME 38 0.8 1.653 0.014 0.091 0.482 
KEGG PYRIMIDINE METABOLISM 78 0.5 1.619 0.049 0.116 0.571 
KEGG PURINE METABOLISM 126 0.4 1.618 0.010 0.107 0.574 
KEGG MISMATCH REPAIR 22 0.7 1.618 0.039 0.099 0.575 
KEGG AMINOACYL TRNA 40 0.6 1.582 0.039 0.117 0.675 
BIOSYNTHESIS 
KEGG P53 SIGNALING PATHWAY 55 0.4 1.487 0.047 0.193 0.871 
Table 4 -3. Gene set enrichment analysis results of KEGG pathways positively correlated 
with %Ki67h1 expression showing that a cell -cycle signature is associated with Ki67 
protein expression levels. ES = enrichment score, NES = normalized enrichment score, 
FDR q -val= Benjamini- Hochberg corrected p- value, FWER p -val = family wise error rate 
corrected p- value. 
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CIS-REGULATORY ANALYSIS. 
We have confirmed that our linear modelling approach correctly integrates our microarray 
dataset with the FACS analysis to identify genes associated with the macrophage 
proliferation program. Next we wanted to identify candidate factors that may regulate this 
proliferation program. In order to do this we analysed the proximal promoters of Ki67 - 
associated genes for over -represented TFBS using Homer (Heinz et al., 2010). 
We took a slightly different, more biologically informed, approach to cis -regulatory analysis 
to the previous analysis presented in chapter 2. Firstly, 7,319 of the peritoneal macrophage 
TSS predictions generated in Chapter 2 were assigned to expressed genes from this 
microarray experiment. A set of TSS belonging to proliferation- associated genes was 
created by assigning 225 TSS belonging to genes that significantly positively correlated with 
%Ki67h' levels. Similarly, an AAMN- associated TSS set was made by identifying the 182 
genes with TSS predictions that positively correlated with %YM1 positivity. H3K4 
trimethylation (H3K4me3) is an epigenetic marker for promoter and enhancer regions 
(Ghisletti et al., 2010). H3K4me3 peaks defined by ChIP -Seq in peritoneal thioglycollate 
elicited macrophages (Heinz et al., 2010) were downloaded, and promoter regions flanking 
TSS were identified based on these peaks. Following the protocols in Heinz et al. (2010) we 
defined a gene's promoter as any H3K4Me3 peak within ±1kb of a predicted TSS. In total 
1,098 H3K4me3 peaks were found to mark the promoters of YM1- associated genes, and 
1,325 H3K4me3 peaks marked the promoters of Ki67- associated genes. To identify over- 
represented TFBS associated with Ki67 and YM -1, hypergeometric analysis for over- 
represented TFBS was performed on these TSS regions using Homer (Heinz et al., 2010) 
with the mouse genome serving as a background control. 
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31 known TFBS were over -represented in YM1- associated promoter regions (Table 4 -4), 
and 40 TFBS were found to be over -represented in Ki67h'- associated promoter regions 
(Table 4 -5). 13 TFBS motifs were common to both Ki67h1- associated and YM1- associated 
promoters (Table 4 -6), including the downstream mediator of M -CSF signalling EIk1 (Yao et 
al., 2005), the AAMO marker Klf4 (Liao et al., 2011) and multiple binding sites for ETS family 
transcription factors implicated in macrophage development (Wu et al., 1994). STAT6 
controls AAMO by mediating IL -4- dependent signalling (Takeda et al., 1996). Interestingly, 
the STAT6 motif was found to be statistically overrepresented in the promoters of YM1- 
associated genes, but was not found in Ki67h'- associated promoters. This observation 
supports our understanding that STAT6 is required for AAMm. Importantly, the absence of 
a STAT6 motif in the promoters of proliferation- associated genes further suggests that 
STAT6 does not directly engage with the machinery of cellular proliferation. This is 
consistent with our PCA and linear modelling analyses, and supports a model wherein 
STAT6- dependent transcription and IL -4- dependent proliferation are mechanistically 
independent processes. 
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Motif name YM1 P value YM1 q value #YM1 
targets 
with motif 
%YM1 
targets 
with motif 
# BG seqs 
with motif 
% BG seqs 
with motif 
SPDEF(ETS) 1.00E-14 0 577 52.55% 17772 40.68% 
TbxS(T-box) 1.00E-10 0 971 88.43% 35493 81.25% 
IRF4(IRF) 1.00E-08 0 206 18.76% 5488 12.56% 
ISRE(IRF) 1.00E-08 0 49 4.46% 741 1.70% 
BORIS(Zf) 1.00E-07 0 262 23.86% 7545 17.27% 
Mef2c(MADS) 1.00E-07 0 150 13.66% 3830 8.77% 
Egr 1.00E-06 0 267 24.32% 7873 18.02% 
EKLF(Zf) 1.00E-06 0 178 16.21% 4918 11.26% 
PRDM1 1.00E-05 1.00E-04 249 22.68% 7640 17.49% 
NFAT(RHD) 1.00E-05 1.00E-04 324 29.51% 10401 23.81% 
SCL/HPC7 1.00E-04 3.00E-04 1055 96.08% 40722 93.22% 
Znf263(Zf) 1.00E-04 5.00E-04 878 79.96% 32742 74.95% 
Srebpla(HLH) 0.001 0.0018 118 10.75% 3371 7.72% 
FOXA1:AR 0.001 0.0024 43 3.92% 962 2.20% 
CEBP(bZIP) 0.001 0.0044 204 18.58% 6532 14.95% 
USF1(HLH) 0.001 0.0048 270 24.59% 8980 20.56% 
STAT6 0.001 0.0058 202 18.40% 6503 14.89% 
STAT5(Stat) 0.001 0.0066 146 13.30% 4505 10.31% 
Table 4 -4. Homer results showing over -represented TFBS unique to AAMc- associated 
promoters. AAMc- associated promoters were defined as H3K4me3 peaks present 
within ±1kb of TSS that were significantly positively correlated with %YM1 positive 
cells. In total 1,098 AAMcD- associated H3K4me3 peaks were defined. BG seqs = 
background sequences. 
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Motif name Ki67 P value Ki67 q 
value 
# Ki67 
targets with 
motif 
% Ki67 
targets with 
motif 
# BG 
seqs 
with 
motif 
% BG seqs 
with motif 
E2F7(E2F) 1.00E-108 0 459 34.64% 4713 11.39% 
E2F4(E2F 1.00E-98 0 845 63.77% 14542 35.13% 
E2F(E2F) 1.00E-75 0 249 18.79% 1960 4.74% 
NFY(CCAAT) 1.00E-71 0 762 57.51% 13814 33.37% 
E2F6(E2F) 1.00E-56 0 808 60.98% 16278 39.32% 
GFY-Staf 1.00E-40 0 168 12.68% 1565 3.78% 
CHR 1.00E-25 0 377 28.45% 6919 16.72% 
GFY 1.00E-17 0 122 9.21% 1615 3.90% 
BMYB(HTH) 1.00E-14 0 804 60.68% 20630 49.84% 
MYB(HTH) 1.00E-13 0 913 68.91% 24325 58.77% 
JunD(bZIP) 1.00E-10 0 107 8.08% 1659 4.01% 
ETS:RUNX 1.00E-07 0 108 8.15% 1981 4.79% 
TEAD4(TEA) 1.00E-05 0 432 32.60% 11186 27.02% 
CRE(bZIP) 1.00E-05 0 218 16.45% 5029 12.15% 
Nanog (Hox) 1.00E-05 0 1180 89.06% 34997 84.55% 
GFX 1.00E-04 4.00E-04 44 3.32% 721 1.74% 
FOXA1 1.00E-04 4.00E-04 479 36.15% 12878 31.11% 
ETS1(ETS) 0.001 8.00E-04 658 49.66% 18454 44.58% 
Lhx3 (Hox) 0.001 0.0011 401 30.26% 10698 25.85% 
Atf1(bZIP) 0.001 0.0022 345 26.04% 9142 22.09% 
ZBTB33 0.001 0.0012 98 7.40% 2108 5.09% 
Foxh1 0.001 0.0048 273 20.60% 7137 17.24% 
(Forkhead) 
Pax7 ( H ox) 0.001 0.001 21 1.58% 261 0.63% 
Tcf4(HMG) 0.01 0.0067 223 16.83% 5733 13.85% 
bHLHE40(HLH) 0.01 0.0073 144 10.87% 3506 8.47% 
EWS:FLI1- 0.01 0.0072 391 29.51% 10689 25.82% 
fusion(ETS) 
NF1:FOXA1 0.01 0.0059 32 2.42% 546 1.32% 
Table 4 -5. Homer results showing over -represented TFBS in promoters of %Ki67h' 
associated transcripts. %Ki67"- associated promoters were defined as H3K4me3 peaks 
within ±1kb of TSS that were significantly positively correlated with %Ki67h'. In total 
1,325 AAMcD- associated H3K4me3 peaks were defined. BG seqs = background 
sequences. 
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Motif name YM1 P value YM1 q value #YM1 
targets 
with 
motif 
% YM1 
targets 
with motif 
# BG 
seqs 
with 
motif 
% BG 
seqs 
with 
motif 
Sp1(2f) 1.00E -37 0 598 54.46% 15425 35.31% 
EIk1(ETS) 1.00E -35 0 596 54.28% 15569 35.64% 
K1f4(20 1.00E -26 0 472 42.99% 12159 27.83% 
ELF1(ETS) 1.00E -21 0 514 46.81% 14271 32.67% 
FIi1(ETS) 1.00E -21 0 719 65.48% 22318 51.09% 
E1k4(ETS) 1.00E -21 0 552 50.27% 15767 36.09% 
GABPA(ETS) 1.00E -08 0 551 50.18% 18137 41.52% 
ETS(ETS) 1.00E -07 0 302 27.50% 9109 20.85% 
Maz(Zf) 1.00E -07 0 892 81.24% 32567 74.55% 
NRF1 1.00E -05 1.00E -04 244 22.22% 7442 17.04% 
HIF2a(HLH) 1.00E -04 5.00E -04 249 22.68% 7865 18.00% 
NRF1(NRF) 0.001 0.0031 231 21.04% 7460 17.08% 
E2F1(E2F) 0.001 0.0033 302 27.50% 10108 23.14% 
Motif name Ki67 P value Ki67 q value # Ki67 % Ki67 # BG % BG 
targets targets seqs seqs 
with with motif with with 
motif motif motif 
Sp1(Zf) 1.00E -53 0 714 53.89% 15425 35.31% 
EIk1(ETS) 1.00E -28 0 672 50.72% 15569 35.64% 
K1f4(2f) 1.00E -23 0 516 38.94% 12159 27.83% 
ELF1(ETS) 1.00E -21 0 602 45.43% 14271 32.67% 
FIi1(ETS) 1.00E -11 0 803 60.60% 22318 51.09% 
E1k4(ETS) 1.00E -37 0 713 53.81% 15767 36.09% 
GABPA(ETS) 1.00E -09 0 665 50.19% 18137 41.52% 
ETS(ETS) 1.00E -16 0 411 31.02% 9109 20.85% 
Maz(Zf) 0.001 0.001 997 75.25% 32567 74.55% 
NRF1 1.00E -14 0 340 25.66% 7442 17.04% 
HIF2a(HLH) 1.00E -08 0 321 24.23% 7865 18.00% 
NRF1(NRF) 1.00E -18 0 358 27.02% 7460 17.08% 
E2F1(E2F) 1.00E -76 0 599 45.21% 10108 23.14% 
Table 4 -6. Homer results detailing over -represented TFBS common in both 1,098 AAMcD 
and 1,325 %Ki67h" associated promoters (H3K4me3 peaks within ±1kb of gene TSS). BG 
seqs = background sequences. 
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A ROLE FOR E2F TRANSCRIPTION FACTORS IN MACROPHAGE PROLIFERATION? 
The most over -represented TFBS's associated with Ki67 associated genes are for E2F family 
transcription factors which modulate DNA synthesis and cell cycle progression (Table 4 -5, 
(Dyson, 1998). E2F family members are highly conserved, in mouse a total of 8 E2F family 
members (E2f1, E2f2, E2f3, E2f4, E2f5, E2f6, E2f7 and E2f8) play both positive and negative 
roles in cell cycle regulation (Dyson, 1998). The transcription factors Tfdp1 (Transcription 
factor DP1) or Tfdp2 (Transcription factor DP2) and Eapp (E2F- associated phosphoprotein) 
interact with E2F family members to mediate E2F transcriptional activity (Dyson, 1998). 
We explored the dynamic expression profiles E2F complex members to ascertain whether 
these factors may govern the commitment of IL -4- dependent cell cycle in macrophages 
(Figure 4 -10). Only E2f2 and E2f8 showed a statistically significant correlation with Ki67, and 
none correlated significantly with YM1. We did however observe a general tendency for the 
expression of the DNA binding E2F transcription factors (E2f1, E2f2 and E2f3) to correlate 
with Ki67, consistent with their role in cell cycle control and DNA synthesis (Dyson, 1998). 
Interestingly the peak of E2f1 and E2f3 expression is day 8, and this correlates with our 
expectation for the peak of IL -4- independent proliferation during L. sigmodontis infection (S 
Jenkins unpublished). E2f2 levels were induced by day 8 but did not peak until day 11 
(Figure 4 -10). This profile that is consistent with the IL -4- dependent component of 
proliferation. Thus there is an apparent divergence in correlation between E2F family 
members and the IL -4- independent and IL -4- dependent components macrophage 
proliferation. This raises the possibility that differing proliferative programmes require 
different E2F family complexes. To test this hypothesis we induced macrophages to 
proliferate in vivo in response to IL -4 or recombinant M -CSF, the mechanism underlying the 
IL -4 independent phase of macrophage proliferation (S Jenkins, unpublished). RT -PCR 
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analysis of FACS purified macrophages confirmed that E2F transcription factor gene 
expression was associated with proliferation. There was however no clear distinction in the 
E2F transcriptional profiles between M -CSF and IL -4 induced proliferation (data not shown). 
While this supports the idea that E2F factors drive macrophage proliferation, from this 
experiment we are unable to state whether distinct E2F transcriptional profiles are driven 
in response to IL -4 and M -CSF. 
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Figure 4 -10. Expression profiles of E2F gene family members in F4/80h1 macropahges 
over the time course of L. sigmodontis infection. E2F1 and E2F2 expression profiles 
appear to peak with the M -CSF and IL -4- dependent components of proliferation at days 
8 and 11 respectively. Error bars represent SEM calculated for each day independently. 
Days 0 and 4 were pooled to form naïve group (day 0). 
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4.3.5 COMPARISONS BETWEEN L. SIGMODONTIS AND B. MALAY/- 
ELICITED AAM(1) - IDENTIFICATION OF A 'CORE' NEMO 
EXPRESSION PROFILE 
We have inferred nematode -induced IL -4Ra- dependent macrophage gene expression 
profiles both directly and indirectly in three separate experiments in this thesis. Using the B. 
malayi implant model in the BALB /c strain we have directly identified IL -4Ra- dependent 
gene expression by comparing gene expression profiles between WT and IL- 4Ra-1- infected 
mice. Using the same model we have identified differential gene expression by comparing 
WT thioglycollate- elicited macrophages to WT B. ma /ayi- elicited AAMO, a substantial 
component of which is IL -4Ra- dependent (Thomas et al., 2012a). Finally, using the L. 
sigmodontis infection model we have identified AAMO- associated genes by correlating 
gene expression profiles with YM1 levels defined by FACS analysis. 
We set out to definitively compile a list of NeMO- associated genes by integrating the 
results of our microarray and RNA -Seq analyses. By identifying common NeMO- associated 
genes using experiments performed in different host strains (BALB /c and C57BL /6), and 
with different parasite species (B. malayi and L. sigmodontis) that localize to different body 
cavities we are able to define a core list of such genes by removing species- and platform - 
specific biases. 
No analytically meaningful way exists to directly compare gene expression profiles 
measured by RNA -Seq and microarray profiling as the data types are fundamentally 
different. We can however compare results from these two data types using a non - 
parametric rank -based approach. The OrderedList meta -analysis technique (Lottaz et al., 
2006) determines the degree of similarity between two ranked gene lists by computing a 
'similarity score'. The similarity score is based on the overlap between two ranked lists, 
weighting genes towards the top of the list, importantly the score depends upon rank 
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rather than expression level. A p -value is assigned to the similarity score by means of a 
permutation test. This is achieved by randomising one of the lists and re- calculating the 
similarity score multiple times. The final results are a p -value and a list of the genes that 
contribute most to the similarity score (Lottaz et al., 2006). 
To identify genes positively associated with alternative activation we performed two list 
comparisons. Genes from our microarray analysis were ranked according to the significance 
of their correlation with YM1, this list was compared against a list of gene rankings derived 
from the WT -NeMO vs. WT- ThioMO comparison from our RNA -Seq analysis. We observed 
a highly significant similarity between the two lists (P value < 0.0001, based on 100,000 
permutations) with 390 genes contributing towards this similarity (Figure 4 -11a). The same 
analysis was performed, only this time we compared YM1- associated genes against a list of 
rankings drawn from the WT -NeMm vs. IL- 4Ra / --NeMN comparison from our RNA -Seq 
analysis. Again, we found a high degree of similarity between the two lists (P value < 
0.0001, based on 100,000 permutations), with 343 genes contributing to this similarity 
score (Figure 4 -11a). In total 241 genes were found to overlap between the two lists, and 
these comprise our 'core' NeMcD- associated genes (Table 4 -7). Within this list are all of the 
major genes we would expect to see, including Chi313, Retnla, Arg1 and Ppargclb (Loke et 
al., 2002; Pesce et al., 2009; Vats et al., 2006). Additionally multiple genes previously 
characterized as AAM4)- associated 'immune effectors', including the chemokine receptor 
Cxcr7, cytokine receptors lllrll and 1127ra, as well as the cytokines Bmp6 and Wnt2 (Kersten 
et al., 2005; Kurowska -Stolarska et al., 2009; Rückerl et al., 2006; Sánchez -Martín et al., 
2011; Staal et al., 2008). We also identified the complement component C3 and inhibitory 
Fc -gamma receptor Fcgr2b as core AAMcD- associated genes. Surface markers to facilitate 
the isolation and characterization of in vivo -derived AAMm are relatively scarce. The C -type 
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lectins mMGL1 and mMGL2 have previously been described as candidate AAMO- associated 
surface markers (Raes et al., 2005). mMGL2 (mg12) but not mMGL1 (CleclOa) is identified 
amongst the list of 'core' AAMO- associated genes. This was due to the fact that CIeclOa 
was not significantly correlated with YM1 expression in our microarray time course. 
Interestingly, other C -type lectins including Clec4g and Clec4a3 were amongst the core list 
(Table 4 -7) and may warrant further investigation as AAMO- associate marker proteins. 
Finally we have also identified a number of core NeMm genes that are associated with 
alternative activation in human monocyte- derived macrophages includingAloxs, Cd209 and 
114 (Martinez et al., 2006; Satoh et al., 2010). Irf4 has previously been shown to regulate 
the transcription of AAMCD marker genes (Satoh et al., 2010), our cis -regulatory analysis 
also identified an 114 signature, this may represent a key conserved component of AAMc 
transcriptional regulation. 
The analysis was performed for down -regulated genes by reversing the agene lists. We 
found 383 common down -regulated genes between WT B. ma/ayi-elicited macrophages 
and YM1 correlated genes in the response to L. sigmodontis infection (Figure 4 -11b). 
Interestingly, there was relatively less overlap (68 genes) between the genes negatively 
associated with YM1 from the microarray analysis and down -regulated genes between WT 
and IL- 4Ra -1- NeMm, although the majority of these, 55, were shared with the 383 down - 
regulated genes from the set above. This comprises our list of 'core' down -regulated NeMQ 
genes and can be found in Table 4 -8. 
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A) 
WT Inf vs 
WT Thio 
common 
B) 
Up- regulated 'core' NeMac genes 
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WT Inf vs 
IL4Ra-/- Inf 
common 
241 
WT Inf vs 
WT Thio 
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Down -regulated 'core' NeMac genes 
WT lnf vs 
IL4Ra-/- Inf 
Figure 4 -11. Summary of OrderedList analyses defining `core' -NeMcD genes. Venn 
diagrams showing the number of a) up- regulated, and b) down -regulated, genes 
determined by OrderedList analysis. Genes ranked by correlation with %YM1 positivity 
in the microarray analysis were compared against gene lists derived by ranking both the 
WT -NeM® vs. WT- ThioMcD (left circles) and WT -NeM D vs. IL -4Ra / -NeMcP (right circles) 
comparisons from the RNA -Seq analyses. 
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Symbol Entrez Lito vs. WT WT 
ID YM1 Brugia Brugia vs. 
vs. WT IL -4Ra 
Thio Brugia 
Description 
Clec4g 75863 1.19E -13 5.67E -130 1.53E -225 
Ucp1 22227 3.47E -12 3.55E -75 5.75E -73 
Pde4dip 83679 7.21E -11 1.73E -26 2.40E -28 
SIc7a2 11988 1.04E -10 1.69E -52 4.78E -32 
Gm5150 381484 1.04E -10 2.93E -32 7.53E -51 
Cst7 13011 1.11E -10 1.47E -83 1.23E -77 
Hfe 15216 2.82E -10 4.99E -47 4.85E -43 
Mrvi1 17540 7.09E -10 5.83E -51 8.46E -79 
TIn2 70549 7.09E -10 2.55E -70 7.59E -41 
Ear11 93726 7.09E -10 1.19E -125 8.68E -223 
Clec4a3 73149 8.86E -10 1.05E -24 1.00E -10 
Arl4d 80981 3.00E -09 1.61E -34 1.05E -42 
Mg12 216864 3.26E -09 1.30E -90 2.59E -173 
Prkaa2 108079 5.15E -09 8.92E -50 5.73E -76 
Nrg4 83961 5.35E -09 1.16E -08 9.56E -10 
Dzip1 66573 6.38E -09 8.01E -24 4.48E -28 
Prkcq 18761 6.48E -09 1.69E -34 7.71E -18 
Nb11 17965 8.00E -09 2.15E -43 1.48E -73 
C -type lectin domain 
family 4, member g 
uncoupling protein 1 
(mitochondria], proton 
carrier) 
phosphodiesterase 4D 
interacting protein 
(myomegalin) 
solute carrier family 7 
(cationic amino acid 
transporter, y+ system), 
member 2 
predicted gene 5150 
cystatin F 
(leukocystatin) 
hemochromatosis 
MRV integration site 1 
talin 2 
eosinophil- associated, 
ribonuclease A family, 
member 11 
C -type lectin domain 
family 4, member a3 
ADP -ribosylation factor - 
like 4D 
macrophage galactose 
N- acetyl- galactosam i ne 
specific lectin 2 
protein kinase, AMP - 
activated, alpha 2 
catalytic subunit 
neuregulin 4 
DAZ interacting protein 
1 
protein kinase C, theta 
neuroblastoma, 
suppression of 
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A530064D06Rik 328830 8.00E -09 4.54E -37 1.49E -36 
Gsto1 14873 8.25E -09 3.29E -13 5.59E -15 
Car12 76459 9.04E -09 8.37E -51 1.45E -66 
Fxyd6 59095 1.48E -08 1.47E -83 1.76E -77 
Btbd11 74007 1.65E -08 1.61E -58 1.11E -77 
Fut8 53618 1.80E -08 1.02E -07 8.98E -16 
Rab38 72433 1.82E -08 6.36E -05 8.84E -05 
Bcat2 12036 2.47E -08 6.02E -07 2.57E -09 
Tcf23 69852 2.47E -08 3.25E -76 3.97E -77 
AIdh111 107747 2.61E -08 4.00E -35 2.37E -14 
Pdp2 382051 4.17E -08 2.88E -02 3.80E -03 
Lrrc1 214345 5.72E -08 3.60E -05 1.22E -04 
Baiap2 108100 6.39E -08 3.60E -04 8.91E -05 
Chchdl0 103172 7.02E -08 7.82E -25 1.09E -33 
SIc46a1 52466 9.45E -08 1.78E -07 3.16E -11 
Agl 77559 9.45E -08 1.85E -03 1.47E -04 
Aldh5al 214579 9.87E -08 2.15E -05 9.67E -09 
Hibadh 58875 1.05E -07 3.46E -13 3.82E -10 
SirtS 68346 1.14E -07 1.42E -05 9.85E -07 
tumorigenicity 1 
RIKEN cDNA 
A530064D06 gene 
glutathione S- 
transferase omega 1 
carbonic anyhydrase 12 
FXYD domain - 
containing ion transport 
regulator 6 
BTB (POZ) domain 
containing 11 
fucosyltransferase 8 
RAB38, member of RAS 
oncogene family 
branched chain 
aminotransferase 2, 
mitochondria) 
transcription factor 23 
aldehyde 
dehydrogenase 1 
family, member L1 
pyruvate dehyrogenase 
phosphatase catalytic 
subunit 2 
leucine rich repeat 
containing 1 
brain -specific 
angiogenesis inhibitor 
1- associated protein 2 
coiled- coil -helix -coiled- 
coil -helix domain 
containing 10 
solute carrier family 46, 
member 1 
amylo -1,6- glucosidase, 
4- alpha- 
glu canotransferase 
aldhehyde 
dehydrogenase family 
5, subfamily Al 
3- hydroxyisobutyrate 
dehydrogenase 
sirtuin 5 (silent mating 
type information 
regulation 2 homolog) 5 
156 
Chi313 12655 1.58E -07 5.97E -34 3.35E -67 
Cd209a 170786 1.58E -07 2.49E -90 1.82E -153 
Prkcdbp 109042 1.76E -07 2.63E -14 8.56E -25 
Sla 20491 1.76E -07 5.28E -31 1.30E -11 
Isynal 71780 1.86E -07 5.03E -40 1.42E -29 
Prodh 19125 2.35E -07 9.58E -15 1.27E -07 
Lparl 14745 3.09E -07 3.47E -34 4.80E -09 
Tanc1 66860 3.30E -07 4.42E -23 1.95E -15 
Ppargclb 170826 3.34E -07 6.76E -14 8.48E -07 
Brwdl 93871 3.91E -07 3.30E -17 9.77E -17 
C77370 245555 4.00E -07 9.17E -45 1.77E -12 
Cpt2 12896 4.88E -07 1.63E -02 2.22E -05 
Bmp6 12161 5.13E -07 2.19E -44 1.04E -60 
St7 64213 5.56E -07 3.77E -12 6.62E -08 
Mical2 320878 6.48E -07 6.19E -12 2.89E -25 
Cadps2 320405 7.70E -07 3.91E -46 3.81E -21 
Cd209d 170779 8.25E -07 2.38E -75 3.10E -113 
Plxna2 18845 8.25E -07 5.19E -12 2.07E -47 
Fbxol8 50755 8.33E -07 3.41E -03 3.13E -03 
Cdcl4b 218294 1.12E -06 3.77E -12 9.10E -06 
C3 12266 1.15E -06 1.74E -32 1.66E -07 
(S. cerevisiae) 
chitinase 3 -like 3 
CD209a antigen 
protein kinase C, delta 
binding protein 
src -like adaptor 
myo- inositol1- 
phosphate synthase Al 
proline dehydrogenase 
lysophosphatidic acid 
receptor 1 
tetratricopeptide 
repeat, ankyrin repeat 
and coiled -coil 
containing 1 
peroxisome 
proliferative activated 
receptor, gamma, 
coactivator 1 beta 
bromodomain and WD 
repeat domain 
containing 1 
expressed sequence 
C77370 
carnitine 
palmitoyltransferase 2 
bone morphogenetic 
protein 6 
suppression of 
tumorigenicity 7 
microtubule associated 
monoxygenase, 
calponin and LIM 
domain containing 2 
Ca2 +- dependent 
activator protein for 
secretion 2 
CD209d antigen 
plexin A2 
F -box protein 18 
CDC14 cell division cycle 
14B 
complement 
component 3 
157 
Pla2g7 27226 1.17E -06 5.71E -24 1.21E -12 
Pigx 72084 1.20E -06 2.05E -08 1.79E -06 
Tmprssl3 214531 1.54E -06 8.81E -23 4.72E -21 
Cpne8 66871 1.63E -06 1.36E -31 2.73E -24 
Cd55 13136 1.72E -06 1.19E -36 7.33E -14 
Lpcat3 14792 1.74E -06 3.53E -04 2.09E -03 
Nphp1 53885 1.82E -06 6.73E -44 2.03E -26 
Pon3 269823 1.94E -06 1.08E -10 3.26E -15 
Trim72 434246 2.03E -06 1.76E -27 3.75E -15 
Pfkfb4 270198 2.19E -06 3.93E -08 3.06E -13 
Rhou 69581 2.24E -06 2.79E -14 1.73E -06 
Trmt2b 215201 2.46E -06 1.25E -05 1.83E -07 
Sft2d2 108735 2.70E -06 2.20E -09 2.71E -24 
Pvrl2 19294 2.89E -06 7.30E -22 6.30E -09 
Dym 69190 2.91E -06 1.69E -05 4.53E -05 
Bfsp1 12075 3.09E -06 1.91E -07 9.53E -14 
Oxnadl 218885 3.09E -06 3.95E -06 6.30E -06 
Lrg1 76905 3.53E -06 4.11E -35 5.64E -13 
Chi3l4 104183 3.69E -06 7.87E -36 1.69E -57 
Sdsl 257635 3.92E -06 8.67E -16 3.05E -14 
phospholipase A2, 
group VII (platelet - 
activating factor 
acetylhydrolase, 
plasma) 
phosphatidylinositol 
glycan anchor 
biosynthesis, class X 
transmembrane 
protease, serine 13 
copine VIII 
CD55 antigen 
lysophosphatidylcholine 
acyltransferase 3 
nephronophthisis 1 
(juvenile) homolog 
(human) 
paraoxonase 3 
tripartite motif - 
containing 72 
6- phosphofructo -2- 
kinase /fructose -2,6- 
biphosphatase 4 
ras homolog gene 
family, member U 
TRM2 tRNA 
methyltransferase 2 
homolog B (S. 
cerevisiae) 
SFT2 domain containing 
2 
poliovirus receptor - 
related 2 
dymeclin 
beaded filament 
structural protein 1, in 
lens -CP94 
oxidoreductase NAD - 
binding domain 
containing 1 
leucine -rich alpha -2- 
glycoprotein 1 
chitinase 3 -like 4 
serine dehydratase -like 
158 
Emr1 13733 4.19E -06 6.69E -14 9.10E -10 
Erlecl 66753 4.19E -06 7.45E -04 1.64E -03 
Nln 75805 4.97E -06 9.17E -08 5.63E -10 
Ramp3 56089 5.00E -06 8.29E -90 2.31E -83 
Nudt19 110959 5.26E -06 1.44E -15 7.53E -08 
BCO26585 226527 5.26E -06 8.83E -04 1.20E -08 
SIc41a2 338365 5.29E -06 1.64E -06 8.31E -14 
Stim2 116873 5.36E -06 1.62E -03 2.05E -03 
Ust 338362 5.41E-06 2.14E-58 1.20E-44 
Acss1 68738 5.46E -06 1.64E -08 1.71E -41 
Cd209b 69165 5.52E -06 4.26E -93 6.95E -157 
Pi16 74116 5.75E -06 1.07E -61 3.27E -39 
Pcca 110821 6.04E -06 1.01E -05 6.89E -06 
Atp5a1 11946 6.24E -06 9.51E -04 8.36E -04 
NtSe 23959 7.55E -06 1.21E -81 1.11E -64 
Gca 227960 7.63E -06 1.70E -11 4.47E -05 
Setd7 73251 8.48E -06 7.76E -13 3.44E -05 
Fech 14151 9.60E -06 1.29E -04 7.24E -08 
Ndufafl 69702 9.60E -06 2.40E -03 1.23E -03 
EGF -like module 
containing, mucin -like, 
hormone receptor -like 
sequence 1 
endoplasmic reticulum 
lectin 1 
neurolysin 
(metallopeptidase M3 
family) 
receptor (calcitonin) 
activity modifying 
protein 3 
nudix (nucleoside 
diphosphate linked 
moiety X) -type motif 19 
cDNA sequence 
BCO26585 
solute carrier family 41, 
member 2 
stromal interaction 
molecule 2 
uronyl-2- 
sulfotransferase 
acyl -CoA synthetase 
short -chain family 
member 1 
CD209b antigen 
peptidase inhibitor 16 
propionyl- Coenzyme A 
carboxylase, alpha 
polypeptide 
ATP synthase, H+ 
transporting, 
mitochondrial F1 
complex, alpha subunit 
1 
5' nucleotidase, ecto 
grancalcin 
SET domain containing 
(lysine 
methyltransferase) 7 
ferrochelatase 
NADH dehydrogenase 
(ubiquinone) 1 alpha 
subcomplex, assembly 
159 
Mil 108897 9.94E -06 2.07E -15 9.50E -12 
Adamts2 216725 1.02E -05 3.75E -69 1.11E -59 
Srxn1 76650 1.02E -05 3.37E -04 4.75E -08 
Fgfr1 14182 1.07E -05 5.44E -35 1.55E -18 
Prr13 66151 1.09E -05 3.55E -10 3.61E -09 
Pdxdcl 94184 1.11E -05 2.23E -02 1.03E -03 
Foxredl 235169 1.25E -05 1.68E -04 2.14E -02 
Prdx3 11757 1.27E -05 1.30E -16 7.47E -12 
Etf1 225363 1.32E -05 1.78E -09 2.05E -04 
Sdhc 66052 1.40E -05 1.33E -06 3.53E -10 
Coq9 67914 1.40E -05 6.70E -04 3.48E -07 
9130008F23Rik 71583 1.47E -05 8.89E -55 2.22E -56 
Gm826 329554 1.63E -05 4.44E -09 8.53E -15 
Cd244 18106 1.69E -05 8.34E -42 1.01E -11 
Fars2 69955 1.69E -05 2.82E -03 3.17E -03 
Meisl 17268 1.88E -05 2.74E -07 1.61E -08 
Dixdcl 330938 1.97E -05 2.44E -73 6.13E -108 
Gnmt 14711 2.10E -05 1.67E -06 1.21E -03 
Insr 16337 2.14E -05 3.53E -33 4.83E -41 
Igf1 16000 2.15E -05 3.47E -17 4.20E -115 
factor 1 
allograft inflammatory 
factor 1 -like 
a disintegrin -like and 
metallopeptidase 
(reprolysin type) with 
thrombospondin type 1 
motif, 2 
sulfiredoxin 1 homolog 
(S. cerevisiae) 
fibroblast growth factor 
receptor 1 
proline rich 13 
pyridoxal- dependent 
decarboxylase domain 
containing 1 
FAD -dependent 
oxidoreductase domain 
containing 1 
peroxiredoxin 3 
eukaryotic translation 
termination factor 1 
succinate 
dehydrogenase 
complex, subunit C, 
integral membrane 
protein 
coenzyme Q9 homolog 
(yeast) 
RIKEN cDNA 
9130008F23 gene 
predicted gene 826 
CD244 natural killer cell 
receptor 2B4 
phenylalanine -tRNA 
synthetase 2 
(mitochondrial) 
Meis homeobox 1 
DIX domain containing 
1 
glycine N- 
methyltransferase 
insulin receptor 
insulin -like growth 
160 
Chn2 69993 2.26E -05 3.31E -22 1.31E -17 
Fcgr2b 14130 2.28E -05 7.04E -20 1.25E -20 
SIc22a23 73102 2.29E -05 3.35E -20 3.61E -28 
Ube2e2 218793 2.34E -05 1.33E -07 9.02E -04 
Pigz 239827 2.53E -05 9.66E -08 1.92E -08 
Lyplall 226791 2.63E-05 1.32E-09 1.33E-13 
Arg1 11846 2.86E -05 9.96E -11 3.31E -09 
Uqcrc2 67003 2.88E -05 1.03E -06 6.43E -07 
Pfkm 18642 2.95E-05 1.97E-07 1.92E-03 
Casp6 12368 3.13E -05 2.27E -04 1.62E -03 
Tm7sf3 67623 3.17E -05 1.86E -05 1.89E -06 
Acad10 71985 3.64E -05 1.34E -05 2.77E -06 
Trpm3 226025 3.66E -05 4.88E -03 1.45E -04 
Pglyrpl 21946 3.99E -05 9.56E -78 6.62E -38 
Tns4 217169 4.06E -05 2.75E -10 4.13E -06 
Ndufal0 67273 4.06E -05 2.58E -04 6.54E -07 
Cela1 109901 4.09E -05 5.02E -03 9.65E -11 
Aldh6al 104776 4.80E -05 5.38E -03 1.38E -08 
Atp5g3 228033 4.81E -05 4.25E -07 9.91E -06 
factor 1 
chimerin (chimaerin) 2 
Fc receptor, IgG, low 
affinity Ilb 
solute carrier family 22, 
member 23 
ubiquitin- conjugating 
enzyme E2E 2 
phosphatidylinositol 
glycan anchor 
biosynthesis, class Z 
lysophospholipase -like 
1 
arginase, liver 
ubiquinol cytochrome c 
reductase core protein 
2 
phosphofructokinase, 
muscle 
caspase 6 
transmembrane 7 
superfamily member 3 
acyl- Coenzyme A 
dehydrogenase family, 
member 10 
transient receptor 
potential cation 
channel, subfamily M, 
member 3 
peptidoglycan 
recognition protein 1 
tensin 4 
NADH dehydrogenase 
(ubiquinone) 1 alpha 
subcomplex 10 
chymotrypsin -like 
elastase family, 
member 1 
aldehyde 
dehydrogenase family 
6, subfamily Al 
ATP synthase, H+ 
transporting, 
mitochondrial FO 
complex, subunit C3 
161 
Abcd2 26874 4.97E -05 4.51E -28 2.02E -24 
Sdhd 66925 5.06E -05 1.02E -08 1.35E -06 
Kcnk6 52150 5.23E -05 7.46E -06 1.60E -13 
Aqp3 11828 5.33E -05 4.72E -55 1.30E -81 
TIr4 21898 5.51E -05 2.19E -08 3.70E -13 
Acad11 102632 5.83E -05 2.84E -04 1.59E -03 
Fam118b 109229 5.88E -05 4.23E -03 4.25E -06 
Kcnn3 140493 6.98E -05 5.81E -88 5.17E -54 
Slc34a2 20531 7.37E -05 2.06E -46 1.62E -69 
A430107O13Rik 214642 8.87E -05 2.68E -14 3.03E -18 
Tmem143 70209 9.94E -05 4.71E -04 4.04E -07 
Trap1 68015 1.02E -04 3.15E -03 3.80E -03 
Ppl 19041 1.06E -04 5.27E -44 1.44E -43 
Lysmd4 75099 1.06E -04 2.52E -02 2.18E -04 
Thsd4 207596 1.10E -04 2.73E -13 4.84E -21 
Limk1 16885 1.14E -04 8.42E -19 4.36E -12 
Mapk11 19094 1.16E -04 1.59E -15 2.91E -05 
Cdkn2a 12578 1.16E -04 2.98E -39 1.39E -22 
(subunit 9) 
ATP -binding cassette, 
sub -family D (ALD), 
member 2 
succinate 
dehydrogenase 
complex, subunit D, 
integral membrane 
protein 
potassium inwardly - 
rectifying channel, 
subfamily K, member 6 
aquaporin 3 
toll -like receptor 4 
acyl- Coenzyme A 
dehydrogenase family, 
member 11 
family with sequence 
similarity 118, member 
B 
potassium 
intermediate /small 
conductance calcium - 
activated channel, 
subfamily N, member 3 
solute carrier family 34 
(sodium phosphate), 
member 2 
RIKEN cDNA 
A430107O13 gene 
transmembrane protein 
143 
TNF receptor- associated 
protein 1 
periplakin 
LysM, putative 
peptidoglycan- binding, 
domain containing 4 
thrombospondin, type I, 
domain containing 4 
LIM- domain containing, 
protein kinase 
mitogen- activated 
protein kinase 11 
cyclin- dependent kinase 
162 
Idh3g 15929 1.17E -04 7.37E -05 1.76E -03 
Ipmk 69718 1.17E -04 8.14E -03 1.33E -03 
Catsper2 212670 1.17E -04 8.26E -03 4.91E -02 
Oat 18242 1.37E -04 3.60E -08 3.75E -10 
Pecaml 18613 1.46E -04 2.23E -60 4.99E -36 
Bzw2 66912 1.62E -04 4.95E -34 6.14E -18 
Timp1 21857 1.70E -04 2.72E -10 8.02E -15 
Adora3 11542 1.77E -04 5.05E -01 6.59E -01 
Adora3 11542 1.77E -04 7.98E -06 3.64E -03 
1700026L06Rik 69987 1.80E -04 2.61E -04 2.43E -03 
Lyve1 114332 1.83E -04 8.76E -49 1.97E -164 
Mrps25 64658 1.89E -04 4.44E -05 1.89E -08 
Acy3 71670 1.89E -04 1.73E -16 7.49E -08 
Unc5b 107449 1.90E -04 3.24E -10 1.30E -13 
Dnajc3 1000372 1.96E -04 1.22E -12 4.82E -11 
58 
Dfna5 54722 2.01E -04 2.23E -05 8.95E -13 
Idh2 269951 2.15E -04 1.09E -04 8.86E -11 
Dusp23 68440 2.27E -04 9.52E -04 1.35E -03 
Fhl 14194 2.28E -04 7.63E -06 9.56E -06 
Ift52 245866 2.28E -04 1.14E -02 5.21E -03 
Ttc28 209683 2.33E -04 3.66E -25 1.01E -31 
inhibitor 2A 
isocitrate 
dehydrogenase 3 
(NAD +), gamma 
inositol polyphosphate 
multikinase 
cation channel, sperm 
associated 2 
ornithine 
aminotransferase 
platelet /endothelial cell 
adhesion molecule 1 
basic leucine zipper and 
W2 domains 2 
tissue inhibitor of 
metalloproteinase 1 
adenosine A3 receptor 
adenosine A3 receptor 
RIKEN cDNA 
1700026L06 gene 
lymphatic vessel 
endothelial hyaluronan 
receptor 1 
mitochondrial 
ribosomal protein 525 
aspartoacylase 
(aminoacylase) 3 
unc -5 homolog B (C. 
elegans) 
DnaJ (Hsp40) homolog, 
subfamily C, member 3 
deafness, autosomal 
dominant 5 (human) 
isocitrate 
dehydrogenase 2 
(NADP +), mitochondrial 
dual specificity 
phosphatase 23 
fumarate hydratase 1 
intraflagellar transport 
52 
tetratricopeptide repeat 
domain 28 
163 
111111 17082 2.41E-04 1.97E-69 2.87E-130 
Kcnk13 217826 2.49E-04 1.09E-09 1.52E-21 
Cux1 13047 2.72E-04 4.67E-05 1.08E-05 
Vmn2r26 56552 2.85E-04 5.85E-43 2.00E-20 
Zadh2 225791 2.88E-04 2.42E-16 1.70E-13 
Idh1 15926 3.06E-04 6.19E-06 8.83E-06 
Gclm 14630 3.13E-04 8.74E-03 1.49E-02 
Irf4 16364 3.55E-04 1.03E-20 4.30E-26 
Ndufb5 66046 3.64E-04 2.56E-07 2.26E-08 
Cox7a2 12866 3.93E-04 1.90E-12 1.28E-11 
Hsp90b1 22027 4.33E-04 1.68E-06 3.56E-05 
Angptl2 26360 4.41E-04 7.56E-74 5.31E-54 
2410016O06Rik 71952 4.52E -04 3.98E -12 2.02E -07 
Pcdh7 54216 4.71E-04 2.35E-10 1.20E-07 
Retnla 57262 5.05E-04 1.50E-33 2.57E-50 
Pim3 223775 5.74E-04 7.36E-14 9.23E-10 
Srms 20811 5.97E-04 4.33E-04 2.79E-05 
Golm1 105348 6.05E-04 1.94E-10 1.74E-12 
Ctse 13034 6.20E-04 1.37E-27 8.83E-72 
Ggcx 56316 6.73E-04 1.51E-02 3.70E-04 
Ikbkg 16151 6.81E-04 1.54E-02 5.15E-03 
Gstt3 103140 6.90E-04 2.01E-13 2.31E-17 
interleukin 1 receptor- 
like 1 
potassium channel, 
subfamily K, member 13 
cut -like horneobox 1 
vomeronasal 2, 
receptor 26 
zinc binding alcohol 
dehydrogenase, domain 
containing 2 
isocitrate 
dehydrogenase 1 
(NADP +), soluble 
glutamate- cysteine 
ligase, modifier subunit 
interferon regulatory 
factor 4 
NADH dehydrogenase 
(ubiquinone) 1 beta 
subcomplex, 5 
cytochrome c oxidase, 
subunit Vila 2 
heat shock protein 90, 
beta (Grp94), member 1 
angiopoietin -like 2 
RIKEN cDNA 
2410016006 gene 
protocadherin 7 
resistin like alpha 
proviral integration site 
3 
src- related kinase 
lacking C- terminal 
regulatory tyrosine and 
N- terminal 
myristylation sites 
golgi membrane protein 
1 
cathepsin E 
gamma -glutamyl 
carboxylase 
inhibitor of kappaB 
kinase gamma 
glutathione S- 
164 
Cxcr7 12778 7.08E -04 3.45E -53 5.36E -39 
SIc13a3 114644 7.19E -04 4.20E -10 1.09E -04 
Prnp 19122 7.61E -04 1.47E -04 2.01E -32 
Ndufv2 72900 7.66E -04 8.97E -06 7.28E -06 
Gatm 67092 7.77E -04 4.49E -30 3.40E -05 
1300001101 Ri k 74148 8.33E-04 5.38E-08 1.87E-10 
Prickle1 106042 9.06E-04 4.31E-31 3.45E-46 
Atp5b 11947 9.29E-04 8.17E-03 8.25E-03 
Cds2 110911 9.46E-04 7.57E -07 5.38E -12 
A630007B06Rik 213993 9.48E -04 1.43E -06 1.34E -05 
Ftsj d 1 234728 9.56E -04 3.70E -10 5.96E -07 
Gstk1 76263 9.60E -04 3.53E -06 1.40E -06 
Tjp1 21872 9.75E -04 1.39E -23 9.60E -18 
Bcam 57278 1.00E -03 1.18E -57 3.78E -39 
Txnrd3 232223 1.01E-03 1.12E-03 2.17E-03 
Alox5 11689 1.07E-03 1.22E-15 1.58E-08 
Ttc25 74407 1.11E-03 6.29E-40 2.66E-38 
Spint2 20733 1.13E -03 3.43E -79 6.07E -61 
Maml2 270118 1.15E -03 9.13E -05 5.53E -15 
transferase, theta 3 
chemokine (C -X -C 
motif) receptor 7 
solute carrier family 13 
(sodium- dependent 
dicarboxylate 
transporter), member 3 
prion protein 
NADH dehydrogenase 
(ubiquinone) 
flavoprotein 2 
glycine 
amidinotransferase (L- 
arginine:glycine 
amidinotransferase) 
RIKEN cDNA 
1300001101 gene 
prickle homolog 1 
(Drosophila) 
ATP synthase, H+ 
transporting 
mitochondria) F1 
complex, beta subunit 
CDP- diacylglycerol 
synth ase 
(phosphatidate 
cytidylyltransferase) 2 
RIKEN cDNA 
A630007B06 gene 
Fts1 methyltransferase 
domain containing 1 
glutathione S- 
transferase kappa 1 
tight junction protein 1 
basal cell adhesion 
molecule 
thioredoxin reductase 3 
arachidonate 5- 
lipoxygenase 
tetratricopeptide repeat 
domain 25 
serine protease 
inhibitor, Kunitz type 2 
mastermind like 2 
(Drosophila) 
165 
Ppat 231327 1.21E -03 4.48E -11 1.18E -06 
Dcaf6 74106 1.27E -03 7.93E -05 4.67E -05 
Ak3 56248 1.30E -03 9.20E -08 1.10E -12 
Uaca 72565 1.38E -03 5.37E -22 1.27E -16 
Mdhl 17449 1.46E -03 1.61E -14 1.36E -12 
Tm e m 119 231633 1.50E -03 4.15E -17 3.58E -18 
Gnail 14677 1.56E -03 3.24E -23 6.66E -33 
Hebp2 56016 1.58E-03 6.38E-12 2.88E-20 
0610009O20Rik 66839 1.61E-03 9.75E-06 1.05E-03 
Clec4a1 269799 1.63E-03 1.49E-14 5.13E-04 
1127ra 50931 1.64E-03 2.77E-35 6.08E-12 
Aldhla2 19378 1.81E-03 2.88E-18 1.14E-18 
Btk 12229 2.11E-03 3.60E-05 2.46E-03 
St3gal4 20443 2.12E-03 1.14E-27 5.20E-16 
Acpp 56318 2.15E-03 9.59E-44 1.93E-26 
Qdpr 110391 2.17E-03 1.30E-03 5.62E-09 
Cisdl 52637 2.18E -03 3.35E -09 1.68E -08 
Gng4 14706 2.30E -03 6.90E -03 2.56E -05 
Mttp 17777 2.38E-03 2.93E-04 6.00E-07 
phosphoribosyl 
pyrophosphate 
amidotransferase 
DDB1 and CUL4 
associated factor 6 
adenylate kinase 3 
uveal autoantigen with 
coiled -coil domains and 
ankyrin repeats 
malate dehydrogenase 
1, NAD (soluble) 
transmembrane protein 
119 
guanine nucleotide 
binding protein (G 
protein), alpha 
inhibiting 1 
heme binding protein 2 
RIKEN cDNA 
0610009020 gene 
C -type lectin domain 
family 4, member al 
interleukin 27 receptor, 
alpha 
aldehyde 
dehydrogenase family 
1, subfamily A2 
Bruton 
agammaglobulinemia 
tyrosine kinase 
ST3 beta- galactoside 
alpha -2,3- 
sialyltransferase 4 
acid phosphatase, 
prostate 
quinoid 
dihydropteridine 
reductase 
CDGSH iron sulfur 
domain 1 
guanine nucleotide 
binding protein (G 
protein), gamma 4 
microsomal triglyceride 
transfer protein 
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1110002N22Rik 68550 2.38E -03 5.90E -02 2.68E -02 
Add3 27360 2.49E -03 3.98E -05 4.58E -03 
Ptcd2 68927 2.75E -03 5.02E -04 1.13E -02 
Pdk2 18604 2.89E -03 1.28E -05 1.00E -06 
Adcyaplrl 11517 2.96E -03 4.16E -16 1.51E -19 
Wnt2 22413 3.07E -03 1.77E -90 9.57E -79 
RIKEN cDNA 
1110002N22 gene 
adducin 3 (gamma) 
pentatricopeptide 
repeat domain 2 
pyruvate 
dehydrogenase kinase, 
isoenzyme 2 
adenylate cyclase 
activating polypeptide 1 
receptor 1 
wingless -related MMTV 
integration site 2 
Table 4 -7. Core up- regulated NeMm genes defined by OrderedList analysis. Genes 
ranked by correlation with %YM1 positivity in the microarray analysis were compared 
against gene lists derived by ranking both the WT -NeMO vs. WT- ThioMcD and WT -NeMcD 
vs. IL -4Ra -NeMcD comparisons from the RNA -Seq analyses. The intersection of genes 
defined as common between both comparisons are the `core' NeMm genes included in 
this table. P- values shown are corrected for multiple testing (Benjamini- Hochberg 
method). 
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Symbol Entrez ID Lito vs 
YM1 
WT Brugia vs 
WT Thio 
WT Brugia vs 
-/- Brugia 
Lcp1 18826 8.32E -15 6.55E -182 6.44E -157 
Emb 13723 8.95E -11 1.72E -64 2.30E -109 
Corola 12721 1.04E -10 1.18E -187 1.92E -189 
Ebi3 50498 1.70E -10 2.12E -11 5.39E -22 
Ngfrapl 12070 2.42E -10 1.92E -66 2.23E -08 
Fkbpla 14225 2.42E -10 1.62E -53 8.50E -21 
P2ry6 233571 3.40E -10 1.27E -132 2.71E -42 
Lst1 16988 1.47E -09 4.00E -43 4.94E -71 
Rassf2 215653 3.55E -09 5.19E -42 1.05E -16 
Lsr 54135 3.55E -09 3.80E -68 8.68E -34 
Trim3 55992 5.99E -09 5.04E -21 2.61E -09 
Trpv2 22368 1.70E -08 4.43E -97 2.85E -28 
Gliprl 73690 1.70E -08 4.64E -55 1.03E -05 
Ptms 69202 2.68E -08 1.03E -177 6.60E -65 
Ogfrll 70155 1.35E -07 5.03E -19 8.42E -14 
Irf8 15900 1.92E -07 2.19E -172 9.30E -166 
Adrb2 11555 2.17E -07 6.63E -37 2.54E -21 
Anxa5 11747 2.40E -07 2.90E -59 2.17E -04 
Smox 228608 2.75E -07 3.31E -24 1.48E -41 
Arid3a 13496 5.18E -07 3.23E -70 1.99E -48 
Description 
lymphocyte cytosolic 
protein 1 
embigin 
coronin, actin binding 
protein lA 
Epstein -Barr virus 
induced gene 3 
nerve growth factor 
receptor (TNFRSF16) 
associated protein 1 
FK506 binding 
protein la 
pyrimidinergic 
receptor P2Y, G- 
protein coupled, 6 
leukocyte specific 
transcript 1 
Ras association 
(RaIGDS /AF -6) 
domain family 
member 2 
lipolysis stimulated 
lipoprotein receptor 
tripartite motif - 
containing 3 
transient receptor 
potential cation 
channel, subfamily V, 
member 2 
GLI pathogenesis - 
related 1 (glioma) 
parathymosin 
opioid growth factor 
receptor -like 1 
interferon regulatory 
factor 8 
adrenergic receptor, 
beta 2 
annexin A5 
spermine oxidase 
AT rich interactive 
domain 3A (BRIGHT- 
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TIe1 21885 7.58E -07 4.49E -18 5.63E -10 
Fcgr1 14129 1.17E -06 3.28E -229 0.00E +00 
Gng2 14702 1.40E -06 1.81E -83 1.32E -11 
Endod1 71946 1.46E -06 9.53E -24 3.67E -04 
SIc11a1 18173 2.77E -06 1.32E -15 1.80E -12 
SIc16a10 72472 4.22E -06 1.83E -36 1.69E -18 
Ccrl2 54199 4.47E -06 1.00E -38 5.36E -66 
Mpeg1 17476 5.35E -06 2.38E -56 6.01E -26 
Map4k4 26921 6.32E -06 1.93E -33 1.89E -19 
Cd300a 217303 6.56E -06 1.20E -22 4.16E -04 
Cyp27a1 104086 6.60E -06 3.98E -32 1.10E -03 
Znrf1 170737 8.39E -06 3.68E -41 5.85E -08 
Lgalsl 16852 8.48E -06 9.87E -111 4.32E -35 
Sgms2 74442 1.02E -05 2.17E -66 8.32E -35 
Hopx 74318 1.23E -05 8.89E -32 5.13E -16 
Lpl 16956 1.33E -05 5.29E -135 1.15E -37 
Agpat3 28169 1.34E -05 3.19E -13 1.01E -04 
Nuak1 77976 1.39E -05 1.15E -10 5.31E -27 
Tsc22d3 14605 1.68E-05 1.00E-16 2.78E-08 
like) 
transducin -like 
enhancer of split 1, 
homolog of 
Drosophila E(spl) 
Fc receptor, IgG, high 
affinity I 
guanine nucleotide 
binding protein (G 
protein), gamma 2 
endonuclease 
domain containing 1 
solute carrier family 
11 (proton -coupled 
divalent metal ion 
transporters), 
member 1 
solute carrier family 
16 (monocarboxylic 
acid transporters), 
member 10 
chemokine (C -C 
motif) receptor -like 2 
macrophage 
expressed gene 1 
mitogen- activated 
protein kinase kinase 
kinase kinase 4 
CD300A antigen 
cytochrome P450, 
family 27, subfamily 
a, polypeptide 1 
zinc and ring finger 1 
lectin, galactose 
binding, soluble 1 
sphingomyelin 
synthase 2 
HOP homeobox 
lipoprotein lipase 
1- acylglycerol -3- 
phosphate 0- 
acyltransferase 3 
NUAK family, SNF1- 
like kinase, 1 
TSC22 domain family, 
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S100a4 20198 2.07E -05 4.13E -43 3.91E49 
Pid1 98496 2.21E -05 8.21E -31 2.83E -28 
Cryba4 12959 2.42E -05 1.19E -05 2.70E -03 
Tnfrsfl3b 57916 2.83E -05 3.83E -24 5.71E -14 
Lamc1 226519 2.99E -05 1.31E -33 5.67E -10 
Nrp1 18186 3.66E -05 4.59E -44 1.77E -05 
Dgkg 110197 4.05E -05 1.43E -09 8.41E -47 
Dcakd 68087 4.05E -05 5.96E -11 7.08E -06 
Pilra 231805 4.06E-05 1.43E-35 1.10E -187 
Apobecl 11810 4.21E -05 1.02E -42 2.04E -09 
Rap 2a 76108 4.55E -05 3.15E -33 2.22E -18 
Ccl3 20302 5.91E -05 7.67E -133 1.48E -68 
Evl 14026 6.38E -05 1.37E -80 9.74E -54 
Dtx3 80904 6.92E -05 3.63E -49 1.60E -25 
Mef2c 17260 6.97E -05 1.29E -33 5.89E -09 
Nt5dc2 70021 7.43E -05 1.67E -49 1.54E -09 
member 3 
S100 calcium binding 
protein A4 
phosphotyrosine 
interaction domain 
containing 1 
crystallin, beta A4 
tumor necrosis factor 
receptor superfamily, 
member 13b 
laminin, gamma 1 
neuropilin 1 
diacylglycerol kinase, 
gamma 
dephospho -CoA 
kinase domain 
containing 
paired 
immunoglobin -like 
type 2 receptor alpha 
apolipoprotein B 
mRNA editing 
enzyme, catalytic 
polypeptide 1 
RAS related protein 
2a 
chemokine (C -C 
motif) ligand 3 
Ena- vasodilator 
stimulated 
phosphoprotein 
deltex 3 homolog 
(Drosophila) 
myocyte enhancer 
factor 2C 
5'- nucleotidase 
domain containing 2 
Table 4 -8. Core down -regulated NeM D genes defined by OrderedList analysis. Genes 
ranked by reverse correlation with %YM1 positivity in the microarray analysis were 
compared against gene lists derived by reverse ranking both the WT -NeMcD vs. WT- 
ThioMcD and WT -NeMO vs. IL -4Ra-/ -NeMcD comparisons from the RNA -Seq analyses. 
The intersection of genes defined as common between both comparisons are the 'core' 
NeMcD genes included in this table. P- values shown are corrected for multiple testing 
(Benjamini- Hochberg method). 
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4.3.6 KINETIC EXPRESSION PROFILES OF PPAR -PROSTACYCLIN AXIS 
GENES 
A drawback of our RNA -Seq analysis is that we cannot state whether certain genes are 
required in a transient manner during alternative activation. We were particularly 
interested in Pparg, which as been described as required for AAMcD mitochondria) 
metabolism (Odegaard et al., 2007). However, our RNA -Seq analysis did not support a role 
for Pparg in the AAMcP response to B. malayi implant 21 days P.I. However, it is still 
possible that Pparg is required early during alternative activation and down -regulated later 
on. Our time course data allowed us to assess gene expression changes over time, and 
argued against an early up- regulation of Pparg (Figure 4 -12). In chapter 2 we propose that a 
PGI2 -PPAR6 axis maintains PPAR- dependent gene expression in AAMO in the absence of 
PPARy expression. In the microarray time course the expression profiles of genes involved 
in PGI2 synthesis and PPAR activity were entirely consistent with this hypothesis. Pparg was 
expressed at a much lower level than Ppard throughout the time course, and both 
constituents for PGI2 synthesis Ptgsl and Ptgis are highly and constitutively expressed 
(Figure 4 -12). As expected, the expression profile of the PPAR co- activator protein Ppargclb 
significantly correlated with YM1 levels. Thus these data support our previous 
interpretation that Ppard compensates for low Pparg expression in resident tissue AAMO 
by enhanced production of PGI2 (Figure 4 -12). 
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Figure 4 -12. Expression profiles of PPAR transcription factors, the PPAR co- activator 
protein Ppargclb, and genes associated with PGI2 synthesis. The gene expression 
profile in L. sigmodontis- induced pleural cavity AAMm is consistent with the peritoneal 
B. malayi- induced AAMm profile presented in Chapter 2 for these genes, and is 
consistent with a prostacyclin - PPARÖ transcriptional axis maintaining PPAR- dependent 
gene expression in AAMm derived from both infection models. Day 0 and day 4 
expression values were pooled, and considered as day 0 to generate error bars. Error 
bars represent standard error (SEM) values. 
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4.3.7 L. SIGMODONTIS INFECTION LEADS TO AN UP- REGULATION OF 
MITOCHONDRIAL METABOLIC PATHWAYS 
GSEA was performed on YM1- asosociated genes to identify molecular pathways that 
correlate with YM1 expression. This analysis recapitulated the findings of our RNA -Seq 
study, showing marked up- regulation of molecular pathways associated with cellular 
metabolism. In particular we observed a gene expression profile consistent with increased 
mitochondrial metabolism, including the TCA cycle (Table 4 -9, Figure 4 -13a). 
Curiously our cis -enrichment analysis did not identify over -represented PPAR motifs in the 
promoters of YM1- associated genes. This is in contradiction to both the RNA -Seq analysis 
presented in Chapter 2 and the GSEA results here. The expression profile of TCA cycle - 
associated genes shows a marked positive correlation with %YM1 levels (Figure 4 -13b). 
Furthermore, an analysis of PPAR motif presence in promoters showed that 70% (19/27) of 
TCA cycle genes contained PPAR response elements, relative to a background frequency of 
34.7% as determined by Homer. This supports the notion that PPAR transcription factors 
are required for AAMO mitochondria) metabolism. To assess whether the observed gene 
expression profiles correlate with changes in mitochondria) mass we used the 
mitochondrial dye MitoTracker Green. This fluorescent dye accumulates within the 
mitochondria of live cells, and provides a direct measure of mitochondrial mass 
(Pendergrass et al., 2004). Confirming our GSEA results we observed a marked increase in 
MitoTracker green intensities in pleural cavity macrophages at 28 days post L. sigmodontis 
infection relative to naïve tissue resident macrophages (Figure 4 -13c). 
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NAME SIZE Enrichment 
Score 
NES Nominal 
P -va! 
FDR q- 
val 
KEGG CITRATE CYCLE TCA CYCLE 25 0.801 1.658 0.010 0.089 
KEGG VALINE LEUCINE AND 37 0.748 1.927 0.000 0.047 
ISOLEUCINE DEGRADATION 
KEGG PYRUVATE METABOLISM 28 0.719 1.855 0.000 0.056 
KEGG PROPANOATE 23 0.711 1.743 0.012 0.068 
METABOLISM 
KEGG OXIDATIVE 93 0.701 1.698 0.012 0.078 
PHOSPHORYLATION 
KEGG PENTOSE PHOSPHATE 19 0.668 1.687 0.000 0.078 
PATHWAY 
KEGG PARKINSONS DISEASE 88 0.667 1.718 0.023 0.079 
KEGG BUTANOATE METABOLISM 23 0.659 1.755 0.000 0.085 
KEGG FATTY ACID METABOLISM 31 0.656 1.786 0.004 0.096 
KEGG GALACTOSE METABOLISM 20 0.654 1.646 0.016 0.094 
KEGG GLYCOLYSIS 39 0.620 1.716 0.010 0.072 
GLUCONEOGENESIS 
KEGG FRUCTOSE AND MANNOSE 26 0.611 1.643 0.014 0.090 
METABOLISM 
KEGG HUNTINGTONS DISEASE 132 0.599 1.785 0.002 0.072 
KEGG ALZHEIMERS DISEASE 128 0.551 1.754 0.008 0.073 
KEGG VIBRIO CHOLERAE 42 0.503 1.565 0.022 0.154 
INFECTION 
KEGG TRYPTOPHAN 23 0.501 1.612 0.016 0.112 
METABOLISM 
KEGG AMINO SUGAR AND 36 0.491 1.492 0.047 0.225 
NUCLEOTIDE SUGAR 
METABOLISM 
KEGG SNARE INTERACTIONS IN 29 0.489 1.556 0.024 0.156 
VESICULAR TRANSPORT 
KEGG PEROXISOME 67 0.487 1.660 0.015 0.096 
Table 4 -9. Gene set enrichment analysis results of KEGG pathways significantly 
positively correlated with %YM1 expression as measured by FACS showing metabolic 
pathways associated with alternative activation (nominal p -value < 0.05, FDR < 0.25). ES 
= enrichment score, NES = normalized enrichment score, FDR q -val= Benjamini- Hochberg 
corrected p- value. 
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Figure 4 -13. A) GSEA plot showing the positions of KEGG TCA -cycle associated genes in a 
list of genes ranked according to Pearson's correlation between gene expression and 
%YM1 positivity as measured by FACS. 
B) Volcano plot showing correlation of gene expression against %YM1 positivity (y -axis 
truncated at 10 for clarity). TCA cycle genes are shown as triangles. TCA cycle genes 
with predicted PPAR motifs in the proximal promoter sequence are coloured in red, 
those without are shown in black. The dotted red line depicts the significance threshold 
B =4.6. 
C) MitoTracker green staining showing mitochondrial dye uptake in F4 /80 positive 
pleural cavity macrophages from L. sigmodontis infected mice 28 days post infection. 
175 
4.3.8 BOTH PROLIFERATING AND NON -PROLIFERATING AAM(13 ARE 
ASSOCIATED WITH INCREASED MITOCHONDRIAL METABOLISM. 
IL -4 induces both alternative activation and macrophage proliferation in vivo. Proliferating 
cells typically utilize aerobic glycolysis, as evidenced by both proliferating cancer cells 
(Vander Heiden et al., 2009) and T -cells undergoing clonal expansion (Fox et al., 2005). Thus 
it is curious that IL -4 enhances both mitochondrial metabolism associated with AAMm as 
well as proliferation. We set out to address whether macrophages induced to proliferate in 
response to IL -4 also demonstrate enhanced mitochondria) respiration. The MitoTracker 
orange CMH2xROS dye is redox- sensitive and provides a measure of mitochondrial 
membrane potential and, hence, mitochondrial respiration (Arita et al., 2006). It is 
selectively taken up by mitochondria and oxidised to generate the fluorescent molecule 
that is measured. In contrast to the MitoTracker Green dye this small molecule dye can be 
fixed, and is compatible with intracellular staining and flow cytometry. We therefore 
optimized a method to allow concurrent visualization of mitochondria) abundance, cellular 
proliferation and AAMm. 
We applied this staining protocol to pleural cavity macrophages elicited during a time series 
of IL -4c treatment. Consistent with previous studies within the lab YM1 was induced by 12h 
(Figure 4 -14a), however we did not observe robust proliferation until 24h (Figure 4 -14b). 
Furthermore IL -4c treated macrophages were competent to express AAM0 markers whilst 
up- regulating the marker of proliferation Ki67 (Figure 4 -14c). IL -4c treatment also increased 
mitochondrial abundance associated with alternative activation (Figure 4- 14d,e). Ki67h' 
proliferating macrophages possessed an increased mitochondrial mass relative to naive and 
PBS treated controls (Figure 4 -14f). These data do not preclude the possibility that IL -4- 
dependent macrophage proliferation is facilitated by aerobic glycolysis, they do however 
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tell us that the mitochondria) phenotype associated with AAMO is not mutually exclusive 
with IL -4- dependent proliferation. 
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Figure 4 -14. Pleural cavity macrophage alternative activation, proliferation and 
mitochondrial mass in a time- course of IL -4 complex (IL -4c) treatment. 
A) Frequency of YM1+ F4 /80ni pleural cavity MO, b) frequency of proliferating, Ki67ni 
F4 /80 
ni macrophages, c) YM1 and Ki67 staining in naive and IL -4c- treated macrophages 
24h after stimulation showing concurrent proliferation and alterative activation. D) 
Representative gating for Ki67n1, Ki67°` and Ki67bOw staining against MitoTracker CM- 
H2Xros intensity in naïve and IL -4c- treated macrophages, e) Histogram showing 
MitoTracker CM- H2Xros intensities in naive and IL -4c- treated macrophages 24 hours 
after IL -4c administration. F) Breakdown of MitoTracker CM- H2Xros intensities in 
proliferating and non -proliferating macrophages in response to IL -4c treatment. 
179 
4.4 DISCUSSION 
In this chapter we present the first transcriptomic time -course analysis of the macrophage 
response to a nematode infection using the filarial parasite L. sigmodontis. It has previously 
been shown by our lab that IL -4 stimulates macrophages both to alternatively activate and 
proliferate in vivo (Jenkins et al., 2011), however treatment of macrophages with IL -4 in 
vitro does not drive this proliferative response. We sought to investigate this phenomenon 
to generate testable hypotheses explaining this process. Further, this experiment has 
allowed us to validate findings inferred from our RNA -Seq analysis in chapter 2, and assess 
whether differences in AAMO responses can be observed between early and late time 
points. 
We had noted previously that the kinetics of proliferation and alternative activation are 
discordant in the response to filarial nematode infection, and this observation was 
confirmed in this experiment (Figure 4 -1). There is initially a proliferative phase, which we 
had found to be independent of IL -4, followed by an IL -4- dependent proliferative burst 
(Jenkins et al., 2011). The peak of IL -4- dependent proliferation coincides with robust 
induction of AAMW at day 11 (Figure 4 -1, S Jenkins unpublished). In our time course AAMcD 
persisted from day 11 however proliferation dropped after this point (Figure 4 -1). We 
capitalized on these differential kinetics by array profiling FACS -purified F4/80h' 
macrophages, and combining this with a single cell phenotypic analysis. By correlating 
global gene expression profiles with YM1 and Ki67h' levels determined by FACS we have 
defined transcriptional repertoires associated with alternative activation and proliferation 
respectively. To our knowledge this is the first time microarray and FACS has been used to 
deconvolute transcriptional signatures from heterogeneous populations. 
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4.4.1 ARE ALL F4/80H1 MACROPHAGES EQUAL? 
Thirteen genes were significantly correlated with both YM1 and Ki67h' levels. The majority, 
nine, of these genes were more highly expressed in proliferating than in naive cells, and 
were down -regulated later in the time course. This list contained genes that were involved 
in chromosomal remodelling and proliferation. Because these genes positively correlated 
with Ki67h' and negatively correlated with YM1, this may suggest macrophages do not have 
an indefinite capacity to proliferate in response to IL -4. Indeed at day 18 P.I. we observed a 
crash in proliferation, with levels dropping well below baseline (Figure 4 -1). This may reflect 
exhaustion driven by the depletion of factors required for proliferation. Yet because 
alternative activation continues to increase at day 18 P.I. this factor may not be IL -4. 
Alternatively, any limited capacity for macrophages to proliferate in response to IL -4 may 
be cell intrinsic. Either of these possibilities could explain how AAMm are sustained without 
continued proliferation during the later phases of L. sigmodontis infection. 
It is important to consider that our analysis has profiled a population of cells, and that due 
to the stochastic nature of gene expression, functional heterogeneity always exists within a 
'pure' populations of cells (Raj and van Oudenaarden, 2008). This property, by definition, 
restricts the potential of a population of cells to perform a given task (in response to a 
stimulus) to a sub -population at any given moment in time. This will include the ability of a 
cell with mitogenic properties to retain self -renewal capacity or differentiate (Yamanaka, 
2009). We have observed the differential regulation of chromatin -remodelling genes 
associated with YM1 and Ki67h' levels. It is possible that this differential expression is driven 
by a cell- intrinsic limitation in the ability of tissue -resident macrophages to proliferate in 
situ. If so, then the frequency of macrophages competent to proliferate will change during 
the L. sigmodontis infection time course and may explain the crash in proliferation that we 
observe at day 18 P.I. It follows that distinct 'early' and 'late' populations of F4/80h' 
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macrophages that differ in their mitogenic capacity may exist within the pleural cavity. Cell - 
surface markers that correlate, positively or negatively, with the expression profile of these 
chromatin remodelling genes may serve as effective markers for these populations and 
would provide a starting point to explore this hypothesis. It is worth noting that this 
hypothesis refers to the 'life history' traits of macrophages, and can be independent of 
alternative activation per se. 
Included in the list of genes that positively correlated with Ki67h', and negatively correlated 
with YM1, was the cell surface marker Sell (L- selectin, Rosen, 2004) and migration - 
associated marker Coroal (Gatfield et al., 2005). Following on from the hypothesis 
presented above, L- selectin may provide a surface marker for 'early' tissue Mm. To define 
Sell positive macrophages as 'early' Mm, which are competent to proliferate, it would be 
necessary to see if Sell positive macrophages incorporated BrdU in advance of other F4 /80h' 
tissue macrophages in response to IL -4c treatment. BrdU is a tractable DNA analogue that is 
used to ascertain whether cells have proliferated during administration (Yu et al., 1992). A 
BrdU pulse delivered over the initial phase of macrophage proliferation in response to L. 
sigmodontis infection would label all proliferating macrophages, and I predict this would 
include a high proportion of all Sell positive macrophages. The down -regulation of Sell and 
Corola later in infection supports our previous interpretation that AAMm have decreased 
migratory capacity (Thomas et al., 2012). Two genes, Cd209b and Ccbll, negatively 
correlated with Ki67h' and positively correlated with YM1 expression as determined by 
FACS. The cell surface marker Cd209b (DC -SIGN) has previously been defined as a marker 
for mature dendritic cells (Cheong et al., 2010) and may also identify 'late' tissue MO, i.e. a 
final tissue resident MD population to develop that is refractory to in situ proliferation. 
Cd209b could thus be a useful marker to determine whether IL -4- dependent proliferation is 
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associated with terminal differentiation. Using the same BrdU experiment suggested above, 
an early pulse of BrdU during infection would label the first round of proliferating 
macrophages induced during L. sigmodontis infection. My prediction is that this initial 
labelling would not include many Cd209b positive macrophages. Cessation of the BrdU 
pulse, followed by assessment of BrdU positive macrophages later during infection, would 
enable the characterization of 'late' tissue Mo. As stated above, my hypothesis would be 
that these 'late' tissue Mo are Cd209b positive and are no longer responsive to IL -4- 
induced proliferation. 
4.4.2 No EVIDENCE FOR AN EARLY INDUCTION OF PPARy OR DYMNAMIC 
MODULATION OF IL -4Ra- DEPENDENT GENES 
We were specifically interested in the PPARy gene expression profile as this has been 
shown to be required for AAM(D and the associated metabolic phenotype in vitro. We 
therefore performed a direct assessment of the expression profiles of genes associated 
with our previous hypothesis, that a PPAR6-PGI2 axis maintains alternative activation in the 
presence of low PPARy expression (Chapter 2). The results of this time course supported 
this hypothesis showing that there was no early spike in PPARy expression. A more global 
analysis of temporal gene expression profiles after accounting for YM1 and Ki67h1 
expression determined by FACS was also performed. Hierarchical clustering of studentized 
residual errors after fitting the linear model did not reveal any additional temporal gene 
expression features in the dataset. This argues against the presence of 'early' and 'late' 
waves of alternative activation with unique IL -4Ra- dependent gene expression profiles. 
Specifically, there was no obvious cluster of genes with outlying residual errors during the 
time course that would identify an additional gene signature that was not already captured 
by the linear model. However, a more focussed analysis of temporal differential expression 
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profiles has not yet been performed. An alternative, perhaps more sensitive, approach to 
identifying temporal changes in gene expression would be to apply correlation network 
analysis, such as implemented in BioLayout Express 3D (Theocharidis et al., 2009). This 
approach is capable of identifying small numbers of genes with shared expression profiles, 
and could unveil more subtle temporal gene expression profiles. Such analysis could be 
applied to either normalized expression data or to residual errors, and is an outstanding 
objective for this microarray data analysis project. 
4.4.3 A PUTATIVE MECHANISM FOR IL -4- DEPENDENT MACROPHAGE 
PROLIFERATION 
Several lines of evidence support the idea that IL -4- dependent macrophage proliferation 
and alternative activation are transcriptionally independent. 
The kinetics of the two processes are discreet. 
The two major axes of variation in the dataset, as defined by PCA, are explained by 
alternative activation (YM1) and proliferation (Ki6711 respectively. Furthermore, 
these do not correlate. GSEA confirmed that Ki67h'- associated gene expression 
profiles represent a cell cycle signature. 
Computational analysis of over -represented cis -regulatory motifs in the promoters 
of genes correlated with YM1 and Ki67' identified STAT6 motifs in the promoters of 
YM1- associated, but not Ki67h'- associated promoters. 
Cis -regulatory analysis of cell cycle- associated genes showed that macrophage proliferation 
was associated with E2F, NFY and MYB motifs (Table 4 -5). This is consistent with a previous 
analysis of cell cycle regulatory motif activity in the promoters of monocyte -like THP1 cells 
(Suzuki et al., 2009). We have unveiled a possible link between IL -4- dependent proliferation 
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and TFBS for E2F family transcription factors. The dynamics of E2F transcription factor gene 
expression indicate that IL -4- dependent and IL -4- independent phases of proliferation may 
be governed by different E2F family members. We attempted to confirm this observation 
using FACS -purified macrophages induced to proliferate in response to M -CSF or IL -4 in 
vivo. Our objective was to correlate M -CSF and IL -4- dependent proliferative profiles with 
differing E2F gene expression profiles, however RT -PCR analysis of these samples did not 
support this initial finding. It is still possible that different E2F family members drive M -CSF 
and IL -4- dependent proliferation and if this were the case it would show the two processes 
are mechanistically independent. At this stage all we can state is that E2F gene expression 
profiles correlate with a proliferative signature that is also associated with over- 
represented E2F TFBS. Therefore these factors probably mediate IL -4- dependent 
macrophage proliferation. 
How can it be that IL -4 drives proliferation in vivo but not in vitro? In addition to the 
evidence presented above, data from our lab using whole -body lethally irradiated C57BL /6 
mice engrafted with State- bone marrow has demonstrated a requirement for STAT6 in IL- 
4- dependent macrophage proliferation (S Jenkins, unpublished). Furthermore, IL -4c treated 
mice up- regulate the expression of AAMN markers within a few hours but macrophages are 
not induced to proliferate after 1 day (Figure 4 -14). These data support a model wherein IL- 
4- dependent proliferation is downstream of STAT6. The most parsimonious explanation for 
this is one wherein IL -4 /STAT6 sensitizes macrophages to proliferate in vivo via the 
induction of a second factor (factor X, Figure 4 -15). The in vivo, but not in vitro, 
environment would provide constitutive access to a co- factor for factor X that governs the 
commitment to proliferate. This would explain how in the presence of IL -4 macrophages 
proliferate in all bodily sites at which we have so far looked (Jenkins et al., 2011). 
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Figure 4 -15. Proposed model for IL -4- dependent macrophage proliferation. STAT6 is 
activated by IL -4Ra- dependent signalling and drives the expression of a second gene X, 
postulated to be a receptor. In turn factor X permits the macrophage to divide in 
response to a second signal provided by the external environment. 
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4.4.4 CELLULAR MITOCHONDRIAL METABOLISM IN ALTERNATIVE 
ACTIVATION 
Finally, we have shown that in vivo AAMO induced by IL -4c injection, or L. sigmodontis 
infection, increase mitochondria) mass as measured by MitoTracker fluorescence intensity. 
This was expected based upon the GSEA in our time course associating the TCA cycle with 
YM1 expression. This is also consistent with the pathway enrichment and analysis of cis - 
regulatory elements presented in our RNA -Seq analysis. Surprisingly however, the cis - 
enrichment analysis presented alongside this time course failed to define a PPAR signature 
associated with YM1 expression. Szanto et al have reported that macrophage PPARy- 
dependent gene expression is augmented by STAT6 in response to IL -4 (Szanto et al., 2010). 
However, in the same paper, the transcription of AAMcD STAT6- dependent target genes 
was relatively unaffected by the absence of PPARy (Szanto et al,, 2010). This latter finding 
directly contradicts the findings of the Chawla laboratory who show that the same AAMO 
target genes are impaired in response to IL -4 in macrophage- specific Ppargl- mice 
(Odegaard et al., 2007). Regardless, one of the main differences between the RNA -Seq and 
microarray analyses we have presented is the number of DE genes we were able to detect, 
presumably due to the enhanced sensitivity and dynamic range provided by RNA -Seq. We 
have shown that TCA -cycle associated genes are induced in AAM(D, but many were not 
statistically significantly correlated with YM1 expression in our microarray (Figure 4 -13). 
These genes were also shown to have over -represented PPAR motif presence within 
promoter regions. Therefore, one possible explanation for these findings is that STAT6 does 
augment PPAR- dependent gene expression (Szanto et al., 2010), and these genes include 
key AAMD- associated metabolic pathways. However, not all STAT6- dependent changes in 
gene expression are PPARy- dependent (indeed it is hard to imagine how this could be the 
case). At the transcriptional level STAT6 may alter PPAR- dependent gene expression subtly, 
and these changes may not readily be detected by microarray. However, RNA -Seq may 
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provide enough sensitivity to identify these genes as significantly DE. This interpretation 
reinforces our understanding that the most inducible changes in IL -4- dependent 
transcription are driven by STAT6. It is clear that alterations in macrophage cellular 
metabolism induced by PPARs and STAT6 can have profound effects on systemic 
metabolism, and perhaps wider aspects of AAM physiology. The extent to which 
transcriptional changes in AAMm are mediated directly by STAT6, PPARs, or are 
downstream of either of these processes remains to be elucidated. ChIP -Seq methods 
would be needed to directly correlate gene expression profiles with TF -DNA occupancy to 
address this. However, the induction of the TCA cycle in CD8 +T -cells has profound effects 
on cellular life history characteristics (Pearce et al., 2009). It is thus possible that alterations 
in mitochondria) metabolism may exert their effects on AAMm less so by modulating 
macrophage gene expression, but rather population structure in vivo. 
We have shown that proliferating AAMm also have increased mitochondrial mass. This does 
not mean that IL -4- dependent proliferation does not utilize glycolysis and, in this context, it 
may be of interest to note that the insulin receptor, responsible for the control of glucose 
uptake, was amongst the list of core -NeMcD genes we identified. The data we have 
presented do however seem to contradict the generally accepted notion that cellular 
proliferation 'prefers' aerobic glycolysis to oxidative metabolism as a means to maximise 
carbon availability, and to minimise DNA damage caused by mitochondrial reactive oxygen 
species (Vander Heiden et al., 2009). An alternative mechanism for glycolysis- independent, 
glutaminolysis- dependent proliferation has recently been reported in B -cell like P493 cells 
(Le et al., 2012). Importantly, this process occurred in glucose- deprived conditions and 
depended upon the mitochondria) TCA cycle (Le et al., 2012). There is one report of low 
level proliferation of primary macrophages induced by IL -4 in vitro, which was reported to 
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have occurred under low glucose conditions (Odegaard et al., 2008). It is tempting to 
speculate that IL -4- dependent macrophage proliferation relies upon a similar 
glutaminolysis- dependent mechanism. However because all proliferating cells require 
glutamine for the production of intermediate metabolites the hypothesis would be difficult 
to test (Matés et al., 2002, 2009). An in vitro system will be required to directly study the 
metabolic requirements of IL -4- dependent macrophage proliferation. This is also necessary 
to further our understanding of the cellular role of mitochondrial metabolism in alternative 
activation. Thus, the advancement of this line of research will be greatly aided by the 
definition of additional co- factors required to induce IL -4- dependent macrophage 
proliferation in vitro. 
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5 DISCUSSION 
In this thesis I have presented two independent systems -level analyses detailing the 
physiological responses of macrophages to filarial nematode infections. The results that I 
present in Chapter 2 combine RNA -Seq gene expression profiling, TSS mapping and cis - 
regulatory analysis with targeted lipidomics to characterize IL -4Ra- dependent molecular 
pathways associated with AAMm during B. malayi infection. This particular analysis 
necessitated the development of a novel method for TSS mapping with RNA -Seq data. This 
leveraged the high -quality genomic annotation information available for mouse (and other 
models for basic mouse biology such as humans), and was developed into the software tool 
TSS- Predictor. The algorithmic logic and performance of TSS- Predictor is presented in 
Chapter 3. In Chapter 4 I present a novel approach to microarray time series expression 
profiling. Linear modelling was used to integrate FACS -based cellular phenotyping with 
genome -wide gene expression profiling during a time course of the response to L. 
sigmodontis infection. 
The analyses presented in this thesis support the currently accepted view that AAMO are 
anti -inflammatory, or at least are not pro -inflammatory (Gordon and Martinez, 2010). The 
gene expression profiles of IL -4Ra- dependent AAMm- derived cytokines, chemokines and 
their receptors have been characterized, some of which have unknown function, in the 
response to nematode infection (Thomas et al., 2012). I hope that these data and analyses 
serve as a resource to catalyse the study of these molecules. I have also combined NeMm 
gene expression signatures associated with filarial nematode infection from two separate 
experiments to define a 'core' list of IL -4Ra- dependent NeMm- associated genes. This list 
was derived from macrophage gene expression measurements taken in response to 
different filarial parasites (B. malayi and L. sigmodontis) that occupy different physiological 
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sites (peritoneal and pleural cavity) in different host strains (BALB /c and C57BL /6), and 
measured using different technologies (RNA -Seq and microarray). This list may not be all 
encompassing, as technical artefacts may have led to the omission of additional 'true' core- 
NeM0 genes. My hope that this stringent approach has led in the generation of a high 
confidence list of IL -4Ra- dependent NeMc- associated genes and will thus have wider 
utility. For example highly expressed cell surface genes may serve as useful markers to 
identify polarized NeMcD by FACS. 
In addition to the gene -level characterizations above I have confirmed that nematode 
infection, and specifically IL -4, induces metabolic pathways associated with mitochondrial 
metabolism in AAMO in vivo. This has been shown indirectly with GSEA and directly using 
MitoTracker staining, and is further supported by cis -regulatory element analysis. In vitro 
studies have previously demonstrated that AAMO- associated mitochondria) metabolism is 
mediated by PPARy (Odegaard et al., 2007). Furthermore, in vitro, macrophage Pparg itself 
is induced in response to IL -4 (Huang et al., 1999). It therefore came as a surprise that 
NeMO in the highly IL -4 dependent context of B. malayi infection did not express 
appreciable levels of Pparg. However, B. malayi- induced NeMCD abundantly expressed 
Ppard, showed a PPAR transcriptional signature in the genes of IL -4Ra- dependent 
promoters, and up- regulated mitochondrial metabolic pathways. Based on these data I set 
out to define putative PPAR6 ligands. Because NeMO showed differential regulation of 
arachidonic acid metabolism, a key pathway that serves as a source of PPAR ligands, we 
performed targeted lipidomics to screen AAMcD- derived eicosanoids in collaboration with 
colleagues in Inverness (Philip Whitfield and Ben Maskrey, University of the Highlands and 
Islands). With this technology we identified the PPAR6 ligand PGI2 (Forman et al., 1997) as 
the most abundant AAMO- derived eicosanoid and propose that a PPAR6 -PGI2 axis 
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maintains PPAR- dependent transcription in the NeMO response to B. malayi infection. The 
patterns of gene expression in our L. sigmodontis time course experiment supported this 
initial hypothesis. 
The L. sigmodontis time course experiment proved useful in characterizing the dynamic 
expression profiles of NeMc genes, and provided strong support for the conclusions drawn 
from my RNA -Seq experiment. However, the primary purpose of this experiment was to 
gain insight into the differing roles of IL -4 in macrophage proliferation and alternative 
activation. Linear modelling was used to deconvolute macrophage transcriptional 
responses associated with alternative activation and proliferation and was achieved 
combining FACS measurements of YM1 and Ki67 expression with microarray profiling. From 
this I was able to show that it is unlikely that STAT6 drives macrophage proliferation directly 
by binding the promoter regions of cell -cycle- associated genes. Based on the findings of this 
analysis and our understanding that IL -4- dependent macrophage proliferation is STAT6- 
dependent I have proposed a working model for IL -4- dependent macrophage proliferation. 
A pictorial overview of the main findings arising from the work presented in this thesis can 
be found in Figure 5 -1 below. In the remainder of this discussion I will identify the main 
outstanding biological themes arising from this thesis, and discuss approaches I would take 
to develop each of these. Finally I consider the utility of systems -wide computational 
approaches in advancing our understanding of immune processes. 
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Figure 5 -1. Schematic overview of the findings in this thesis. Using the nematode 
infection models B. malayi and L. sigmodontis I have characterized IL -4Ra- dependent 
gene expression profiles and metabolic pathways. Additionally I have investigated 
mechanisms of IL -4Ra- dependent macrophage proliferation. NeMm up- regulate 
pathways associated with complement activity and mitochondrial metabolism. I have 
shown that NeMm increase mitochondrial mass and metabolism, however do not 
express high levels of the PPAR transcription factor Pparg. Instead, NeMm express the 
related Ppard gene and abundantly produce the PPAR6 ligand prostacyclin via the up- 
regulation of genes in the biosynthetic arachidonic acid metabolism pathway. My 
analysis of IL -4Ra- dependent macrophage proliferation supports does not suggest that 
STAT6 drives macrophage proliferation directly, and may act via an intermediate 
protein, perhaps a receptor. The activity of this intermediate factor is predicted to 
mediate IL -4Ra- dependent proliferation via E2F family transcription factors. 
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5.1.1 PREPARING TSS- PREDICTOR FOR PUBLICATION 
TSS- Predictor (Chapter 3) was developed to predict the primary TSS usage for a gene from 
RNA -Seq data. It was necessary to develop this tool because Cufflinks, the only other 
application that has this capability (Trapnell et al., 2010), generated predictions that were 
considered inaccurate, largely because of over extension of the 5' end of putative 
transcriptional units. The initial decision to make TSS- Predictor was based upon a 
qualitative judgement informed by observing read mapping to the reference genome 
alongside annotations and Cufflinks gene predictions. As expected, I have since shown that 
TSS- Predictor does outperform Cufflinks using our dataset. Prior to publication however it 
will be desirable to test TSS- Predictor on a wider range of RNA -Seq datasets derived from 
model organisms. Many such datasets are now deposited online, and are available at the 
European Nucleotide Archive (ENA). A simple search for 'RNA -Seq' at the ENA returned 819 
results (http: / /www.ebi.ac.uk /ena /, 22 March 2013). 
TSS will be predicted for RNA -Seq datasets from a range or RNA -Seq experiments across 
species with 'high quality' TSS predictions, such as those in the ENCODE and modENCODE 
projects (Consortium, 2004; Gerstein et al., 2010; Roy et al., 2010). TSS predictions will be 
compared against TSS defined by Cufflinks in relation to reference annotations, as done in 
Chapter 6. TSS- Predictor relies on the transcript annotations to determine high quality 
transcription start sites. The distance between the nearest annotated TSS for a gene and 
the predicted TSS also serves as the metric for algorithm performance. I decided that this 
was appropriate because it was clear that one of the Ensembl- predicted TSS was correct in 
the vast majority of cases. Furthermore, Cufflinks had a tendency to systematically predict 
transcript TSS that were upstream of the 'true' TSS. This justification however will need to 
be supported by empirical evidence prior to the publication of TSS- Predictor. In order to 
obtain this I plan to identify an experimental condition (i.e. particular tissue or cell line) for 
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which both CAGE and RNA -Seq are available. This will allow me to compare TSS predictions 
derived from Cufflinks and TSS- Predictor against an independent gold standard. 
5.1.2 THE COMPLEMENT CASCADE IN AAMO 
Pathway analysis from our RNA -Seq dataset revealed a previously uncharacterized role for 
the complement cascade in the AAMO response to B. malayi infection. Macrophages are 
known to be a source of complement (Nathan, 1987), and complement components have 
been shown to interact with, and contribute towards the killing of microfilariae (Carter et 
al., 2007). I was struck by the high levels of expression level of complement components, in 
particular C3, by AAMm. Additionally my analyses identified components of the mannose 
binding lectin pathway, specifically Fcna, as highly up- regulated in the response to B. malayi 
implant. My subsequent analysis of macrophages from L. sigmodontis infected mice did not 
reveal a complement signature to the same extent, although C3 was placed within the list 
of 'core' NeMO genes, suggesting that this is induced in response to IL -4. 
One possible explanation for this discrepancy is that complement up- regulation is restricted 
to macrophages in the peritoneal cavity. A key background control for the RNA -Seq 
experiment is the thioglycollate- elicited macrophage group. Macrophages are acutely 
recruited from the bloodstream in response to thioglycollate (Hopper, 1986) and may not 
yet have been induced to express resident peritoneal levels of complement. The peritoneal 
cavity occupies a particularly sensitive niche in body due to its proximity with the gut. This 
may necessitate the provision of innate immune components such as complement by a 
resident population of macrophages, in order to minimize the flow of material between the 
peritoneal cavity and systemic circulation. This mechanism may not be required within the 
pleural cavity. 
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An alternative explanation is that complement components are induced in response to 
microfilaria, the offspring produced by female filarial nematodes that circulate in the 
bloodstream. Microfilariae are known to induce a more inflammatory, Th1- biased, immune 
response than adult filarial nematodes (Lawrence et al., 1994; MacDonald et al., 2003) and 
presence /absence patterns of microfilariae are a major difference between the B. malayi 
and L. sigmodontis models (Le Goff et al., 2002). The adult B. malayi implanted during the 
RNA -Seq experiment constitutively produce microfilariae throughout the course of the 
experiment. However this will not have been the case during the L. sigmodontis time 
course. L. sigmodontis do not produce microfilariae until 50 days post infection (Hoffmann 
et al., 2000b), and indeed never do in the resistant C57BL/6 strain that we profiled 
(Hoffmann et al., 2001). A final possibility of course is that these differences in 
complement expression are reflective of mouse strain differences (C57BL/6 vs. BALB /c). 
This may be of interest regarding the susceptibility of BALB /c mice. Although complement is 
well established as a mediator of host defence, it is increasingly being appreciated as a 
regulator of immunity also (Heeger and Kemper, 2012). Thus it is also plausible that 
complement induction by AAMN in BALB /c, but not C57BL/6, mice may actually confer 
susceptibility to L. Sigmodontis infection in the BALB /c strain. 
To drive this line of research forwards it would first be necessary to determine the 
conditions under which macrophages produce complement in response to filarial 
nematode infection. The role of B. malayi relative to L. sigmodontis, and the relative 
contribution of microfilariae could be tested using an implant model. Young (< day 50) and 
old (> day 50) adult L. sigmodontis, microfilariae producing and non -producing respectively, 
could be surgically implanted into the peritoneal cavities of BALB /c mice. A control group 
for this experiment would be B. malayi implantation and would serve as a direct reference 
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to the RNA -Seq experiment that we have performed. This would enable the contrast 
between parasite species and the presence of microfilariae in the context of the peritoneal 
cavity. 
RT -PCR analysis of various complement components (C3, Cl complex and MBL 
constituents) produced by purified macrophages would need to be performed. Depending 
on the outcome of this experiment it would be of interest to determine whether 
macrophages are induced to produce complement in the pleural cavity response to L. 
sigmodontis microfilariae. After determining the conditions under which complement is 
produced I would then identify a role for complement in the response to filarial nematode 
infection. As discussed above, potential roles for complement in helminth infection range 
from conferring host susceptibility to mediating anti -microfilarial responses. Complement 
inhibitors and /or genetic approaches would be needed to determine the functions and 
roles of the relative components of the complement system in the response to nematode 
infection. The liver and macrophages are amongst the most abundant producers of 
complement. An attractive strategy to define roles of macrophage- derived complement in 
the response to filarial nematode infection would be to make use of bone marrow chimeras 
in which complement deficient bone marrow was grafted into lethally irradiated wild -type 
hosts. This would allow specific depletion of complement within the hematopoietic system. 
This approach is feasible as a range of complement- deficient mice are available on both 
C57BL/6 and BALB /c genetic backgrounds (Trendelenburg et al., 2005). 
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5.1.3 UNDERSTANDING THE MECHANISMS BEHIND IL -4- DEPENDENT 
MACROPHAGE PROLIFERATION IS A CENTRAL QUESTION IN 
MACROPHAGE BIOLOGY 
Tissue resident macrophages occupy almost all bodily tissues and display a tremendous 
degree of transcriptional heterogeneity (Gautier et al., 2012). While all macrophages 
require Csflrfortheir development (Hume and MacDonald, 2012), the relative importance 
of additional polarizing factors downstream of Csflr remains an underexplored area. 
Indeed, the major challenges in myeloid cell biology today are underlain by our ignorance 
of the ontological relationships between, and the functions of, the various tissue resident 
macrophage subsets (Hashimoto et al., 2011). It is proposed that macrophages acquire 
their tissue -specific properties as a result of the microenvironment they experience. For 
example, migratory Langerhans cells, tissue resident macrophages of the epidermis, display 
a unique phenotype. Upon migration to the lymph nodes, these same Langerhans cells 
acquire a cell surface expression profile indistinguishable to migratory dendritic cells when 
measured by FACS (Merad et al., 2008). This observation proves either phenotypic 
plasticity, or the continuation of a macrophage developmental programme that is 
influenced in a tissue specific context. 
Many resident macrophage populations require Csf1r- dependent signalling for their 
maintenance in the steady state (MacDonald et al., 2010). However, in addition to Csflr, 
tissue macrophage cellular identity can require specific factors. For example Spic is 
necessary only for the development of splenic red pulp macrophages (Kohyama et al., 
2009). We know from our own experiments that Csflr- dependent signalling is not required 
for IL -4- dependent macrophage proliferation (S Jenkins unpublished), although it may or 
may not be necessary for the long term maintenance of steady state peritoneal and pleural 
cavity populations. Therefore the identification of a second factor driving IL -4- dependent 
macrophage proliferation, and thus the establishment and maintenance of a Th2 context- 
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dependent macrophage population, has implications for our understanding of basic 
macrophage biology that extend beyond the fields of alternative activation and Th2 
immunity. 
5.1.4 AN EXPERIMENTAL PLAN TO IDENTIFY FACTOR X 
Based upon the evidence outlined in Chapter 4 I have presented a model for IL -4- induced 
macrophage proliferation. My hypothesis predicts that IL -4 drives the expression of a 
second factor that is required to allow macrophages to divide in response to a signal 
provided by the in vivo environment. This relatively simple mechanism would explain why 
macrophages proliferate in response to IL -4 in vivo, but not in vitro. 
The programmes of cellular proliferation and growth in mammalian cells are governed by 
growth factors and cytokines (Lemmon and Schlessinger, 2010), and these factors operate 
through broad family of evolutionarily conserved receptor tyrosine kinases (RTK) 
( Schlessinger, 2000). Thus, RTKs are responsible for relaying cell extrinsic growth and 
differentiation signals to cellular metabolic and signalling cascades. Amongst the RTK family 
is Csflr, the canonical receptor driving the macrophage proliferation profile (Hume and 
MacDonald, 2012). Studies from within the Allen lab have already discounted the possibility 
that Csflr is responsible for IL -4- dependent macrophage proliferation (S Jenkins 
unpublished). I hypothesise that factor X, induced by STAT6, belongs to the large family of 
RTK receptors. For this hypothesis to hold true, factor X must be part of the list of 'core' 
NeMc genes that I have identified. However, it is also plausible that the candidate RTK is 
constitutively expressed, and that an adapter protein or co- factor is present in the 'core' list 
of NeMm genes. I have identified candidate RTKs by examining the expression profile of all 
RTK family members (GO term GO:0004714) in both the RNA -Seq and microarray 
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experiments I have performed (Appendix 5). This has resulted in the identification of 7 
candidate receptors for downstream analysis (Table 5 -1). All of these receptors were 
moderately to highly expressed in both experiments, but not necessarily up- regulated in 
AAMcV. Only two of these factors lnsr (insulin receptor), and Fgfrl (fibroblast growth factor 
receptor 1) were present in the 'core' NeM0- associated gene list. 
In order to test these candidates my approach would be to deliver IL -4c to mice alongside 
selective inhibitors of the candidate receptors to identify RTK pathways that are required 
for IL -4- dependent macrophage proliferation in vivo. An important prediction regarding the 
phenotype of the knockdown /inhibition of candidate X is that proliferation, but not 
alternative activation, would be impaired. Because off -target inhibition is a common 
problem with pharmacological approaches, this will serve as a starting point to narrow 
down candidates for in vitro proliferation assays. In vitro assays would identify ligands that 
induce macrophage proliferation in the presence of IL -4, identifying these would represent 
a significant advance in our understanding of macrophage biology. With the development 
of an in vitro system for IL -4- dependent macrophage proliferation siRNA or similar 
knockdown approaches could then be used to confirm the functional relevance of 
individual receptor genes to IL -4- dependent macrophage proliferation. 
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Gene RTK Family 
Symbol 
AxI MER/AXL/TYRO3 
Csflr PDGF 
Epha2 EPH 
Fgfrl FGF 
FIt1 VEGF 
lnsr INSR 
Mertk MER/AXL/TYRO3 
Nrpl NRP 
Table 5 -1. Candidate receptors mediating IL -4Ra- dependent macrophage proliferation. 
Transmembrane receptors with tyrosine kinase activity (GO term GO:0004714) 
expressed by both B. ma /ayi- elicited and L. sigmodontis -elicited AAM D. 
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5.1.5 MITOCHONDRIAL METABOLISM AND THE PHYSIOLOGY OF TH2 
IMMUNE RESPONSES 
AAMm orchestrate major changes in whole body metabolism by the preferential uptake of 
lipids, and their catabolism via oxidative phosphorylation in a PPAR- dependent fashion 
(Vats et al., 2006). This is accompanied by the systemic redistribution of glucose and lipids, 
mediated via paracrine activities of AAMN on the major metabolic tissues (Odegaard and 
Chawla, 2011) with the consequence of enhancing insulin action. In the context of type -2 
diabetes and the metabolic syndrome, IL -4 and AAM(p help to counteract the adverse 
metabolic consequences of insulin resistance (Odegaard et al., 2007). We know that 
helminth infection leads to a large expansion of a resident macrophage population. 
Furthermore, the helminth parasite N. broziliensis ameliorates HFD- induced insulin 
resistance (Wu et al., 2011). Our transcriptomic data show that helminth- elicited AAMCD 
increase lnsr expression. Thus contrary to the dogma that AAMO preferentially oxidise 
lipids (Vats et al., 2006), the lnsr expression profile implies that AAMcD may also act as a 
significant glucose sink. It would be of considerable interest to determine if, and to 
characterize how, AAM(D behaviour is differentially affected by the utilization of different 
carbon sources. 
A great deal of work still remains to be done to understand the molecular relationship(s) 
between oxidative metabolism and AAMm immunogenic properties. I have established that 
AAMD are characterized by an increase in mitochondrial mass, and that this is induced by 
IL -4 in vivo. This is important as previous studies have only shown this in vitro. From in vivo 
studies we know obese white adipose tissue (WAT) is associated with inflammatory 
macrophages (Weisberg et al., 2003), and that lean WAT has an AAMcD signature and 
enhanced expression of TCA cycle- associated gene expression (Lumeng et al., 2007; Vats et 
202 
al., 2006). However, a direct comparison between obese and lean WAT macrophage - 
associated gene expression is not valid as obese WAT is characterized by macrophage 
hyperplasia (Weisberg et al., 2003). 
I have already considered that mitochondrial metabolism in AAMCD may contribute to 
AAMCD immune activity by affecting systemic metabolism. Furthermore, oxidative 
metabolism could extend AAMCD lifespan, affecting macrophage 'population structure', 
with numerous possible consequences for immunity. There is precedence for the assertion 
that metabolic pathways of resource utilization at the cellular level can profoundly affect 
cellular inflammatory properties. The mitochondrial citrate carrier Slc25a1 catalyses the 
export of citrate, a key TCA cycle intermediary, from the mitochondria and is required for 
robust LPS- induced inflammation in macrophage -like U937 cells (Infantino et al., 2011). 
Furthermore, in a manner dependent upon glycolysis, the TCA cycle intermediary succinate 
drives inflammatory gene expression by stabilizing the transcription factor HIF1a (Tannahill 
et al., 2013). Chemical inhibitors of mitochondrial activity ablate AAMCD function, at least as 
measured by arginase activity (Vats et al., 2006), and PPAR activation suppresses 
inflammatory gene expression (Ogawa et al., 2005; Straus and Glass, 2007). 
My findings are consistent with the above models, namely that mitochondrial metabolism 
and PPAR activity impart anti -inflammatory gene expression profiles in macrophages. It will 
be important however to determine which functions of AAMCD are directly STAT6- 
dependent, which are PPAR- dependent, and which are downstream of other regulatory 
mechanisms induced during alternative activation. Furthermore, an unresolved debate 
exists as to whether PPARs require STAT6 or if STAT6 requires PPARs to drive AAMCD- 
associated gene expression (Odegaard et al., 2007; Szanto et al., 2010). In reality the 
situation is probably not quite so black and white that we might expect one transcription 
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factor to require the other for its activity. Nor is it necessary to assume that Th2 responses 
and AAMO need a particular metabolic phenotype, although the evident coupling between 
AAMO anti -inflammatory gene expression and oxidative metabolism suggests that this may 
be the case. To date, studies of AAMO polarization and metabolism tend to have focussed 
on obesity and Th2 diabetes as models. It is indisputable that, under these circumstances, 
alternative activation of adipose tissue macrophages is intimately associated with a 'lean' 
metabolic phenotype. I believe however that the questions that ought to be asked in the 
context of helminth infection are: How are immune and metabolic processes are 
intertwined ?; What components of AAMO are affected by alterations in metabolism, both 
systemic and cellular ?; And, how do the metabolic components of macrophage activation 
relate to wider aspects of Th2 immunity and defence against disease? 
INFORMATICS APPROACHES TO IMMUNE CELL BIOLOGY 
A combination of systems biology and immune cell biology approaches have been used to 
characterize and define molecular pathways associated with AAMc in vivo. Such in vivo 
approaches are absolutely essential to understand the true roles of immune cell subsets as 
the complexity of live parasite infection, and the associated heterotypic cellular responses, 
cannot be recapitulated in vitro. The success of the transcriptomic experiments in this 
thesis has been contingent upon the isolation of highly purified macrophage populations 
using FACS. FACS is an essential tool for the phenotypic screening and functional analysis of 
cellular subsets derived in vivo. However, FACS is restricted by limits to the number of 
variables that can be simultaneously observed, and indeed the availability of appropriate, 
specific antibodies for sorting. 
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By virtue of the ability to measure gene expression profiles genome wide, the combination 
of FACS and transcriptomic approaches used in this thesis have provided fundamental new 
insights into IL -4Ra- dependent molecular pathways associated with AAMO during 
nematode infection. Furthermore, the analysis of regulatory elements in the promoters of 
AAMO and proliferation- associated genes has allowed us to infer the transcriptional 
regulatory mechanisms that may underlie these pathways. Thus, systems biology 
approaches are highly complementary to widely used immune cell biology methods. 
Together these provide a powerful engine for hypothesis generation and testing, facilitating 
functional studies to elucidate the roles of immune cell subsets and their products. 
Several large consortia are involved in the systems -level classification of mammalian 
regulatory elements and immune cell types. The ENCODE and FANTOM consortia are 
engaged in the large -scale characterization of transcriptional activity and epigenetic 
modifications across the genomes of target species using RNA -Seq, ChIP -Seq and variants 
thereof. The objectives FANTOM and ENCODE are to catalogue all genomic regulatory 
elements (Consortium, 2004; Kawaji et al., 2010). The aim of these programmes is to 
elucidate fundamental mechanisms of transcriptional regulation, and cell subset 
specification using both cell lines and mammalian tissues. The Immgen consortium is 
undertaking the transcriptomic characterization of many immune cell types to describe 
their gene expression repertoires, and to determine developmental and functional 
relationships between immune cell subsets. These are large and labour- intensive projects 
that provide the wider research community with valuable resources, and access to methods 
that would not otherwise be available. However, these large -scale projects focus on the 
description and classification of steady state or development in tissue or cell populations, 
or established cell lines. 
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A niche remains available for researchers with informatics skills to address biological 
questions that involve the study of specific cells, or molecules, in the context of a disease or 
environmental perturbation. Indeed the vast majority of basic biology takes this form. Thus, 
an unprecedented window of opportunity is provided by genomic technologies to 
interrogate fundamental cell biological processes at a genome wide level. Several key 
unanswered questions regarding the regulation of immune cell types can now be 
addressed. For example, transcription factors such as STATs, PPARS, and their related family 
members play overarching roles in immune regulation. Such factors operate in multiple 
immune cell types, and 'direct' or polarize immune responses in a coordinated manner. Yet, 
the transcriptional responses induced by individual transcription factors are cell- specific. 
Such cell- specific action is regulated through coordinated, often layered, activities of 
different transcription factor combinations. We are now able to begin to decipher how 
these interactions regulate the function of their host cell types. In doing this we may begin 
to generate a predictive understanding of effects of molecular or pharmacological 
perturbations on immune responses, and apply such predictive science to medical 
interventions in health and disease. 
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Al -sl. Representative gates showing F4 /80 high macrophage populations obtained 
during flow sorting for WT and IL -4ra ', B. malayi- elicited and thioglycollate- elicited 
macrophages. APC = F4/80, FITCc = CD4. 
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A1-s2. Hierarchical cluster analysis of genes with residual variance >20. Replicates WT- 
thioglycollate 3, IL -4ra 1 - infected 1 and IL- 4ra-'-- infected 2 cluster distinctly, and 
separately, from the remaining samples, all of which show similar expression profiles. 
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A1-s3. Hierarchical sample clustering with all Ensembl genes prior to outlier removal. 
This shows that the measured gene expression profiles are dominated by biologically, 
rather than technically, induced variation. 
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A1-s4. Mean vs standard deviation plot for genes after application of variance - 
stabilization. The black dotted line represents the non -specific cut -off filter used to 
enforce homoscedasticity prior to limma analysis. 
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A1-s5. Bar chart showing the median absolute deviation between predicted TSS and the 
nearest Ensembl TSS across all loci on chromosome 2. This is shown for both forward 
(red) and reverse (blue) trimming policies at a variety of x cutoffs ranging from 1% to 
60 %. 
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A1-s6. MAD plot showing the median absolute deviation between predicted TSS and 
nearest TSS as a function of expression level for all expressed genes. Genes were ranked 
by expression level and 20 bins containing equal numbers genes were created. For each 
bin the MAD from the nearest Ensembl TSS is shown. 
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A1-s7. MvA plots demonstrating the differences in the magnitude of differential 
expression between the 3 key comparisons, WT -NeM4 vs WT- ThioM4 (top left), WT 
NeM4) vs IL -4ra 
-/ 
-NeM4 (top right) and WT- ThioM(0 vs IL -4ra' -ThioM4, (bottom left). 
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A1-s8. Expression profile of all genes assigned to clusters using hierarchical 
agglomerative clustering. The following clusters were assigned as AAM- associated: 
AAM -up.1 = 5, AAM -up.2 = 8, AAM -up.3 = 10, AAM -up.4 = 12, AAM -up.5 = 3, AAM - 
down.l = 1, AAM- down.2 = 7, AAM- down.3 = 14, AAM- down.4 = 2, AAM- down.5 = 9. 
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A1-s9. Graphical representation of the complement cascade highlighting genes 
expressed by NOM.. Abundantly expressed genes (thick node borders) are within the 
10% most highly expressed WT -NeM4 transcripts. This figure clearly shows that AAM4 
produce C3bbb C3/5 convertase complex components as well as FicolinA (Fcna) and C1q 
complex components. 
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Al -s10 a) Heatmap showing GSEA profiles of all KEGG pathways for the comparisons 
WT -NeM4 vs WT- ThioM4 and WT- NeM, vs. IL -4ra 1 -NeM4. B) Close -up view of the red 
box in a) showing the over -representation of KEGG metabolic pathways in WT -NeM4 
relative to both control conditions. 
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Al -s11. The expression level of mitochondria) TCA cycle genes. 
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A1-s12. Heatmap showing relative expression of mitochondria) electron transport chain 
(ETC) components between WT -NeM4 , IL-Ara' -NeM4) and WT- ThioM4. The majority of 
ETC components are most highly expressed in WT -NeM4. 
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A1-s13. Expression levels of phospholipase a2 enzymes in macrophage populations show 
no association with alternative activation. 
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A1-s14. Concentration of measured eicosanoids in 12 hour cultures of adherence - 
purified peritoneal macrophages ex vivo (left panel) and peritoneal lavage supernatant 
(right panel) 21 days post implantation with B. malayi or 3 days post thioglycollate 
injection in BALB /c (WT) and IL -4ra-' (KO) mice. N.D. = not detectable. 
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Al -s15 a) Counts of the total number of F4/80 positive macrophages in the peritoneal 
cavities of WT and 1L -4ra ' B. malayi implanted mice. B) Linear regression showing the 
significant positive correlation between lavage macrophage number and peritoneal 
TxB2 concentration. 
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Group library ID % Purity (library) 
WT -Thio BTG1 98.5 
WT -Thio BTG2 98.1 
WT -Thio BTG3 98.3 
WT- Infected BNe1 96.5 
WT- Infected BNe2 99.4 
WT- Infected BNe3 99.3 
KO -Thio 4TG1 97.2 
KO -Thio 4TG2 96.6 
KO -Thio 4TG3 97 
KO- Infected 4Ne1 94.9 
KO- Infected 4Ne2 96.1 
KO- Infected 4Ne3 96.1 
Supplementary Table Al -ST -1. F4 /80h' macrophage purities in FACS sorted macrophage 
popultaions used for RNA -Seq gene expression profiling. 
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CcI6 40318 65555 54537 192247 7.05E-02 1.86E-01 1.42E-03 
CcI9 16563 19075 12169 42256 5.60E-01 8.85E-02 1.53E-03 
CcI24 3718 438 987 1041 2.90E-37 4.52E-24 4.52E-04 
CclB 176 7 28 49 6.35E-21 4.12E-15 5.97E-04 
Cxcl12 9 2 1 2 5.11E-02 2.06E-04 1.00E+00 
Cxcl13 40 1 13 0 2.08E-10 2.23E-03 7.20E-01 
Ccl3 9 592 279 603 7.67E-133 1.48E-68 1.00E+00 
Cc14 6 308 162 419 3.51E-78 2.39E-42 3.38E-01 
Cc12 6 373 169 618 1.74E-95 2.27E-45 1.88E-01 
CcI7 4 109 50 185 4.28E-30 1.01E-13 2.41E-01 
Cxcl14 164 239 673 412 2.96E-02 6.90E-34 6.17E-02 
Cxcr7 7401 369 1225 341 3.45E-53 5.36E-39 8.99E-01 
Ccr1 4166 2264 2448 5464 1.41E-05 1.56E-05 1.66E-04 
Ccr2 332 2523 4029 5557 2.94E-82 1.36E- 1.87E-03 
124 
Cxcr1 0 3 1 2 7.03E-03 3.81E-01 6.62E-01 
Cxcr2 3 12 11 27 4.55E-03 1.19E-02 1.68E-01 
Cxcr3 0 5 11 11 9.95E-03 3.44E-06 4.71E-01 
CcrS 2421 2991 5162 3798 1.52E-01 6.58E-12 4.76E-01 
Ccrl2 194 874 1244 1094 1.00E-38 5.36E-66 7.18E-01 
111rI1 2097 40 17 30 1.97E-69 2.87E- 5.98E-01 
130 
1127ra 1139 121 460 57 2.77E-35 6.08E-12 5.19E-02 
Gfra2 1059 74 13 21 3.50E-41 1.33E-99 4.31E-03 
Lepr 443 1 30 2 7.01E-56 1.19E-43 8.73E-01 
116 157 2 76 3 4.11E-24 3.12E-04 9.30E-01 
Wnt2 2275 9 114 3 1.77E-90 9.57E-79 2.19E-01 
Bmp6 315 1 2 0 2.19E-44 1.04E-60 7.20E-01 
1110 1 1 4 2 1.00E+00 4.92E-02 8.79E-01 
Tnf 9 93 211 92 2.47E-19 9.48E-52 9.00E-01 
Lif 1 7 10 2 5.12E-03 7.37E-05 1.96E-01 
II1b 20 58 869 160 8.57E-05 5.69E- 1.20E-02 
156 
1116 165 391 279 402 7.69E-10 7.02E-04 1.00E+00 
Tnfsf9 1 15 50 17 8.03E-06 7.20E-20 7.70E-01 
Ebi3 16 86 131 83 2.12E-11 5.39E-22 1.00E+00 
Pparg 18 632 20 927 2.63E-119 1.00E+00 2.33E-01 
Ppard 547 538 724 100 1.00E+00 3.73E-02 1.15E-09 
Ppara 1 1 0 0 9.50E-01 7.65E-01 7.20E-01 
Supplementary Table A1-ST -3. List of genes, and gene expression values (average 
number of reads mapped per condition after adjustment for library size in DESeq) for all 
discussed genes in Chapter 2. 
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Cd81 Gbp3 Lrg1 Ptprm ViII 
Cdkn2a GbpS Ltbp1 Ramp3 Vmn2r26 
Cish Gm4951 Mall S1pr5 Wnt2 
CIdn10 Gpr116 Mst1r Saa3 
Clmn Grlf1 Nbl1 Sardh 
AAM up 3 
1700084C01Rik Chi317 Gm10384 Maml2 Scamps 
1810011010Rik Chit1 Gm7120 Mapk12 Sema3b 
2010110P09Rik Co113a1 Gm826 Mkx Sh3d19 
4931408A02Rik Csn3 Gng4 Mmp28 SIc15a5 
5033411D12Rik Cst13 Grrp1 Mog SIc16a1 
A4galt Ctsf Gstt3 Mpp6 Slc2a5 
A930005104Rik Cux2 Hc Nova1 Smtn12 
Abcd2 Cyp2abi Hecw1 Npdc1 Sprr2a1 
Acss1 Cyp2u1 Hormadl Npl Sprr2a2 
Adck3 D6Wsu116e Hrct1 Nrap Srms 
Adcy3 Dhrs9 Hs3st2 Nrg4 St3gal4 
Afap111 Dhtkdl Hydin Odz4 Stap2 
Agmo Dnaicl Igf1 OIfr1033 Su1t2b1 
Aldh1a2 Dnm1 111r12 Pcyoxll Tbc1d30 
Aldh5a1 Dpp6 1120rb Pde4d Thbs4 
Amhr2 E030010A14Rik Irf4 Pde4d Tjp2 
Arhgap12 Ear12 Itgax Pde4díp Tmem119 
Armc2 Ear2 Itgb3 Pdgfc Tmem52 
Asb11 Ear3 Itgb4 PgmS Tmem64 
Asz1 Efs Jup Pla2g2e Tmigdi 
BC048546 Ehd2 Kcnk13 PIa2g7 Tmprss5 
Bend6 Eid2 Kcnt2 Plxna2 Tppp 
Bfsp1 Epas1 K1h113 Prkcdbp Trf 
Bzw2 Fam115c Kpna6 Prnp Trim12a 
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Cacnala Fam198b Lgi3 Prox1 Trim43a 
CaIrn14 Fam19a5 Lhx8 Ptprg Usp9y 
Cc124 Fcgr2b Lipc Ptrf Wtip 
Ccl8 Fcna L0C100044656 Rasgefla Zfyve28 
Cd209f Fcrls L0C100503254 Remi 
Cd209g FgdS L0C100504580 Reni 
Cdh1 Fhl1 Lrp3 Rent 
Cdr2I GaInt14 Lypd6 Ripk4 
Chchdl0 GIb1 Lyplall Ripply3 
AAM up 4 
1110067D22Rik Cpeb3 Ibtk Nr1d1 SIc26a2 
1300001101Rik Crim1 Ids Nr3c2 SIc2a8 
1300010F03Rik Crtap Igf2 Ntn4 SIc35d1 
1600029D21Rik Csf1r 114ra Nucbi SIc37a1 
1700020L24Rik Cttn 116st Numbl SIc9a3r2 
1700040L02Rik Cux1 Inadl Nup153 Smap2 
2310022B05Rik Cyb561 Ip6k3 Nupr1 Smc1b 
2310028H24Rik Cyp1b1 Igck Nynrin Smg5 
2410016O06Rik Cyp46a1 Itch Ogdh Smurfl 
2610507B11Rik D18Ertd653e Itfg3 Otud7b Snd1 
4931406P16Rik Dach1 Itsn1 Pacs1 Sorti 
4932438A13Rik Deptor Jrk Pcbp3 Sox13 
5430411K18Rik Dip2c Kcnab3 Pcx Spi 
5730419109Rik Dnahc2 Kcnb1 Pdcd4 Spats2 
9030418K01Rik Dnaja4 Kcnk6 Pde10a Spinti 
9030625A04Rik Dopeyl Kctd9 Pde2a Src 
9430020K01Rik Dstyk Khk Pde3b Ssh2 
Acad10 Dusp10 KIc1 Pdk2 St3gal2 
Acot11 Dym KIf12 Pdpr St7 
Adam15 Dysf KIf4 Peli3 Steap3 
Add1 Efnb1 KIf9 Pex26 Stoni 
Agfg2 Eif2ak4 KIhI21 Pex6 Sun1 
Agtrap Ell Krba1 Pfkl Syt3 
A1314180 Epb4.111 Krt7 Pfkm Tarmi 
Aki Epb4.9 La ptm 5 Pigq Tbcid2b 
Ak8 Epn2 Layn Pik3r3 Tbl1x 
AIdh18a1 Espii Ldhd Pik3r4 Tctn1 
Als2cl Espn Ldlr Pim3 Tctn2 
Angell Etohil Lgals3bp Pitpncl Tctn3 
Ankrdl3b Etv3 Lgr4 PIcd1 Tek 
Ano6 Ext2 LOC100046899 PId1 Tep1 
Apin F10 LOC100504473 Plekha6 Thal 
Arhgefl2 Fam102a L0C100504500 Plekhfl Thada 
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Arl4c Fam117a LOC100505126 Plekhg3 Thsd4 
Arvcf Fam13a LOC100505278 Podx12 Tmcc2 
Asah2 Fam167a Lpar5 Pofuti. Tmem190 
Asb10 Fam20a Lpin1 Polrla Tmem20 
Asgr2 Fam43a Lrig3 Pouófl Tmem201 
Ashll Fam53b Lrp6 Prkcb Tnfrsfla 
Atm Fam73b Lrrc1 Prkdc Tnik 
Atp8a1 Fam92a Lrrc36 Ptger4 Tns4 
Axin2 FbxI20 Lrrc66 Ptpn13 Tom1I2 
Bank1 Fbxo40 Lrrc8b Ptpn3 Tprn 
Baz2b Fbxw7 Luzp1 Ptprh Traf4 
Bbx Fchsd2 Lyst Pygl Trim30c 
BC016423 Fcrlb Magi1 Pyroxd2 Trim46 
BC051628 Fermt3 Man2b1 Rabllfip3 Trim65 
BC057079 Fgd6 Man2b2 Rabllfip5 Trp53inp2 
BC068157 Fgf11 Mansci. Rab44 Trpv4 
Bcas3 FgfrIl Map3k6 Rad54b Tshz1 
Bhlhe40 Fgr Mapk11 Ralgapa2 Tspanl8 
Bmp2 Ficd Mays Ralgpsl Txndcll 
Bmprla Fkbp9 Mbd5 Rarb Ubr1 
Braf Foxc2 Meis3 Rarg Uggt1 
Brwd1 Foxo1 Mertk Rassf5 Unc5b 
Btbd2 Frk Mfsd7a Rbpms Urgcp 
Btg2 Frmd4b Mga Reep6 Utp20 
C1gc Fto Micall Rfx2 Vash1 
C2cd3 Fzd4 Mical2 Rhoq Vg114 
C330019G07Rik Gaa Micalcl Rhpn2 Vopp1 
C85492 Gabpb2 Mlec Ric3 Vps13a 
Cablesl Gemin5 Msi2 Rini. Wfikkn2 
Cacnalc Gm16515 Mtmr4 Rnf216 Wipi1 
Cbx5 Gm608 Mtr Rp1 Wrn 
Cbx7 Gng7 Mtss1 Sbf2 Zadh2 
Cc2d2a Gnmt Mxd4 Sec1411 Zbed3 
Ccdc19 Golim4 Myo6 Sec24a Zbtb20 
Ccdc50 Gphn Myo9a Sec24d Zbtb38 
Ccrn4I GprcSa Nacc2 Sec31a Zbtb46 
Cd209c Gprc5b Nbas Se111 Zc3h12a 
Cd51 GrkS ND2 Sema4b Zc3h7b 
Cdc42bpa Grk6 ND4 Sema6b Zcchcll 
Cds2 Gtf2i ND5 Sep-11 Zdhhcl4 
Cdsn H6pd ND6 Setx Zfp106 
Celsr2 Hdlbp Nedd4 Sf3b3 Zfp192 
Cgnl1 Heatr5a Neo1 Sh2d4b Zfp219 
Chn1 HeatrSb Net1 Sh3bp51 Zfp395 
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Chst13 Hhipll Nf1 Shpk Zfp629 
Clcn5 Hk1 Nfe2 SIc10a6 Zfp652 
Co120a1 Homer3 Nipal3 SIc25a23 Zfyve20 
Copz2 Hyou1 No16 SIc25a42 
AAM up 5 
0610007P08Rik Cdk5rap3 Glul Ndufabl Sirt5 
0610009O20Rik CdkI4 Gm10191 Ndufafl Slamf9 
0610010O12Rik Cela1 Gm11992 Ndufaf4 SIc10a3 
0610031J06Rik Cenpv Gm13004 Ndufsl SIc22a18 
1110008L16Rik Cep57 Gm19444 Nek1 S1c25a12 
1110031102Rik Cept1 Gm4459 Neu3 S1c25a39 
1190002H23Rik Cfp Gm5150 Nfs1 SIc30a4 
1500012F01Rik Cisd1 Gm6762 Nln SIc35b1 
1700026L06Rik CIcn3 Gm7689 NIrp10 SIc39a12 
1700034H14Rik CIec10a Gm8759 Nop2 SIc39a8 
1700037H04Rik Clec2d Gmppb Nop58 SIc39a9 
1810012P15Rik Clec4al Gna11 Nphp3 SIc41a2 
1810030O07Rik Clec4a3 Gna15 Nradd SIc46a1 
1810033B17Rik Clec4bl Gnb5 NsI1 Smad5 
2010011120Rik CIk4 Gne Nucb2 Smagp 
2010106GO1Rik CIrn3 GnI3 Nudt17 Smyd4 
2200002DO1Rik Clybl Golgal Nudt19 Snap29 
2210411K11Rik Cmtm6 Golm1 Nudt5 Snap47 
2310008H09Rik Cnot6I Goraspl Nudt8 Snx10 
2310046O06Rik Coasy Gpd1I Numb Snx13 
2410002O22Rik Cog4 Gpx7 Oat Snx22 
2410066E13Rik CogS Grinlla Ogfodl Snx29 
2610301B20Rik Cog6 Gsg1 OIfm1 Socs5 
2810055F11Rik Comt Gsta4 Optn Spacal 
4732418C07Rik Copg Gstm5 Oxnadl Spcs2 
4833442J19Rik Copz1 Gsto1 Oxsm Sphk1 
4921513D23Rik Cpne3 Gtf2e1 P2ry1 Srgn 
4930572J05Rik Cpsf3 Gtf3c4 P2ry14 Srm 
4933403F05Rik Cpt2 Gyk P2ry2 Srp72 
4933421E11Rik Cr11 Hbegf P4hb Srxn1 
6030446N20Rik Crat Heatr3 Paics Ssr1 
6330578E17Rik Crebl2 Hebp2 Parn Ssr3 
6530418L21Rik Creld2 Hectd2 Pcca Ssr4 
6720456H2ORik Cry1 Herc4 Pcmtd2 St6gall 
A430107O13Rik Cryl1 Herpudl Pde8b Stambp 
A530054K11Rik Csell Hibadh Pdha1 Stbd1 
A630007B06Rik Ctps Hibch Pdia3 Stim2 
A830007P12Rik Ctsa Histlh2bc Pdia4 Stt3a 
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A930001NO9Rik Ctso Histlh2be Pdia6 Stxbp3a 
A930038C07Rik Cxcl12 Histlh2bg Pdk1 Suox 
Abcb8 Cxcl16 Hist2h2bb Pdk3 Supt3h 
Abce1 Cyb5d2 Hmg20a Pdlim2 Supv311 
Abcf3 Cyc1 Hnll Pdp2 Susdl 
Abad11 Cyd Hpn Pdxdcl Syp 
Abadl4a Cysltr2 Hps5 Pecr Tars2 
Abadl4b Cytip Hpse Pex11a Tbc1d10a 
Abhd4 D10Wsu102e Hsf2 Pex12 Tbc1d23 
Acad12 D15Ertd621e Hsp90b1 Pfkfb4 Tbcld8b 
Acat1 D3Ertd751e Hspa13 Pgm2 Tbccdl 
Acer2 D630037F22Rik Hspa5 Pgm3 Tbrg4 
Acox1 Dapp1 Hspa9 Phf6 Tcfec 
AcsI5 Dars2 Hyal2 Phkb Tcn2 
Adal Dbndd2 Hyal3 Phlda3 Tcp1112 
Adam10 Dbt 1830077J02Rik Phyh Tef 
Adc Dcaf4 lars2 Piga Tfdp2 
Adck4 Dcaf6 Ica1 Pign Tfg 
Add3 Dck Ide Pigz Tgfbr2 
Adhfel Dclrelb Idh3a Pitrml Thap11 
Adipor2 Dcps Ikbkg Pja2 Ticaml 
Adora2b Dcunld4 1118r1 Plala Timp1 
Adora3 Ddost Impad1 PIa2g15 Timp2 
Adss Dennd2c Inpp5a PIa2g16 Tiparp 
Afg312 Dfna5 Ipmk PIa2g5 TIr4 
Ag l Dgka Ipo11 Plekha3 Tm7sf3 
Agpat9 Dguok Irak4 Plscr4 Tm9sf2 
Ahcyl2 Dhcr7 !sod. Plvap Tmed3 
A1467606 Dhrs7 Ispd Pm20d1 Tmem106a 
Aifm 1 Dhx40 Itgam Pold4 Tmem129 
Aifm2 Dkc1 Itgb1 Polr3g1 Tmem135 
Ak2 Dlat Ka rs Pomt2 Tmem143 
Ak3 Dnaja3 Kcnn1 Pon3 Tmem177 
Akap1 Dnajb9 Kcnn4 Pop4 Tmem186 
Akap7 Dnajcl0 Kctd21 Pot1a Tmem22 
Alas1 Dnajc28 Kdecl Ppapdclb Tmem39a 
Aldh4al Dnajc3 Kdelc2 Ppat Tmem4la 
Aldh6al Dnd1 Kdelrl Ppfibp2 Tmem53 
Aldoa Donson Kdelr2 Ppib Tmem69 
Aldoartl Dpagtl KdeIr3 Ppif Tnfaip8 
AIg12 Dse Kif9 Ppm1k Tnfrsf26 
AIg2 Dtd1 KIf10 Pramef8 Tnfsfl3b 
Amacr Dusp19 Klhdcl Prdx3 Tomm70a 
Ang Dusp23 KI h 110 Prdx4 Trap1 
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Ang2 Dusp3 K1h112 Prdx5 Trex1 
Ankrd46 Ears2 K1h122 Preb Trim30a 
Ankrd55 Echdcl K1h124 Prepl Trim35 
Ap4b1 Eci2 K1h17 Prkd3 Trmt2b 
Ap1p2 Edem2 Klragi Prkrir Trpm3 
Appl2 Ednrb Krt18 Prorsdl Ttc15 
Arf4 Eef1b2 Lancll Pros1 Ttc21b 
Arfgap3 Eg1n3 Lap3 Prr13 Ttc23 
Arfipi Ehd1 Laptm4b Prrg1 Ttc3 
Arg1 Eif2akl Lbx2 Psme4 Ttc30b 
Arhgef3 Eif3e Letmdl Pspc1 Tubb3 
Armc8 Eif3f Lipn Ptp4a3 Txndc5 
Armc9 Eif4a2 Lman1 Ptplad2 Txnip 
Arsg Eif4e3 Lmbr1 Ptpn4 Txnrd3 
Asap2 Elmod2 LOC100045212 Ptpn7 Uap1 
Asb13 Elp3 LOC100045796 Pxk Ube2e2 
Asnsdl Em12 LOC100046166 Pxmp4 Ube2t 
Aste1 Em16 LOC100046302 Qrs11 Ube3c 
Ate1 Emr1 LOC100504754 Qtrtdl Ubxn2a 
Atf5 Entpol LOC100504962 Rab32 Uhmk1 
Atg13 Entpd4 LOC100505031 Rab33a Uhrf1bp11 
Atp5a1 Entpd5 LOC100505081 Rab38 Uqcrh 
Atp5b Epm2a LOC631033 Rab4a Uso1 
Atxn3 Eprs LOC636901 Rac2 Usp3 
Auh Eps8 LOC636969 Rai14 Uty 
Avil Erap1 LOC638399 Ranbp6 Vkorcl 
B230219D22Rik Ergici Lpcat3 Rasgrp2 Vmac 
B2m Erleci Lrch3 RasllOa Vprbp 
B3galt1 Erp44 Lrp8 Rassf4 Vps37a 
Bag2 Esrra Lrpprc Rb12 Vps53 
Bag5 Esyt2 Lrrc34 Rcli Wdpcp 
Baiap2 Etf1 Lrrc40 Rd3 Wdr3 
Bbs12 Etfdh Lysmd4 Rdh13 Wdr36 
BC017612 Exd1 Magt1 Reep3 Wdr7S 
BCO26585 Extl2 Mania Retsat Xbp1 
BCO26590 Fahd2a Manba Rfk Xpo7 
Bcap29 Fam114a2 Manf Rhoh Xrcc6 
Bcat2 Fam135a Map11c3a Rint1 Yme1l1 
Bcs11 Fam162a Mapk1 Ripk2 Ypel2 
Betl Fam20b Mapk9 Rlim Zbtb6 
Bfar Fam63b Mar-01 Rmnd5a Zbtb8a 
Bin1 Fam81a Mar-07 Rnasel Zdhhc2 
Birc2 Fas Mbtpsi Rnf144b Zfp187 
Bola3 Fastkdi Mccc2 Rnf167 Zfp213 
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Btk Fbpl Mcm8 Rnf185 Zfp235 
C030006K11Rik Fbxol8 Mdhl Rpal Zfp260 
C130050018Rik Fbxo22 Mdh2 Rp131 Zfp296 
C1qa Fech Med22 Rpn1 Zfp322a 
Clqb Fem1c Med27 Rpn2 Zfp324 
Clqbp Fert2 Meis1 Rppl4 Zfp397 
Cacnb4 Fgf9 Mfsd5 Rprdla Zfp456 
Cagel Fkbp5 Mfsd9 Rpsa Zfp518a 
Ca1hm2 Fkbp7 Mgmt Rras Zfp560 
Calr Fktn Mi112 Rras2 Zfp672 
Camk2d FmoS M1h3 Rtn3 Zfp719 
Car6 Foxredl Mlph Sacmll Zfp748 
Casp1 Fpgt Mmachc Scampi Zfp809 
Casp7 Ftsjdl Mobklla Scfdl Zfp866 
Catsper2 Fut8 Morc4 Scfd2 Zfp869 
Ccbll Fyttdl Mn 1 Scrn3 Zfp87 
Ccdc122 G3bp2 Mras Sdf2l1 Zfp931 
Ccdc69 G6pc3 Ms4a8a Sdf4 Zfp939 
Ccngl G6pdx Mstl Sdha Zfp943 
Ccng2 Galnt7 Mthfdl Sdr42e1 Zfp945 
Ccpgl Ganc Mtml Sec22b Zfp958 
Cd164 Gars Mttp Sec23b Zfp963 
Cd3001g Gatsl3 Mtus2 Selplg Zfr 
Cd80 Gba Mut Senp8 Zkscanl 
Cd82 Gca Mxi1 Sepsecs Zkscan5 
Cd86 Gclm N4bp211 Serpinb9 Zkscan6 
Cd9 Gda Naglu Sft2d2 Zmatl 
Cdcl4b Ggcx Naip2 Sfxnl Znrdlas 
Cdc40 Ghr Nars2 Sgmsl Znrf2 
Cdc42ep3 Glce Nbr1 Sh3bgrl Zrsrl 
Cdk2ap2 Glipr2 Ndrg3 Sill Zyg11b 
AAM down 1 
1110007C09Rik Clecla Gpr85 N4bp3 Satl 
2310022AlORik Cnn2 Gpr97 Ndrgi Sbsn 
2610018G03Rik Corola Gpx3 Nek10 Sdcl 
4930402H24Rik Corolc Gstm1 NIrc3 Sestdl 
4930503L19Rik Coro2a Gusb Nr1h3 Sft2d1 
Abcbla Cox6a2 Havcr2 Nrpl Sgms2 
Abcblb Creg2 Heyl Nt5dc2 Sgpll 
Abcb4 Cryba4 Hgsnat Ogfrll Sh2d1b1 
Acvrli Crybbl Hmga2 Osbpl8 Sh2d3c 
Adap2 Cttnbp2nl Hopx P2ry6 Sh3bp5 
Adrb2 Cx3crl Hsdllbl Pabpcll SIc15a3 
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Adrbk2 Cxcrl Htral Palm3 SIc16a10 
AF251705 Cxcr2 Ifi2712a Papss2 SIc26a11 
Ambp Cyp27a1 Igf2bp2 Parvg SIc38a4 
Amz1 Cyp4f39 111f9 Pcytla S1c38a7 
Ankrd34a DlErtd622e Insigl Pde7b SIc3a2 
Ap1s3 D1g3 Igcd Penk SIc40a1 
Apbbl Dock10 Irf8 Pid1 SIc7a11 
Apobecl Dtx3 ItgbS Piral SIc9a7 
Apoc2 Dtx4 Kcne3 Pirall SIc9a9 
Apoe E230008N13Rik Kcnk12 Pira4 SIfn10-ps 
Aprt E2f1 Kdr Pira6 SIfnS 
Armcx2 Eepdl KifSc Pira7 Smad7 
Armcx6 Egr2 KIf6 Plagll Smpd3 
Arpc5 Elov16 KIk9 Plekhol Snx27 
Atp8b2 Emb Lass4 PIin2 Soat1 
Atp8b4 Endodl Lat PIk2 Sox4 
B230120H23Rik Eno2 Lat2 PIp2 Sparc 
Bambi Evl Lcpl Por Sgle 
Bc1211 Fads1 Ldlrapl Prdml St3gaI6 
Bhlhe4l Fam105a LilraS Prkch St6galnac6 
Bri3 Fam107b Lilra6 Procr St8sia4 
Bri3bp Fam129a Lmna Prokrl Stat4 
Bstl Fam134b Lmo2 Psd2 Stom 
Btbd17 Fam71f2 LOC100504922 Psen2 Stx4a 
Card11 Fam83f L00674895 Pstpipl Tcfeb 
Ccdc48 Fcgrl Lonrfl Ptafr Tiel 
CcI2 Fcrll Lpar6 Ptchdl TIe1 
Cc13 Fgfl Lpl Ptms T1e6 
Ccl4 Fkbpla Lrfn4 Ptpla T1r5 
Cc17 Fos Lsr Ptprd T1r7 
Ccr2 Ft11 Lstl Rabl5 Tmem158 
Cd22 Ft12 Lyll Rab37 Tnfrsflla 
Cd276 Gcnt2 Lyz2 Rab7 Tnfrsfl3b 
Cd300a Gdpd5 Mapk3 Rap2a Tpcn2 
Cd300Id Ggtal Marcks Rasa4 Tpd52 
Cd3001f GIis3 Masp1 Rassf2 Tpm4 
Cd36 GIp2r Matn2 Rftnl Trpv2 
Cdk14 Gm11710 Mdk Rgs2 Tsc22d3 
Cdk15 Gm11711 Mef2c Rnf149 Ube2v1 
Cdk5r1 Gm12854 Met Rnft2 Usf2 
Cdknlc Gm14548 Mfng Rph3a Usp2 
Ceacaml9 Gm15448 Mmp8 Rsph9 Vegfa 
Cebpa Gm15448 Mpegl S100a11 Vim 
Cenpb Gm6377 Ms4a14 S100a4 Vsig8 
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Chic1 Gnb4 Ms4a6b S100a6 Zranb3 
Chstll Gpr157 Ms4a6c S1pr2 
CIec12a Gpr34 Mtap7d3 Samd4 
AAM down 2 
1110004F10Rik Dnajc30 H3f3c Mrp148 Rs124d1 
1110038F14Rik Dnajc9 Haghl MrpI51 Rtp4 
1700025G04Rik Dok3 Hck Mrps10 Sap18 
1810037117Rik Dpys12 HcIs1 Mrps21 Satb1 
2410127L17Rik Dr1 Hdgf Mrps26 Scarbl 
2500003M10Rik Dusp16 Hifla Ms4a4c Scel 
2610318NO2Rik Dusp2 Hlcs MshS Scm14 
3110003A17Rik Dynlll Hmgbl Mxdl Sdc4 
6530409C15Rik E130303B06Rik Hmgcr Myd88 Sema4d 
A630001G21Rik Ebi3 Hmgn2 My112b Senp3 
Acaala Edfl Hmgn2-ps1 Nabi Sep-06 
Acbd6 EgIn1 Hmgn5 Nab2 Setd3 
Acot1 Eif1 Hnrnpa2bl Nampt Setd8 
Acsl1 Eif2s1 Hnrnpab Napsa Sfpi1 
Actr2 EifSa Hnrpdl Ncaph2 Sgkl 
Adamts6 Epb4.113 Hsh2d Nck2 Siah2 
Aen His Hspa8 Neur13 Skil 
Afmid F3 Hspel Nful Slamf8 
Ager Fam103a1 Htra4 Nhp2I1 Slbp 
Aif1 Fam76a Hus1b Nrgl SIc17a7 
Aim1 Fam82a2 Id3 Nsfllc Slc1a5 
Akirinl FbxlS Ifi204 Nup93 SIc20a1 
Akt3 Fbxw17 111205 Oas1a SIc25a10 
Amical Fdftl Ifi30 Obfc2a SIc25a25 
Anp32b Fen1 11144 Ogfr Slc25a5 
Aoah Fnbp11 Ifit1 Osbp13 SIc44a2 
Ap1ar Fnbp4 Ifit2 Oscp1 Smox 
Apitdl Foxd2 Ifit3 Otud6b Snf8 
Aplpi Foxn2 Ifitm2 P2ry13 Snrnp48 
Arf1 Fpr1 Igj P4hal Snrpa 
Arhgap28 Fut7 1110ra Pa2g4 Snrpdl 
Arhgef7 Galnt3 II12rb1 Padi3 Sntb1 
Arid3b Gdi2 I11b Parp8 Snx18 
Arti GIrx3 119r Pcgfl Socs6 
ArlSa Gm10094 Immpll Pck2 Sodl 
Arl 5c Gm10146 Irak2 Pdcd5 Sord 
Armc10 Gm10224 Irf7 Pde12 Sp100 
Arpclb Gm10282 Itgal Pdlim4 Spin1 
Arrb2 Gm10713 Itpk1 Pesi Spn 
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Atf1 Gm10767 Jarid2 Pfkfb3 Spop 
Atp5f1 Gm11964 Kcna3 Pfkp Spredl 
Atp7a Gm12657 Kctd3 Pgap1 Srsf10 
AU040320 Gm12952 Klhdc3 Pgs1 Srsf3 
Azi2 Gm13342 Kynu Phf20 Ssbp1 
B430306NO3Rik Gm13880 Lbr Phldal Stardl0 
Bex6 Gm14277 Ldhb Pilra Stfa3 
Bhlhb9 Gm14535 Lfng Pisd Stk19 
Bmf Gm14698 Lif Pkp3 Stx2 
Bzrapl Gm15427 Limd2 Plbdl Styx 
C5ar1 Gm15466 Lipg Plekha2 Supt4hl 
Cacna2d4 Gm15776 Llph Plekha5 Syt11 
Cacnb3 Gm1862 Lman2I PIk4 Taf10 
Ccdc114 Gm19945 Lmbr1I Plscrl Tarbp2 
Ccdc115 Gm2036 LOC100039181 Pmaipl Tbk1 
Ccdc12 Gm3258 LOC100044374 Pnkp Tceb2 
Ccdc88a Gm3837 LOC100044750 Ppfia3 Terf1 
Ccr5 Gm4199 LOC100045191 Ppfia4 Tgfbi 
CcrI2 Gm4332 LOC100045999 PphIn1 Thoc4 
Cd180 Gm4356 LOC100046104 Ppm1m Tifab 
Cd2 Gm4581 LOC100046297 Ppplcc Timml7a 
Cd300e Gm4596 LOC100046650 Ppp1r14b TIr1 
Cd4 Gm5161 LOC100047252 Prelidl TIr11 
Cd69 Gm5450 LOC100048410 Psat1 TIr6 
Cd72 Gm5471 LOC100048847 Psma4 Tmeffl 
Cdc34 Gm5514 LOC100503218 Psmb3 Tmem173 
Cdk10 Gm5616 LOC100504743 Psmd2 Tmem4lb 
Cdk2 Gm5637 LOC100505005 Psmd3 Tmsb10 
Cdk9 Gm5963 LOC100505147 Pten Tnf 
Cep135 Gm6115 LOC100505328 Ptgs2 Tnfaip3 
Chmpla Gm6181 LOC631287 Ptma Tnfrsflb 
Chst7 Gm6314 LOC631966 Ptplb Tnfsf9 
Cks2 Gm6421 LOC632329 Ptpn6 Tomm5 
Clec4n Gm6428 LOC634785 Ptprc Tpi1 
Clec5a Gm6594 LOC637733 Qsox1 Tra2b 
Clec7a Gm6749 Lpcat4 Rab5a Traf3ip3 
Cpn1 Gm6750 Lrrci6a Raetic Trappc6b 
Cpne2 Gm7194 Lrrc42 Raetle Triobp 
Cpsf7 Gm7227 Lrwd1 Ran Tsg101 
Cpt1a Gm7589 Lsm7 Rangapi Tspan13 
Csda Gm7931 Ltb Rbbp5 TtcS 
Csnklg3 Gm8069 Ltb4r1 Rbbp7 Tt113 
Ctnnd2 Gm9525 M6pr Rbm17 Tubb2b 
Ctsc Gm9733 Maff Rbm38 Twistnb 
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Ctu2 Gm9830 Mag Rbm4b Twsg1 
Cwc15 Gm9840 Malt1 Rbm8a Ube2d3 
Cxcl14 Gnb3 Map3k8 Rbmxrt Ube2j2 
Cxcr3 GngS Map4k1 Rbx1 Uck2 
Cyp4f16 Golga7 Map4k4 Rdh12 Ufm1 
D11Wsu99e Gpankl Mapk1ip11 Rel Usf1 
D3Bwg0562e Gpc1 Mapkapk2 Rmnd1 Usp12 
Daxx Gpc2 Mar-05 Rnase6 Vangl2 
Dazapl Gpd2 Marcksll Rnd3 Vav1 
Dbn1 Gpr141 Mdm1 Rnf126 Vcan 
Dcaf15 Gpr65 Mdm2 Romo1 Was 
Dcunldl Gps2 Med29 Rpl10a Whsc111 
Ddx19a Gpsm3 Mef2a Rp115 Wnt6 
Ddx50 Grb2 Megf9 RpI18a Wsb2 
Dedd2 Gtf2a1 Metap2 Rps20 Ywhaz 
Dek Gxyltl Mgst2 Rps21 Zbtb2 
Dexi H28 Minppl Rps26 Zc3h12d 
Dgkg H2afy Mlflip Rps9 Zc3h15 
Dna2 H2afz Mmel1 Rrad Zdhhc2l 
Dnahcl7 H3f3a Mmp14 Rrs1 Zfand5 
Dnajc2 H3f3b MrpI21 Rsad2 Zfp28 
AAM down 3 
1200009106Rik Ccdc99 Gm12166 Necap2 Sc5d 
2010002N04Rik Cd101 Gm12693 Nfkbib Scandl 
2010007H12Rik Cd14 Gm12844 Nme1 Sdcbp 
2010111101Rik Cd3001b Gm13540 Nme2 Seim 
2210404J11Rik Cd302 Gm13736 Nras Sep-10 
2310004N24Rik Cd9912 Gm14680 Nt5c Sepw1 
2310011J03Rik Cdc37 Gm16517 Nt5c2 Serinc3 
2310035K24Rik Cdk20 Gm1673 Ntper Sertadl 
2310036O22Rik Cdkn2aipnl Gm4705 Nubp1 Sft2d1 
2400001E08Rik Cenpa Gm6334 Nus1 Shfm1 
2410001C21Rik Cgrrfl Gm6941 Oaf Siva1 
2410004B18Rik Chaflb Gm885 Ocel1 SIc16a7 
2410042D21Rik Chmp4b Gng11 ORF19 SIc31a1 
2610029G23Rik Cklf Gpt Ostm1 SIc9a3r1 
2900073G15Rik Cldndl Gpx1 P2rx4 Slfn2 
4930412F15Rik Clec4a2 Gtf2h2 Pafahlb3 Sms 
4930420K17Rik Clec4d H2afj Pdap1 Snrpal 
5430437P03Rik Clptml Haao Pdcd21 Snrpf 
6330409N04Rik Clta Hebp1 Pdcl3 Snx12 
8430410A17Rik Cmpk1 Hes6 Pepd Snx24 
9430023L20Rik Cndp2 Hmox2 Pgk1 Snx3 
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A630033H2ORik Cno Hrasl Pgrmcl Snx8 
Abcg2 Cox4nb Hsd3b7 Phf23 Spg20 
Abcg3 Crlf3 Hsdl1 Pkib Srp9 
Abad12 Csrpl Hspbapl Pkig Ssbp2 
Abt1 Csrp2 Ifi202b Plau Steap4 
Acss2 Ctnnbll Ifitm3 Plekhal Stkl7b 
Actl6a Ctsb Ifngrl Plekhjl Stxll 
Ada Ctss Ifngr2 PIin3 Stx3 
Adam17 Ctsz Ifrd1 P1s3 Suds3 
Adiporl Cuedc2 Igfbp6 Pnol Sumfi 
Adssll Cyb5r1 Igsf6 Pomp Susd3 
Agpat2 Cyp39a1 111r2 Ppal Svip 
Aim2 Cyp4v3 Hybl Ppmla Sypl 
Alcam Cyp51 Ing4 Primi Tbcc 
Aldh3bl D230037DO9Rik Ino80b Prmt2 Tctexld2 
Aldh9al Daglb Isyl Prrg2 Tgfbrl 
Alkbh7 Dcxr Jdp2 Psma6 Tifa 
Anxa2 Dffa Kank3 Psmb6 Timm13 
Ap3s1 Dhps Kcmfl Psmd8 Tmco3 
ArfS Dhrsl Kitl Psmd9 Tmem120a 
Arf6 Dhrs3 K1h19 Psmg4 Tmem144 
Arhgap24 Dirc2 Lage3 Ptger2 Tmem165 
Arhgap9 Dmkn Lain Ptpro Tmem19 
Ar110 Dnajcl4 Lass5 Rabi Tmem192 
Ar13 Dnalc4 Leprotll Rabl3 Tmem205 
Arl6ip4 Dnaselll Lin7c Rab21 Tmem38b 
Arpc2 Dok1 Lmo4 Rabacl Tmem86a 
Arpc3 Dpy1914 L0C100038947 Rala Tnfaip812 
Asl Echdc3 L0C100044068 Ralb Tnfrsfl2a 
Asnal Efhd2 L0C100048137 Raly Tnfrsf8 
Atplb3 Eiflax L00675577 Ranbpl Tnni2 
Atp5k Eif2b2 Lsm4 Rap2b Tor2a 
Atp6ap2 Eif4a3 Lspl Rbfa Tppp3 
Atp6v0b Eif5a2 Lta4h Rbm7 Tpst2 
Atp6v1b2 Eif6 Ly86 Rdbp Tradd 
Atp6vlf Empl Maged2 Rdhll Trappc3 
Atp6v1g1 Emp3 Mapkapk5 Rdh5 Trim13 
Atxn10 Epstil Mbd2 Reep5 Tspan4 
Aup1 Erh Meal Rexo2 Tspan5 
B020018G12Rik Exosc3 Med10 Rftn2 Tst 
B3gat3 Fabp7 Metapl Rhoa Ttc12 
B3gnt2 Faim Metrnl Rilpl2 Tuba4a 
B4galt7 Fam105b Mfsdl Rnaseh2b Tubb2a 
B630005N14Rik Fam158a Mfsdll Rnaseh2c Tusc3 
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Bax Fam173a Mgst3 Rnf115 Twf2 
BC003266 Fam73a MIf2 Rnf130 Ubtdl 
BC031181 Fam96b Mocos Rnf180 Ubxn6 
BC096441 Fbxo30 Mpdu1 Rnhl Ugdh 
Blocls2 Fibp Mpnd Rp134 Ugtlaóa 
Bola2 Fnip1 Mpp1 Rp134-ps1 Ugtla6b 
Brmsl Fth1 M pst Rps19 Umps 
Btbd10 Fuca2 M rp119 Rps19-ps4 Vapb 
C3arl Fxn Mrpsl8c Rps19-ps6 Vdac2 
Cab39 Gabarapll Ms4a6d Rps19bp1 Vma21 
Cacybp GaInt9 Msrl Rraga Vmpl 
Calmi Gch1 Msrb2 Rragc Wdfyi 
Calm2 Get4 Mthfd2l Rsul Wdrl 
Calm3 Gins2 Mtpn Rwdd1 Wsb1 
Camkl Gipc1 Myozl Ryr1 Ydjc 
Capg Gm10086 Naa20 S100a9 Ypel3 
Car5b Gm10094 Nasp Sap18 Zfp771 
Ccdc124 Gm10131 Ndufbll Sap30 
AAM down 4 
1110012D08Rik Dnajb14 Jag2 Plxnb3 SIc2a3 
1110014N23Rik Dok2 Klhdc4 Pnpla7 SIc30a1 
1190002N15Rik Dtx2 Kras Poc1b SIc39a3 
1600027NO9Rik Dusp5 Lass2 Ppap2c SIc41a3 
1700019L03Rik Dusp6 LcaS Ppplrl2c Snrnp35 
2510009E07Rik Dv12 Lemd2 Ppp2r5a Snrpc 
4930471M23Rik Dync11i2 Lilrb3 PqIc2 Snx20 
Acbd5 Eaf1 L0C100045021 Prdx6 Snx32 
Acp2 Eea1 L0C100047702 Prkar2b Speccl 
Actn4 Eed LOC100504508 Prkcd Spnb4 
Adck5 Efcab4b L00677654 Psap Sptic2 
Ado Ehd4 Loxl3 Psmc3ip Ssh3 
Agap3 Eif4ebpl Lpcatl Ptpra Stard3 
Agpat6 Elkl Lrrfipl Pwwp2b Stat6 
Ahrr EIk3 Lrrfip2 Pygb Stkll 
A1846148 Elov11 Maf Rab20 Stk25 
AK010878 Epb4.112 Mafk Rab22a Stk30 
Ankrdl3a Ezr Map2k1 Rab24 Stub1 
Ankrdl3d Fam110b Map2k2 Rab34 Swap70 
Ankrd40 Fam134a Mapk6 Rabgefl Taf61 
ArlBa Fam187b Mapre2 Rabggta Tall 
Asb6 Fam3c Mbd3 Ranbp3 Tatdn2 
Asph Fam40a M c11 Rapgef6 Tbc1d14 
Atg1612 Fam46c Mcolnl Rb ms1 Tbc1d22a 
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Baiap2I1 Fam50a Mett117 Rcbtbl Tcf4 
Banp Fam89a Mex3b Rcor3 Tex264 
Bbc3 Fance Mex3d Reep4 Tgif1 
BC085271 Fbxw4 Mfsd6 Rfxap Thap3 
BcI7c Fem1b Mfsd7b Rgag4 Thsd1 
Cap1 Fkrp Mgrn1 Rhog Tjp3 
Capn2 Flcn Midlipi Rnasehi TIr13 
Cbfb Frat2 Mknk1 Rnasek Tm6sf1 
Ccdc125 Fut4 Mkrn1 Rnf166 Tmem109 
Ccdc163 Fxyd5 Mmp19 Rnf220 Tmem181a 
Cd2bp2 G0s2 Mobkl2a Rp126 Tmem43 
Cd3001h Gab3 Mtdh Rrp1 Tmem66 
Cd44 Gains Mtmr11 Rtn4 Tmem8 
Cdc42se2 Galt Naa50 Rufy1 Tollip 
Cdk17 Gas8 Ncf1 Rufy3 Trim36 
Cds1 Ghdc Neu1 Samd8 Trim45 
Cebpg GIud1 Neur12 Sap301 Trip10 
Chfr Gm9531 Nfe2I2 Scamp3 Trp53i13 
Chka Gn11 Nfkbill Scamp4 Ttl 
Chmp6 Gpatch3 Nfya Scpepl Ttpal 
Cited2 Gpr146 Nkiras2 Scyi2 Tubb4 
CIk3 Gtf2f1 Npepll Sec62 Tubb6 
CIn3 Habp4 Nr2f6 Senp2 Tuft1 
C1n8 Herc3 Nudc Set Tulp3 
Cnr2 Nup50 Sfmbtl Tusc1 
Col4a3bp Hk3 Pabpnl Sgta Ube2j1 
Cog10a Hmg20b Paqr7 Sh3bgr13 Ube2m 
Crip2 Hnrpll Parp1 Sh3g11 Uhrf2 
Csnkle Hs1bp3 Pbx2 Shf Upf3a 
Ctnnbipl Hspbpl Pcyoxi Shisa5 Usp4 
Ctsd Hvcn1 Pcyt2 Sirt1 Vsig101 
Cwc27 ler2 Pde5a Sirt2 Wbp4 
Cyhr1 Ifnarl Pde8a SIc11a2 Wdr11 
Cyth1 Igsf8 Pfn1 Sic15a4 Zbtb17 
Cyth2 1111ra1 Pgm211 SIc16a6 Zbtb22 
Cyth4 1116 Pgp SIc22a4 Zfp238 
Dcunid3 113ra Phka2 Sic24a6 Zfp444 
Dda1 Ing1 Pi4k2a SIc25a24 Zfp787 
Ddit3 Inpp1 Pik3cb SIc25a28 Zfp821 
Def6 IpoS Pip4k2a SIc25a43 Zfp90 
Dgke IrfS PId4 Sic29a1 Zfyve9 
AAM down 5 
1500002O20Rik Clipi Gtpbp2 Myo1g Smtn 
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1700020C07Rik CIip2 Gtpbp6 Nr4a2 Snrk 
2310014H01Rik CIk2 Hdac5 Nt5dc3 Snrnp70 
2310035C23Rik Cnksr3 Herpud2 ORF61 Sntb2 
2410131K14Rik Cnnm3 Hlx Otud1 Sphk2 
2510012J08Rik Cnnm4 Hmha1 Pacs2 Srebf2 
2510039O18Rik Crebzf Hnrnpm Pacsin2 Srf 
5031439G07Rik Csnk2a2 Hnrnpul2 Palm Srrt 
Acvrlb Ctdp1 Hps6 Papd5 Stim1 
Adamts10 Cxxc1 Hs6st1 Pbxipl Sun2 
Adat3 Ddx23 Igsf9 Pdgfb Sykb 
Adcy7 Ddx54 Incenp Phldb3 Taf1c 
Aebp1 Denndlc Inpp4a Pias4 Tbc1d1 
Aebp2 Dgkh Inppli Pik3r5 Tbcid10b 
Afap1 Dgkq Iggapl Pip4k2c Tbc1d17 
Agpatl Dhx16 Irf2bp1 PipSklc Tbc1d8 
Ano8 Dip2a ItgaS Pkn1 Tchp 
Anxa11 Dusp7 Itprip PId2 Tesk1 
Ap2a1 Dusp8 Itsn2 Plekhml Tfip11 
Arhgef40 Dvl1 Jag1 Plekho2 Tgfb1 
Arih1 Eif3a Jund Plxna3 Tjap1 
Arrdc2 Epn1 Kcnab2 Ppm1h Tmem115 
Atp10a Ets2 Kific Pvr14 Tmem164 
Atp13a2 Exoc8 Klhdc8b Rab43 Tmem184b 
Auts2 Fam160a2 Kri1 Rabep2 Tob2 
Axin1 Fam20c Lasp1 Ralbpl Trim25 
B3gnt3 Fbx119 Lats2 Rasa3 Trim8 
B3gnt7 Fchsdi Lemd3 Rgl2 Trpm4 
B4galnt1 Frmd8 Limd1 Rgmb Tsc22d1 
Bach1 Furin Lmf2 Rhbdll Unc45a 
Bach2 Fxr2 Lnx2 Rnf31 Unk 
BC005537 Fzd5 LOC677502 Rps6ka1 Usp10 
Bc16 Fzd7 Lrch4 Runx1 Vac14 
Bicd2 Gab1 Lrrc45 Safb Yy1 
Brf1 Galnt10 Lrrc8d Samd1 Zbtb42 
Brpf1 Gan Mafb Sap25 Zbtb7b 
C330006K01Rik Gas2I1 Mam13 Sart1 Zcchc24 
Cacnbi Gcc1 Map3k11 Scly Zeb2 
Capn1 Gcfc1 Map3k3 Scyl1 Zfp276 
Cc2d1a Gdf15 Mapk7 Sepn1 Zfp295 
Cc2d1b Gga1 Mapk8ip3 Sh2b3 Zfp316 
Ccdc142 Git2 Mesdcl Sirpa Zfp408 
Ccdc9 Gm2260 Mfhasl SIc12a4 Zfp608 
Cd97 Gm2274 Mgat4b SIc12a9 Zfp668 
Cdk11b Gm962 Mier2 Slci6a14 Zfyvel 
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Cep170 Gpr124 Mtap4 SIc26a10 Zgpat 
Chkb Gramdlb Mtap7dl SIc38a2 Zrsr2 
Ckap4 Gramd4 Mum1 SIc4a2 Zswim4 
Clasrp Gripapl Myh10 SIc6a6 
CIcn7 Gtf2ird2 Myo1c Smo 
Supplementary Table Al -ST -4. List of gene symbol IDs for genes in AAMcD -up and 
AAMCD-down clusters identified in Chapter 2. As described in the methods section, all 
differentially expressed genes between WT -NeMd and either IL4Ra-' -NeM D or WT- 
ThioMa were clustered using heierarchical agglomerative clustering and subdivided 
into 20 clusters using Ward's method. The resulting gene expression profiles were 
assessed and clusters deemed to represent AAMcD -up and AAMm -down gene expression 
profiles were identified. Gene symbols in this table are for the genes in those clusters. 
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APPENDIX 2 - SOFTWARE USED FOR TSS- 
PREDICTOR 
Software /Annotation Version 
TopHat 2.0.0 
Cufflinks 2.0.2 
Ensembl 67 
BEDTools 2.17.0 
SAMTools 0.1.8 
Table A2 -1. List of software and versions used in Chapter 3. 
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APPENDIX 3 - HELP DOCUMENTATION FOR TSS - 
PREDICTOR SOFTWARE 
TSS- Predictor 
Version 1.0 by Graham Thomas 
Contents 
1.0. Introduction 
2.0. Getting Started 
2.1. Dependencies 
2.2. Installation 
3.0. Using TSS -Predictor 
3.1. Preparing your data 
3.2. Mapping reads to the reference genome 
3.3. Running Cufflinks and Cuff compare 
3.4. Generating a .coverage file with GetCoverage.pl 
3.5. Using TSS -Optimizer to identify optimal coverage cutoffs 
3.6. Running TSS -Predictor.pl 
3.7. Post -filtering for sensible results 
3.8. Seecting a high confidence TSS set using SelectTSS.pl 
4.0. Output files and formats 
4.1. Coverage file 
4.2. trim.combined.gtf 
4.3. trìm.gtf.tmap 
4.4. isotigs.trimmed.gtf 
4.5. tss.prediction.bed 
4.6. distances.txt 
4.7. tss.selected.bed 
5.0. Overview of the algorithm 
5.1. Prep4Trim.pl 
5.2. Trim Cufflinks_GTF.pl 
5.3. Get -TSS.pl 
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5.4. GetDistances.pl 
5.5. SelectTSS.pl 
5.6. CollateDistances.pl 
6.0. References 
1.0 Introduction 
TSS- Predictor has been developed to identify promoter usage for genes in RNA - 
Seq experiments. It is designed to be used when both a high quality reference 
genome and annotation set are available, for example human or mouse. The 
output of TSS- Predictor is a BED file containing predicted transcription start 
sites for each reference gene, these may then be used for downstream applications 
such as cis -regulatory analysis. 
TSS- Predictor is written in perl and is available at GitHub https: / /github. 
com /GrahamThomas /TSS- Predictor and as an online tool at Galaxy (Not Yet!!!) 
and GeneProf (Not Yet!!!). 
2.0. Getting Started 
2.1. Dependencies 
In order to use TSS- Predictor you must have working versions of the following 
in your $PATH:- 
1. A short read mapper compatible with Cufflinks. I use TopHat http: 
/ /tophat.cbcb.umd.edu /. 
2. Cufflinks http: / /cufflinks.cbcb.umd.edu/ 
3. BEDTools http : / /code.google.com /p /bedtools/ and 
4. R, with the libraries ggplot2 and reshape2 installed http: //cran. 
r- projact.org/ 
To follow this guide you will need to merge and sort some BAM files. For this 
you will also need SAMtools http: //samtools .sourceforge .net/. 
2 
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2.2. Installation 
TSS- Predictor is implemented in Perl and R. To get up and running all you need 
to do is:- 
1. Add TSS- Predictor /bin to your $PATH variable: - 
$PATH= $PATH: /<Path to installation directory> /TSS- Predictor /bin 
2. And give executable permission to All scripts in the directory. 
cd <Path to installation directory > /TSS- Predictor /bin 
chmod +x * 
3.0. Using TSS- Predictor 
3.1. Preparing your data 
Below is a step -by -step guide on how to use TSS- Predictor beginning with 
raw illumina reads. In this example we use 51 base paired -end Illumina RNA - 
Seq data from a macrophage transcriptomics project (REF). Raw data and 
BAM files for this project are available from the SRA (ACCESSION... http: 
//www.ebi .ac.uk/ena/). All of the intermediate files generated in the working 
example are available at our FTP site . 
cd -/TSS-Predictor-Example/RawData/ 
is 
4Ne_1_F.fastq 4Ne_3_R.fastq 4TG_3_F.fastq BNe_2_R.fastq BTG_2_F.fastq 
4Ne_1_R.fastq 4TG_1_F.fastq 4TG_3_R.fastq BNe_3_F.fastq BTG_2_R.fastq 
4Ne_2_F.fastg 4TG_1_R.fastq BNe_1_F.fastq BNe_3 R.fastq BTG_3_F.fastq 
4Ne_2_R.fastq 4TG_2_F.fastq BNe_1_R.fastq BTG_1_F.fastq BTG_3_R.fastq 
4Ne_3_F.fastq 4TG_2_R.fastq BNe_2_F.fastq BTG_1_R.fastq 
A pre -built Bowtie index for mouse (mm9) was downloaded from http: // 
bowtie-bio.sourceforge.net/index.shtml. 
cd - /TSS- Predictor -Example /Bowtielndexes/ 
wget ftp: / /ftp.cbcb.umd.edu /pub/ data /bowtie_indexes /mm9.ebwt.zip 
unzip mm9.zip 
Reconstitute a reference genome from the bowtie index. 
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cd -/TSS- Predictor -Example / BowtíeIndexes/ 
bowtie- inspect mm9 > mm9.fa 
An Ensembl GTF file containing reference annotations was downloaded from 
the Ensembl FTP site ftp: / /ftp.ensembl.org /pub /release- 67 /gtf /mus_ 
musculus /. Ensembl annotations are preferable as, unlike UCSC annotations, 
a many -to -one relationship exists between gene `gene_id' and `transcript_ id' 
fields of the GTF file. This relationship is required to combine per- transcript 
expression levels to per -gene expression levels. 
cd -/TSS- Predictor -Example /Annotations/ 
wget ftp: / /ftp.ensembl.org /pub /release- 67 /gtf /\ 
mus_ musculus /Mus_musculus.NCBIM37. 67.gtf.gz 
Ensembl chromosomes need converting from NCBIM37 to mm9 style. This can 
be done with Ensembl2UCSC.pl. This script prints the annotations in the same 
order as the FASTA headers in the supplied genome and removes annotations 
belonging to the `random' chromosomes. An alternative approach would be to 
map reads directly to the Ensembl genome build, thereby ommitting this step. 
Ensembl2UCSC.pl -r .. /Bowtielndexes /mm9.fa -e Mus_musculus.NCBIM37.67.gtf \ 
-o Mus musculus.mm9.67.gtf 
3.2. Mapping reads to the reference genome 
Map reads to the reference genome using TopHat (version v2.0.0, Bowtie version 
0.1.18.0 were used in this example). Multi- mapping reads are allowed by using 
the default parameters. Multi- mapped reads are important as they facilitate 
the assembly of transcripts containing repetitive sequence. In downstream 
analysis it may be wise to disregard transcripts containing a large proportion of 
multi -mapped reads as they may be unreliable. 
Transcription start site prediction is more effective with greater sequencing depth. 
My preferred strategy is to map reads for each lane individually, and then merge 
the alignments prior to transcript assembly with Cufflinks. 
Map the reads with TopHat:- 
cd -/TSS- Predictor -Example /TopHat 
tophat -p 5 -o KNe_1_multi_out .. /Bowtielndexes /mm9 \ 
.. /RawData /4Ne_1_F.fastq .. /RawData /4Ne_1_R.fastq 
tophat -p 5 -o BTG_3_multi_out ../Bowtielndexes/mm9 \ 
../RawData/BTG_3_F.fastq ../RawData/BTG_3_R.fastq 
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Merge and sort the alignments. I use SAMtools http : / /samtools. sourceforge. 
net /:- 
cd -/TSS- Predictor -Example /TopHat/ 
## #Reconstitute a SAM header from one of the TopHat alignments 
samtools view -H BNe _1_multi_out / accepted_hits.bam > mm9.header.sam 
samtools cat -h mm9.header.sam -o 
BNe_1_multi_out/accepted_hits.bam 
BNe_3_multi_out/accepted_hits.bam 
KNe_2_multi_out/accepted_hits.bam 
BTG_1_multi_out/accepted_hits.bam 
BTG_3_multi_out/accepted_hits.bam 
KTG_2_multi_out/accepted_hits.bam 
Macrophage.cat.bam \ 
BNe_2_multi_out/accepted_hits.bam \ 
KNe_1_multi_out/accepted_hits.bam \ 
KNe_3_multi_out/accepted_hits.bam \ 
BTG_2_multi_out/accepted_hits.bam \ 
KTG_1_multi_out/accepted_hits.bam \ 
KTG_3_multi_out/accepted_hits.bam 
samtools sort Macrophage.cat.bam Macrophage.sorted 
Cufflinks and Cuffcompare 
Assemble the mapped reads into transcribed fragments `transfrags' using Cufflinks 
(here we have used version 2.0.2). In this example we have not provided reference 
annotations to guide transcript assembly. You may do so if you wish. 
cd -/TSS- Predictor -Example 
cufflinks -p 8 -L Macrophage -Cufflinks -o Cufflinks TopHat/Macrophage.sorted.bam 
Assign the transfrags to reference gene models using Cuffcompare 
cd -/TSS- Predictor -Example /Cufflinks 
cuffcompare -r ../ Annotations /Mus_musculus.mm9.67.sorted.gtf -M \ 
-s .. /mm9.fa -o mm9- EnsGene transcripts.gtf 
3.4. Generating a .coverage file with GetCoverage.pl 
GetCoverage.pl makes use of BEDTools to calculate the per -base read coverage at 
the genomic locations reported in the combined.gtf file produced by Cuffcompare. 
The script takes the following arguments:- 
GetCoverage.pl -c <cuffcompare.combined.gtf> -b <mapped_reads.bam> \ 
-g <.genome file> -o <output> 
5 
263 
Options Description 
-c Path to the cuffcompare combined.gtf file 
-b Path to the mapped reads BAM file 
-g Path to the .genome file 
-o Name of the output .coverage file 
The .genome file is a two column tab -delimited file stating each chromo- 
some /scaffold name and it's size in base pairs. BEDTools is shipped with 
.genome files for mouse and human reference genomes. If you are working with a 
different species you will have to create one yourself, see the BEDTools manual 
(http: / /code.google.com /p /bedtools /)for more information. 
Making the .coverage file can take some time. We make the .coverage file for 
this example as follows:- 
cd -/TSS- Predictor -Example /CoverageFiles 
cp <Path To BEDTools > /genomes /mouse.mm9.genome . 
GetCoverage.pl -c ../Cufflinks/mm9-EnsGene.combined.gtf \ 
-b ../TopHat/Macrophage.sorted.bam -g mouse.mm9.genome \ 
-o mm9-EnsGene.coverage 
3.5. Using TSS -Optimizer.pl to identify optimal cutoffs 
TSS- Optimizer.pl is a wrapper script for the main TSS prediction algorithm. For 
a description of how the main algorithm works see section 5 or the supplementary 
information of (REF MY PAPER). TSS -Optimizer.pl takes one chromosome, 
defined by the user and predicts transcription start sites over a range of cutoff 
fractions. TSS -Optimizer.pl reports, for each gene at each cutoff fraction, the 
distance between the predicted TSS and nearest annotated TSS for the same gene. 
TSS- Optimizer also produces a graph showing the median absolute deviation 
(MAD) between the predicted and nearest annotated transcription start sites at 
each cutoff fraction. We choose the cutoff fraction that gives the lowest MAD 
for use with TSS- Predictor. 
TSS-Optimizer.pl -a <Annotations.gtf> -cd <Cufflinks_directory> \ 
-cc <Cuffcompare_prefix> -t <tmap_file> -co <Coverage_file> -ch <chromosome> 
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Options Default Description 
-a [] The main reference annotation file i.e. the one used 
with Cuffcompare 
-cd [] Path to the Cufflinks directory 
-cc [] Prefix used when running Cuffcompare 
-t [] Path to the Cuffcompare transcripts.gtf.tmap file 
-co [] Path to the .coverage file produced by 
GetCoverage.pl 
-ch [] Name of chromosome for optimization 
-s [0.01] Coverage cutoff fraction to begin trimming 
-e [0.20] Coverage cutoff fraction to end trimming 
[0.01] Increment, or step size, between lower and upper 
coverage cutoff fractions 
-o [. /Optimizer] Output directory (this will be suffixed with the 
selected chromosome) 
Running TSS- Optimizer for our data set is simple. We use the following 
command:- 
cd - /TSS- Predictor -Example 
TSS -Optimizer.pl -a Annotations /Mus_musculus.mm9.67.gtf \ 
-cd Cufflinks/ -cc mm9- EnsGene -co CoverageFiles /mm9- EnsGene.coverage \ 
-ch chrl -o Optimizer -EnsGene -t Cufflinks/ mm9- EnsGene.transcripts.gtf.tmap 
The results of this analysis can be found in the directory . /Optimizer -EnsGene- 
chrl/ as the Optimizer script concatenates the chromosome used to the specified 
output directory. TSS- Optimizer produces a number of files including a chromo- 
some.coverage file, which is simply a reduced version of the .coverage file. TSS - 
Optimizer.pl produces all of the files produced by TSS -Predictor.pl (see section 
4). Multiple copies of isotigs.trimmed.gtf, distances.txt and tss.prediction.bed 
are produced, one for each cutoff fraction interrogated. 
The most informative output of TSS -Optimizer.pl is the graph Optimizer - 
MADPIot.jpg (Figure 1). This barchart shows the MAD between predicted TSSs 
and the nearest annotated TSS for each gene over all cutoff fractions assessed. 
The cutoff fraction that gives the lowest MAD is shown in red, this should be 
given to TSS -Predictor.pl to identify TSS usage genome wide. The actual MAD 
calculated by TSS -Optimizer contains no post -filtering (see section 3.7) and is 
typically much greater than the value obtained in the final predictions. 
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Figure 1: Barchart showing the median absolute deviation between predicted 
transcription start sites and the nearest annotated TSS for the gene over the 
coverage cutoff fractions assessed by TSS -Optimizer.pl. The cutoff fraction with 
the minimum MAD is shown in red (0.04). 
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3.6. Running TSS -Predictor.pl 
In this next step we run TSS- Predictor to predict transcription start sites genome 
wide. This script attempts to identify the major transcription start site for each 
reference gene assigned to a a Cufflinks gene id by cuffcompare. The output will 
include erroneous TSS calls due to a number of factors, these include incorrect 
transcript assembly and selection of the wrong Cufflinks transfrag for trimming. 
Strategies exist to get high confidence TSS predictions, see next section. 
TSS-Predictor.pl -a <Annotations.gtf> -cd <Cufflinks_directory> \ 
-cc <Cuffcompare_prefix> -t <tmap_file> -co <Coverage_file> 
Options Default Description 
-a The main reference annotation file i.e. the one 
used with Cuffcompare 
-cd [] Path to the Cufflinks directory 
-cc [] Cuffcompare prefix 
-t [] Path to Cuffcompare transcripts.gtf.tmap 
-co [] Path to the .coverage file produced by 
GetCoverage.pl 
-f [0.1] Cutoff fraction (of expected per -base coverage) 
to trim annotations 
-u [1] Number of bases upstream of predicted TSS 
to report 
-d [0] Number of bases downstream of predicted 
TSS to report 
Next, predict TSS usage genome -wide with a coverage cutoff of 0.04:- 
cd -/TSS- Predictor -Example 
TSS -Predictor.pl -f 0.04 -a Annotations /Mus_musculus.mm9.67.gtf \ 
-cd Cufflinks/ -cc mm9- EnsGene -co CoverageFiles /mm9- EnsGene.coverage \ 
-t Cufflinks/ mm9- EnsGene.transcripts.gtf.tmap 
3.7. Post -filtering for sensible results 
TSS -Predictor.pl produces a few plots to help you choose an appropriate method 
for cleaning up your data. The final step in the TSS- Predictor pipeline is 
SelectTSS.pl. This takes user -defined cutoffs and reports only transcription start 
sites that pass these filter(s). For SelectTSS.pl usage see the next section. 
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Expression -based filtering 
Transcripts that are expressed at a low level are less likely to be assembled 
correctly, and hence TSS predictions for the least abundant transcripts are less 
likely to be accurate. Expression -based filtering involves disregarding genes 
expressed below a user -defined level, optimal cutoffs vary between experiments 
and depend on a number of factors including sequencing depth and read length. 
In some cases expression -based filtering may not be suitable at all. TSS- Predictor 
uses R to produce two plots to aid the selection of appropriate cutoffs. 
Figure 2 shows the MAD expression plot produced by TSS- Optimizer for our 
sample dataset, this clearly demonstrates the effect of gene expression on TSS 
prediction accuracy. We assume that one of the annotated transcription start 
sites for each expressed gene is correct. For high quality, well annotated genomes 
such as mouse and human this appears to be a relatively safe assumption. The 
MAD expression plot shows the median absolute deviation for genes, grouped 
into bins based on the per -base coverage (expression). We observe a much 
higher variation in the distances between predicted and annotated TSS for genes 
expressed at a lower level. 
The dashed black line in Figure 2 shows the MAD for all genes in the dataset. 
TSS- Predictor advises an expression cutoff as the median per -base gene expression 
of the first bin below the line. The effect of trimming at this cutoff can be 
seen in the ExprCutoffPlot.jpg file produced by TSS -Predictor.pl, which for our 
example dataset is shown in Figure 3. This shows that a large number of lowly 
expressed outliers will be removed by disreagarding genes expressed below the 
red line. In principle this approach facilitates the discovery of novel TSSs by 
identifying highly expressed genes with predicted TSS a large distance from the 
nearest predicted TSS for the gene. In practise however, these `novel' TSSs most 
often arise from incorrect transcript assembly, or selection of an inappropriate 
reference transfrag to trim. For some datasets expression -based filtering does 
not work well, usually because the distinction between low expression (and high 
variance) and high expression (and low variance) is not particuarly clear. In this 
case an alternative approach to filtering is distance based, see below. 
Distance based filtering 
Distance based filtering assumes explicitly that one of the annotated transcription 
start sites for each gene is correct. Genes with a TSS greater than a given distance 
from the nearest predicted TSS are disregarded. 500 bases often appears to be 
a good cutoff. The DistanceCutoffPlot (Figure 4) shows the effect of removing 
TSS greater than 500bp from the nearest annotated TSS for the gene. 
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Figure 2: The MAD expression plot. 
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Figure 3: The expression cutoff plot. TSS- Predictor reports the 
value of the 
expression cutoff to the command line. In this instance it is 65.09, 
this value is 
printed to the terminal during TSS -Predictor analysis. 
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3.8. Selecting a high confidence TSS set using SelectTSS.pl 
SelectTSS.pl is used to filter TSS predictions. A tss.selected.bed file is produced 
which contains only transcription start sites that pass either expression -based or 
distance -based filtering. If both a distance and expression cutoff are supplied 
then only transcripts that pass both filters are reported. There is an additional 
option to specify whether to report the predicted TSS, or the TSS of the nearest 
annotated transcript for the gene. 
SelectTSS.pl [options -d -e -r] -o <output prefix> 
Options Default Description 
-o tss.selected Output file prefix 
-d [] TSS distance cutoff 
-e [] Expression level cutoff 
-r [] Report nearest reference transcription start 
We want to select only high confidence TSS's in our example. The following 
command will report predicted TSS's that satisfy both distance AND expression 
criteria:- 
cd -/... 
SelectTSS.pl -d 500 -e 65.09 
4.0. Output files and formats 
4.1. Coverage file 
The coverage file produced by GetCoverage.pl is a tab -delimited text file contain- 
ing the per -base coverage of each transcribed location on the reference genome 
as determined by Cufflinks. The file format is as follows:- 
Field position Field name Desription 
1 Chromosome Reference chromosome /scaffold 
2 Position Position on the reference chromosome 
3 Read depth Read coverage at position on genome 
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4.2. trim.combined.gtf 
The trim.combined.gtf file is produced by Prep4Trim.pl. This GTF file is a 
reduced version of the Cuffcompare combined.gtf file and contains one trans- 
frag record for each expressed reference gene (as determined by Cuffcompare). 
Specifically, the longest transfrag on the same strand as the reference gene is 
reported. For a detailed descripion combined.gtf format see the Cufflinks manual 
http:// cufflinks .cbcb.umd.edu /manual.html. 
4.3. triin.gtf.tinap 
The trim.gtf.tmap file is an amended version of the transcripts.gtf.tmap file 
produced by Cuffcompare. This tab seperated file contains only the reference 
isotigs selected for trimming. There are also a couple of changes in this file 
relative to the Cuffcompare output. Firstly, the ref id field contains the reference 
gene, as defined by the gene id tag in the annotations GTF file, rather than the 
reference transcript. The second difference is the gene.cov field. The cuffcompare 
output contains a coy field reporting the expected transcript coverage, whereas 
the trim.gtf.tmap contains the expected per -base coverage for the gene calculated 
by summing the length- normalized coverage estimates for all transcripts in the 
gene (see section 5.1). 
TSS- Predictor makes use of fields 2 and 10, the rest of the file is produced by 
Cufflinks. The fields in the trim.gtf tmap file are as follows: 
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Field position Field name Desription 
1 ref_gene_id Gene name assigned by Cuffcompare 
(gene name attribute of GTF file) 
2 ref id gene id attribute of the the GTF file 
3 class_code Cuffcompare class code 
4 cuff_gene_id The gene id assigned by Cufflinks. Multiple 
cuff gene id's may map to a single 
ref gene id attribute 
5 cuff id Name of the Cufflinks transcript id selected for 
trimming for ref gene id 
6 FMI Expression of this isoform relative to major 
isoform for the gene (defined by Cufflnks, not 
used) 
7 FPKM FPKM for the transcript cuff id. Note this is 
the transcript (NOT gene) expression 
8 FPKM_conf to Upper confidence interval for FPKM 
9 FPKM conf hi Lower confidence interval for FPKM 
10 gene.cov The per -base coverage estimate for the gene as 
used by TSS- Predictor 
11 len cuff id transcript length 
12 major_iso_id cuff id of the genes (cuff gene id) major 
isoform 
4.4. isotigs.trimmed.gtf 
The isotigs.trimmed.gtf file is an amended version of the trim.combined.gf file 
(see section 4.1). An additional flag, contain tss, is added to field 9, this contains 
either "yes" or "no" and identifies the exons which are predicted to contain the 
primary TSS for the gene. For transcripts on the ` +' strand with contain tss = 
"yes" the exon start position (field 4) is amended to reflect the predicted TSS. 
When contain tss = "yes" and the transcript is on the ' -' strand the exon end 
position (field 5) is amended accordingly. 
4.5. tss.prediction.bed 
This BED (tab delimited) file contains the TSS predictions for each expressed 
reference gene. By default the TSS Tenth is 1 base. Proximal promoter regions 
flanking the predicted TSS can be extracted by providing TSS- Predictor with 
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the -u and -d flags. Please note that changing the values of -u and -d will 
affect the distance estimates produced in the distances.txt file. The format of 
tss.predictions.bed is as follows: 
Field position Field name Desription 
1 Chromosome Reference chromosome /scaffold 
2 Start TSS prediction start 
3 End TSS prediction end 
4 Gene name The reference gene id 
5 Score Not used 
6 Strand Strand the reference gene is on 
4.6. distances.txt 
The tab -delimited distances.txt file contains a variety of information for each 
expressed reference gene. The format of this file is as follows:- 
Field position Field name Desription 
1 Gene Reference gene id 
2 Chr Chromosome 
3 Prediction start Predicted TSS 
4 Nearest_ transcript Closese reference transcript to TSS 
prediction 
5 Nearest_transcript_start TSS of nearest annotated reference 
transcript 
6 Distance Distance between predicted and 
nearest reference TSS 
4.7. tss.selected.bed 
This BED file contains the subset of tss.prediction.bed containing high- confidence 
TSS predictions (i.e. those which have passed the filters set by SelectTSS.p1). 
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5.0. Overview of the algorithm 
TSS- Predictor works by selecting and trimming Cufflinks gene annotations based 
upon the ratio between the genes expected coverage (expression level) and per - 
base coverage at each position on the gene. Below is an overview of the steps 
involved:- 
1. Firstly, reads are mapped to the reference genome allowing multi- mapping 
reads. Because the Cufflinks output is used by TSS- Predictor I use TopHat, 
but this is not essential. Depth is important for TSS prediction, for 
this reason I merge BAM alignments after read mapping. 
2. Cufflinks is then run with the default parameters and transcribed fragments 
`transfrags' are linked to reference genes using Cuffcompare. Ensembl is my 
favourite annotation source, but all you need is a many -to-one transcript id 
to gene_id relationship in the GTF file. Note UCSC GTF files obtained 
from the table browser do not maintain this relationship. 
3. A coverage file is produced using GetCoverage.pl. This script makes use 
of the Cufflinks output and BEDToo1s to calculate the per -base read 
coverage for every transcribed base reported in the Cufflinks cuffcom- 
pare.combined.gtf file. 
4. TSS -Optimizer uses a reduced dataset of one chromosome to determine 
optimal conditions (see Section 3.5 Using TSS - Optimizer to identify optimal 
coverage cutoffs). TSS- Predictor predicts major TSS utilization genome- 
wide once the optimal conditions have been determined. TSS- Optimizer 
and TSS- Predictor run the same core algorithm and are described together 
below:- 
5. 1. Prep4Trim.pl 
Prep4Trim.pl calculates the expected coverage for each reference gene and selects 
one representative transfrag for trimming. Expected gene expression is calculated 
by summing length -normalized expression (coverage) for all Cufflinks transfrags 
associated with each reference gene, as defined by the gene_id tag in the reference 
GTF file (Figure 5). Additionally, one representative transfrag for each reference 
gene is selected for trimming. Specifically, the longest Cufflinks transfrag on the 
same strand as the reference gene is selected. 
Prep4Trim.pl reports two files - trim.combined.gtf and trim.gtf.tmap. 
Trim.combined.gtf is a reduced version of the Cufflinks cuffcompare.combined.gtf 
file, and contains only the transfrags selected for trimming in the next stage 
of the algorithm. Trim.gtf.tmap is an amended version of the cuffcompare 
.tmap output. This contains a mapping between each Cufflinks transfrag to be 
trimmed and the reference gene, as well as the amended coverage estimate for 
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C(G) = c(Ti)L(Ti) 
i=1 Tmax) 
Figure 5: Gene -wise coverage calculation. Each expressed reference gene G is 
composed of n transfrags (T), each with coverage (C) and length (L). Thus, 
CT,: is the coverage for the ith transfrag of gene G, and LTi is the length of the 
transfrag of gene G. 
the gene (see section 4.3). All other fields in trim.gtf.tmap file are transfrag 
level information generated by Cuffcompare. 
5.2. Trim_ Cufflinks_GTF.pl 
The core of the algorithm. Trim_ Cufflinks_GTF.pl takes the expected gene- 
level coverage information from trim.gtf.tmap and transfrag information from 
trim.combined.gtf. Using the per -base coverage information calculated by Get - 
Coverage.pl each selected isotig is trimmed at a fraction of the expected coverage 
for the gene (X). 
The algorithm iterates, one base at a time, from the last base (3') in the first 
exon of each transfrag (providing it is covered by >X * CG) towards the first 
base. The GTF file is trimmed when the per -base coverage of transfrag T,",az 
drops below X * CG. If the last base of exon 1 is expressed at a lower level than 
X then the second exon is examined, so on and so forth... 
The value of X is provided by the user, and determined through empirical 
optimization. This is what the TSS- Optimizer is for. Optimal values for X are 
then used to predict transcription start sites genome -wide using TSS -Predictor.pl. 
Trim_Cufflinks_GTF.pl reports an isotigs.trimmed.gtf file. This is an amended 
version of trim.combined.gtf with revised transcription start site information. 
An additional variable "contain_tss" is added to the 9th field of the GTF file to 
identify exons predicted to contain transcription start sites. 
5.3. Get -TSS.pl 
This script links reports a predicted transcription start site for each reference 
gene in BED format. By default this is tss.prediction.bed. The -u and -d flags 
are used to set the number of bases upstream (u) and downstream (d) of the 
predicted start site to report. 
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APPENDIX 4 - ARRAYQUALITYMETRICS REPORT 
FOR L. SIGMODONTIS MICROARRAY TIME COURSE 
4/16/13 arrayQualityMetrics report for BSData.vsn.rsn 
arrayQualityMetrics report for BSData.vsn.rsn 
Section 1: Between array comparison 
o Distances between arrays 
o Principal Component Analysis 
Section 2: Array intensity distributions 
o Boxplots 
o Density plots 
Section 3: Variance mean dependence 
o Standard deviation versus rank of the mean 
Section 4: Individual array quality 
o MA plots 
Browser compatibility 
This report uses recent features of HTML 5 which have not yet been implemented by all browsers. Thus, unfortunately, 
browser compatibility currently needs to be considered: 
Firefox 4 - tested, works well, 
Chrome 10 - tested, works well, 
Safari 5 - the interactive (SVG) plots will be missing, since this browser does not support the embedding of the 
<svg> tag in HTML. 
- Array metadata and outlier detection overview 
array *1 *2 *3 Sample Day RNAbatch type Index 
1 15 8 1 I 1 
2 4 4 2 I 2 
3 36 18 2 I 3 
4 23 11 3 I 4 
5 27 14 4 I 5 
6 46 28 4 I 6 
7 20 11 1 I 7 
8 16 8 2 I 8 
9 44 28 2 I 9 
10 29 14 3 I 10 
11 41 0 3 N 11 
12 33 18 4 I 12 
13 34 18 1 I 13 
14 21 11 2 I 14 
15 5 4 3 I 15 
16 45 28 3 I 16 
17 18 8 4 I 17 
18 22 11 5 I 18 
19 43 28 1 I 19 
20 28 14 2 I 20 
21 17 8 3 I 21 
22 32 18 3 22 
23 24 11 4 23 
24 35 18 5 24 
The columns named *1, *2, ... indicate the calls from the different outlier detection methods: 
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1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
24 -... 
20 -, - 
5 -, - 
12- ... .. - 
22 - 
23 - 
14 - 
10 - - 
18- 
4 - 
7- - 
19 - 
9- - 
4/16/13 arrayQualityMetrics report for BSData.vsn.rsn 
1. outlier detection by Distances between arrays 
2. outlier detection by Boxplots 
3. outlier detection by MA dots 
The outlier detection criteria are explained below in the respective sections. Arrays that were called outliers by at least 
one criterion are marked by checkbox selection in this table, and are indicated by highlighted lines or points in some of 
the plots below. By clicking the checkboxes in the table, or on the corresponding points /lines in the plots, you can 
modify the selection. To reset the selection, reload the HTML page in your browser. 
Section 1: Between array comparison 
- Figure 1: Distances between arrays. 
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Figure 1 (PDF file) shows a false color heatmap of the distances between arrays. The color scale is chosen to cover 
the range of distances encountered in the dataset. Patterns in this plot can indicate clustering of the arrays either 
because of intended biological or unintended experimental factors (batch effects). The distance dab between two arrays 
a and b is computed as the mean absolute difference (Li- distance) between the data of the arrays (using the data from 
all probes without filtering). In formula, dab = mean I Mai - Mb; I, where Mai is the value of the -1h probe on the a-th array. 
Outlier detection was performed by looking for arrays for which the sum of the distances to all other arrays, Sa = Fb dab 
was exceptionally large. No such arrays were detected. 
- Figure 2: Outlier detection for Distances between arrays. 
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Figure 2 (PDF file) shows a bar chart of the sum of distances to other arrays Sa, the outlier detection criterion from the 
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4/16/13 arrayQualityMetrics report for BSData.vsn.rsn 
previous figure. The bars are shown in the original order of the arrays. Based on the distribution of the values across all 
arrays, a threshold of 4.83 was determined, which is indicated by the vertical line. None of the arrays exceeded the 
threshold and was considered an outlier. 
- Figure 3: Principal Component Analysis. 
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Figure 3 (PDF file) shows a scatterplot of the arrays along the first two principal components. You can use this plot to 
explore if the arrays cluster, and whether this is according to an intended experimental factor, or according to 
unintended causes such as batch effects. Move the mouse over the points to see the sample names. 
Principal component analysis is a dimension reduction and visualisation technique that is here used to project the 
multivariate data vector of each array into a two -dimensional plot, such that the spatial arrangement of the points in the 
plot reflects the overall data (dis)similarity between the arrays. 
Note: the figure is static - enhancement with interactive effects failed. This is either due to a version incompatibility of 
the 'SVGAnnotation' R package and your version of 'Cairo' or 'libcairo', or due to plot misformating. Please consult the 
Bioconductor mailing list, or contact the maintainer of ' arrayQualityMetrics' with a reproducible example in order to fix 
this problem. 
Section 2: Array intensity distributions 
- Figure 4: Boxplots. 
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Figure 4 (PDF f shows boxplots representing summaries of the signal intensity distributions of the arrays. Each box 
corresponds to one array. Typically, one expects the boxes to have similar positions and widths. if the distribution of an 
array is very different from the others, this may indicate an experimental problem. Outlier detection was performed by 
computing the Kolmogorov- Smirnov statistic Ka between each array's distribution and the distribution of the pooled data. 
- Figure 5: Outlier detection for Boxplots. 
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Figure 5 (PDF file) shows a bar chart of the Kolmogorov -Smimov statistic Ka, the outlier detection criterion from the 
previous figure. The bars are shown in the original order of the arrays. Based on the distribution of the values across all 
arrays, a threshold of 0.0332 was determined, which is indicated by the vertical line. None of the arrays exceeded the 
threshold and was considered an outlier. 
- Figure 6: Density plots. 
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Figure 6 (PDF file) shows density estimates (smoothed histograms) of the data. Typically, the distributions of the 
arrays should have similar shapes and ranges. Arrays whose distributions are very different from the others should be 
considered for possible problems. Various features of the distributions can be indicative of quality related phenomena. 
For instance, high levels of background will shift an array's distribution to the right. Lack of signal diminishes its right 
right tail. A bulge at the upper end of the intensity range often indicates signal saturation. 
Section 3: Variance mean dependence 
- Figure 7: Standard deviation versus rank of the mean. 
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Figure 7 (PDF file) shows a density plot of the standard deviation of the intensities across arrays on the y -axis versus 
the rank of their mean on the x -axis. The red dots, connected by lines, show the running median of the standard 
deviation. After normalisation and transformation to a logarithm( -like) scale, one typically expects the red line to be 
approximately horizontal, that is, show no substantial trend. In some cases, a hump on the right hand of the x -axis can 
be observed and is symptomatic of a saturation of the intensities. 
Section 4: Individual array quality 
- Figure 8: MA plots. 
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Figure 8 (PDF file) shows MA plots. M and A are defined as: 
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M =109201) - 1092(12) 
A = 1/2 (log2(11) +log2(12)), 
where It is the intensity of the array studied, and 12 is the intensity of a "pseudo" -array that consists of the median 
across arrays. Typically, we expect the mass of the distribution in an MA plot to be concentrated along the M = 0 axis, 
and there should be no trend in M as a function of A. If there is a trend in the lower range of A, this often indicates that 
the arrays have different background intensities; this may be addressed by background correction. A trend in the upper 
range of A can indicate saturation of the measurements; in mild cases, this may be addressed by non -linear 
normalisation (e.g. quantile normalisation). 
Outlier detection was performed by computing Hoeffding's statistic Da on the joint distribution of A and M for each array. 
Shown are the 4 arrays with the highest value of Da (top row), and the 4 arrays with the lowest value (bottom row). The 
value of Da is shown in the panel headings. 0 arrays had Da>0.15 and were marked as outliers. For more information on 
Hoeffing's D- statistic, please see the manual page of the function hoeffd in the Hmisc package. 
- Figure 9: Outlier detection for MA plots. 
s 
I I I I I I I I 
0.02 0.04 0.06 0.06 0.10 0.12 0.14 0.16 
Figure 9 (PDF file) shows a bar chart of the Hoef f ding's statistic Da, the outlier detection criterion from the previous 
figure. The bars are shown in the original order of the arrays. A threshold of 0.15 was used, which is indicated by the 
vertical line. None of the arrays exceeded the threshold and was considered an outlier. 
This report has been created with arrayQualityMetrics 3.8.0 under Pt version 2.13.0 (2011- 04 -13). 
(Page generated on Fri Dec 9 13:39:42 2011 by hwdter ) 
localhost/Users/s0898113/Dropbox/litoMicroarray/ProcessingAndExpressionSet/.../index.html 7/7 
13 -1. arrayQualityMetrics report for normalized microarray data from the L. 
sigmodontis infectoin time course presented in chapter 7. 
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A5 -1. Gene expression profiles of expressed receptor tryosine kinase proteins 
(GO:0004714) in the RNA -Seq dataset generated in Chapter 5. 
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A5 -2. Gene expression profiles of expressed receptor tryosine kinase proteins 
(GO:0004714) in the L. sigmodontis microarray time course presented in Chapter 7. 
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APPENDIX 6 - RESEARCH OUTPUT ARISING FROM 
THIS THESIS AT THE TIME OF SUBMISSION 
Aspects of the work within this thesis has been presented at the following conferences: 
"Immunology and Metabolism" - Oral presentation. January 2011. CIML, Marseille, France. 
BSI congress - Poster presentation - December 2011. Liverpool, UK. 
The Biology of Cytokines - Poster presentation. February 2012. Keystone, Colorado, USA. 
Chapter 2 of this thesis has been published in Blood and can be accessed under the 
following citation: 
Thomas, G.D., Rückerl, D., Maskrey, B.H., Whitfield, P.D., Blaxter, M.L., and Allen, J.E. 
(2012). The biology of nematode- and IL -4Ra- dependent murine macrophage polarization 
in vivo as defined by RNA -Seq and targeted lipidomics. Blood. 
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